Allergies: A Wikipedia Guide
Allergies: A Wikipedia Guide
Allergies: A Wikipedia Guide
A Wikipedia Guide
PDF generated using the open source mwlib toolkit. See http://code.pediapress.com/ for more information. PDF generated at: Mon, 14 May 2012 22:04:56 UTC
Contents
Articles
Overview
Allergy Allergen Aeroallergen Allergic inflammation Anaphylaxis 1 1 17 23 26 28 37 37 48 49 53 56 58 64 65 67 69 75 88 88 92 93 96 97 100 102 102 105 111 114
Food Allergies
Food allergy Corn allergy Egg allergy Milk allergy Fruit allergy Peanut allergy Seafood allergy Soy allergy Tree nut allergy Wheat allergy Gluten sensitivity
Other Allergies
Allergic contact dermatitis Drug allergy Latex allergy Insect sting allergy Cat allergy Perfume allergy
Testing
Skin allergy test Patch test RAST test
References
Article Sources and Contributors Image Sources, Licenses and Contributors 141 144
Article Licenses
License 145
Overview
Allergy
Allergy
Classification and external resources
Hives are a common allergic symptom. ICD-10 ICD-9 DiseasesDB MedlinePlus eMedicine MeSH T78.4 995.3 33481 [1] [2] [3] [4] [5]
000812
med/1101 D006967
[6]
An allergy is a hypersensitivity disorder of the immune system.[7] Allergic reactions occur when a person's immune system reacts to normally harmless substances in the environment. A substance that causes a reaction is called an allergen. These reactions are acquired, predictable, and rapid. Allergy is one of four forms of hypersensitivity and is formally called type I (or immediate) hypersensitivity. Allergic reactions are distinctive because of excessive activation of certain white blood cells called mast cells and basophils by a type of antibody called Immunoglobulin E (IgE). This reaction results in an inflammatory response which can range from uncomfortable to dangerous. Mild allergies like hay fever are very common in the human population and cause symptoms such as red eyes, itchiness, and runny nose, eczema, hives, or an asthma attack. Allergies can play a major role in conditions such as asthma. In some people, severe allergies to environmental or dietary allergens or to medication may result in life-threatening reactions called anaphylaxis. Food allergies, and reactions to the venom of stinging insects such as wasps and bees are often associated with these severe reactions.[8] A variety of tests exist to diagnose allergic conditions. These include placing possible allergens on the skin and looking for a reaction such as swelling. Blood tests can also be done to look for an allergen-specific IgE.
Allergy Treatments for allergies include avoiding known allergens, use of medications such as anti-histamines that specifically prevent allergic reactions, steroids that modify the immune system in general, and medications such as decongestants that reduce the symptoms. Many of these medications are taken by mouth, though epinephrine, which is used to treat anaphylactic reactions, is injected. Immunotherapy uses injected allergens to desensitize the body's response.
Many allergens such as dust or pollen are airborne particles. In these cases, symptoms arise in areas in contact with air, such as eyes, nose, and lungs. For instance, allergic rhinitis, also known as hay fever, causes irritation of the nose, sneezing, itching, and redness of the eyes.[9] Inhaled allergens can also lead to asthmatic symptoms, caused by narrowing of the airways (bronchoconstriction) and increased production of mucus in the lungs, shortness of breath (dyspnea), coughing and wheezing.[10] Aside from these ambient allergens, allergic reactions can result from foods, insect stings, and reactions to medications like aspirin and antibiotics such as penicillin. Symptoms of food allergy include abdominal pain, bloating, vomiting, diarrhea, itchy skin, and swelling of the skin during hives. Food allergies rarely cause respiratory (asthmatic) reactions, or rhinitis.[11] Insect stings, antibiotics, and certain medicines produce a systemic allergic response that is also called anaphylaxis; multiple organ systems can be affected, including the digestive system, the respiratory system, and the circulatory system.[12][13][14] Depending on the rate of severity, it can cause cutaneous reactions, bronchoconstriction, edema, hypotension, coma, and even death. This type of reaction can be triggered suddenly, or the onset can be delayed. The severity of this type of allergic response often requires injections of epinephrine, sometimes through a device known as the EpiPen or Twinject auto-injector. The nature of anaphylaxis is such that the reaction can seem to be subsiding, but may recur throughout a prolonged period of time.[14] Substances that come into contact with the skin, such as latex, are also common causes of allergic reactions, known as contact dermatitis or eczema.[15] Skin allergies frequently cause rashes, or swelling and inflammation within the skin, in what is known as a "wheal and flare" reaction characteristic of hives and angioedema.[16]
Allergy
Cause
Risk factors for allergy can be placed in two general categories, namely host and environmental factors.[17] Host factors include heredity, gender, race, and age, with heredity being by far the most significant. However, there have been recent increases in the incidence of allergic disorders that cannot be explained by genetic factors alone. Four major environmental candidates are alterations in exposure to infectious diseases during early childhood, environmental pollution, allergen levels, and dietary changes.[18]
Foods
One of the most common food allergies is a sensitivity to peanuts. Peanut allergies may be extremely severe, but can sometimes be outgrown by children school-age.[19] Tree nuts, including pecans, pistachios, pine nuts, and walnuts, are another common allergen. Sufferers may be sensitive to one, or many, tree nuts.[20] Also seeds, including sesame seeds and poppy seeds, contain oils where protein is present, which may elicit an allergic reaction.[20] Egg allergies affect one to two percent of children but are outgrown by about two-thirds of children by the age of 5.[21] The sensitivity is usually to proteins in the white rather than the yolk.[20] Milk, from cows, goats, or sheep, is another common allergy-causing food, and many sufferers are also unable to tolerate dairy products such as cheese. Lactose intolerance, a common reaction to milk, is not in fact a form of allergy. A small portion of children with a milk allergy, roughly ten percent, will have a reaction to beef. Beef contains a small amount of protein that is present in cow's milk.[22] Other foods containing allergenic proteins include soy, wheat, fish, shellfish, fruits, vegetables, spices, synthetic and natural colors, chicken, and chemical additives.
Non-food proteins
Latex can trigger an IgE-mediated cutaneous, respiratory, and systemic reaction. The prevalence of latex allergy in the general population is believed to be less than one percent. In a hospital study, one in 800 surgical patients (0.125 percent) report latex sensitivity, although the sensitivity among healthcare workers is higher, between seven and ten percent. Researchers attribute this higher level to the exposure of healthcare workers to areas with significant airborne latex allergens, such as operating rooms, intensive-care units, and dental suites. These latex-rich environments may sensitize healthcare workers who regularly inhale allergenic proteins.[23] The most prevalent response to latex is an allergic contact dermatitis, a delayed hypersensitive reaction appearing as dry, crusted lesions. This reaction usually lasts 48 to 96 hours. Sweating or rubbing the area under the glove aggravates the lesions, possibly leading to ulcerations.[23] Anaphylactic reactions occur most often in sensitive patients, who have been exposed to the surgeon's latex gloves during abdominal surgery, but other mucosal exposures, such as dental procedures, can also produce systemic reactions.[23] Latex and banana sensitivity may cross-react; furthermore, patients with latex allergy may also have sensitivities to avocado, kiwifruit, and chestnut.[24] These patients often have perioral itching and local urticaria. Only occasionally have these food-induced allergies induced systemic responses. Researchers suspect that the cross-reactivity of latex with banana, avocado, kiwifruit, and chestnut occurs because latex proteins are structurally homologous with some plant proteins.[23]
Allergy reaction between urushiol and membrane proteins includes redness, swelling, papules, vesicles, blisters, and streaking.[27] Estimates vary on the percentage of the population that will have an immune system response. Approximately 25 percent of the population will have a strong allergic response to urushiol. In general, approximately 80 percent to 90 percent of adults will develop a rash if they are exposed to .0050 milligrams (expected operatorexpected operatorexpected operatorexpected operatorexpected operatorexpected operatorexpected operatorexpected operatorexpected operatorexpected operatorexpected operatorexpected operatorexpected operatorexpected operator105gr) of purified urushiol, but some people are so sensitive that it takes only a molecular trace on the skin to initiate an allergic reaction.[28]
Genetic basis
Allergic diseases are strongly familial: identical twins are likely to have the same allergic diseases about 70% of the time; the same allergy occurs about 40% of the time in non-identical twins.[29] Allergic parents are more likely to have allergic children,[30] and their allergies are likely to be more severe than those from non-allergic parents. Some allergies, however, are not consistent along genealogies; parents who are allergic to peanuts may have children who are allergic to ragweed. It seems that the likelihood of developing allergies is inherited and related to an irregularity in the immune system, but the specific allergen is not.[30] The risk of allergic sensitization and the development of allergies varies with age, with young children most at risk.[31] Several studies have shown that IgE levels are highest in childhood and fall rapidly between the ages of 10 and 30 years.[31] The peak prevalence of hay fever is highest in children and young adults and the incidence of asthma is highest in children under 10.[32] Overall, boys have a higher risk of developing allergy than girls,[30] although for some diseases, namely asthma in young adults, females are more likely to be affected.[33] Sex differences tend to decrease in adulthood.[30] Ethnicity may play a role in some allergies; however, racial factors have been difficult to separate from environmental influences and changes due to migration.[30] It has been suggested that different genetic loci are responsible for asthma, to be specific, in people of European, Hispanic, Asian, and African origins.[34]
Hygiene hypothesis
Allergic diseases are caused by inappropriate immunological responses to harmless antigens driven by a TH2-mediated immune response. Many bacteria and viruses elicit a TH1-mediated immune response, which down-regulates TH2 responses. The first proposed mechanism of action of the hygiene hypothesis was that insufficient stimulation of the TH1 arm of the immune system leads to an overactive TH2 arm, which in turn leads to allergic disease.[35] In other words, individuals living in too sterile an environment are not exposed to enough pathogens to keep the immune system busy. Since our bodies evolved to deal with a certain level of such pathogens, when they are not exposed to this level, the immune system will attack harmless antigens and thus normally benign microbial objects like pollen will trigger an immune response.[36] The hygiene hypothesis was developed to explain the observation that hay fever and eczema, both allergic diseases, were less common in children from larger families, which were, it is presumed, exposed to more infectious agents through their siblings, than in children from families with only one child. The hygiene hypothesis has been extensively investigated by immunologists and epidemiologists and has become an important theoretical framework for the study of allergic disorders. It is used to explain the increase in allergic diseases that have been seen since industrialization, and the higher incidence of allergic diseases in more developed countries. The hygiene hypothesis has now expanded to include exposure to symbiotic bacteria and parasites as important modulators of immune system development, along with infectious agents. Epidemiological data support the hygiene hypothesis. Studies have shown that various immunological and autoimmune diseases are much less common in the developing world than the industrialized world and that
Allergy immigrants to the industrialized world from the developing world increasingly develop immunological disorders in relation to the length of time since arrival in the industrialized world.[37] Longitudinal studies in the third world demonstrate an increase in immunological disorders as a country grows more affluent and, it is presumed, cleaner.[38] The use of antibiotics in the first year of life has been linked to asthma and other allergic diseases.[39] The use of antibacterial cleaning products has also been associated with higher incidence of asthma, as has birth by Caesarean section rather than vaginal birth.[40][41]
Pathophysiology
Allergy
In the early stages of allergy, a type I hypersensitivity reaction against an allergen encountered for the first time and presented by a professional Antigen-Presenting Cell causes a response in a type of immune cell called a TH2 lymphocyte, which belongs to a subset of T cells that produce a cytokine called interleukin-4 (IL-4). These TH2 cells interact with other lymphocytes called B cells, whose role is production of antibodies. Coupled with signals provided by IL-4, this interaction stimulates the B cell to begin production of a large amount of a particular type of antibody known as IgE. Secreted IgE circulates in the blood and binds to an IgE-specific receptor (a kind of Fc receptor called FcRI) on the surface of other kinds of immune cells called mast cells and basophils, which are both involved in the acute inflammatory response. The IgE-coated cells, at this stage are sensitized to the allergen.[18]
Degranulation process in allergy. Second exposure to allergen.1 - antigen; 2 - IgE antibody; 3 - FcRI receptor; 4 - preformed mediators (histamine, proteases, chemokines, heparine); 5 granules; 6 - mast cell; 7 - newly formed mediators (prostaglandins, leukotrienes, thromboxanes, PAF)
If later exposure to the same allergen occurs, the allergen can bind to the IgE molecules held on the surface of the mast cells or basophils. Cross-linking of the IgE and Fc receptors occurs when more than one IgE-receptor complex interacts with the same allergenic molecule, and activates the sensitized cell. Activated mast cells and basophils undergo a process called degranulation, during which they release histamine and other inflammatory chemical mediators (cytokines, interleukins, leukotrienes, and prostaglandins) from their granules into the surrounding tissue causing several systemic effects, such as vasodilation, mucous secretion, nerve stimulation, and smooth muscle contraction. This results in rhinorrhea, itchiness, dyspnea, and anaphylaxis. Depending on the individual, allergen, and mode of introduction, the symptoms can be system-wide (classical anaphylaxis), or localized to particular body systems; asthma is localized to the respiratory system and eczema is localized to the dermis.[18]
Late-phase response
After the chemical mediators of the acute response subside, late phase responses can often occur. This is due to the migration of other leukocytes such as neutrophils, lymphocytes, eosinophils and macrophages to the initial site. The reaction is usually seen 224 hours after the original reaction.[50] Cytokines from mast cells may also play a role in the persistence of long-term effects. Late phase responses seen in asthma are slightly different from those seen in other allergic responses, although they are still caused by release of mediators from eosinophils, and are still dependent on activity of TH2 cells.[51]
Allergy
Diagnosis
Before a diagnosis of allergic disease can be confirmed, the other possible causes of the presenting symptoms should be carefully considered.[52] Vasomotor rhinitis, for example, is one of many maladies that shares symptoms with allergic rhinitis, underscoring the need for professional differential diagnosis.[53] Once a diagnosis of asthma, rhinitis, anaphylaxis, or other allergic disease has been made, there are several methods for discovering the causative agent of that allergy. Effective management of allergic diseases relies on the ability to make an accurate diagnosis.[54] Allergy testing can help confirm/rule out allergies and consequently reduce adverse reactions and limit unnecessary avoidance and medications.[55][56] Correct diagnosis, counseling and avoidance advice based on valid allergy test results will help reduce the incidence of symptoms, medications and improve quality of life.[55] For assessing the presence of allergen-specific IgE antibodies, you can use two different methodsa skin prick test or an allergy blood test. Both methods are recommended by the NIH guidelines and have similar diagnostic value in terms of sensitivity and specificity.[56][57]
An allergy testing machine being operated in the diagnostic immunology lab at Lackland Air Force Base
A healthcare provider can use the test results to identify the specific allergic triggers that may be contributing to the symptoms. Using this information, along with a physical examination and case history, the doctor can diagnose the cause of the symptoms and tailor treatments that will help the patient feel better. A negative result can help the doctor rule out allergies in order to consider other possible. NIH Guidelines state that: sIgE tests are useful for identifying foods potentially provoking IgE-mediated food-induced allergic reactions, and specified cutoff levels, defined as 95% predictive values, may be more predictive than skin prick tests of clinical reactivity in certain populations. It further states, sIgE tests are very useful for detecting the presence of sIgE antibodies, which indicates the presence of allergic sensitization. Fluorescence-labeled antibody assays have comparable sensitivity to that of skin prick tests, and the absolute levels of sIgE antibodies may directly correlate with the likelihood of clinical reactivity when compared with oral food challenges for the identification of foods provoking IgE mediated FA.[58] According to NICE Guidelines, skin prick tests and blood tests are equally cost-effective and health economic evidence show that both the IgE antibody test and the skin prick test were cost effective compared with no test.[55] Also, earlier and more accurate diagnoses save cost due to reduced GP consultations, referrals to secondary care, misdiagnosis and emergency admissions.[59] Allergy undergoes dynamic changes over time. Regular allergy testing of relevant allergens provides information on if and how patient management can be changed, in order to improve health and quality of life. Annual testing is often the practice for determining whether allergy to milk, egg, soy, and wheat have been outgrown and the testing interval is extended to 2 to 3 years for allergy to peanut, tree nuts, fish, and crustacean shellfish.[56] Results of follow-up testing can guide decision-making regarding whether and when it is safe to introduce or re-introduce allergenic food into the diet.[58]
Allergy
Skin testing
Skin testing is also known as "puncture testing" and "prick testing" due to the series of tiny puncture or pricks made into the patient's skin. Small amounts of suspected allergens and/or their extracts (pollen, grass, mite proteins, peanut extract, etc.) are introduced to sites on the skin marked with pen or dye (the ink/dye should be carefully selected, lest it cause an allergic response itself). A small plastic or metal device is used to puncture or prick the skin. Sometimes, the allergens are injected "intradermally" into the patient's skin, with a needle and syringe. Common areas for testing include the inside forearm and the back. If the patient is allergic to the substance, then a visible inflammatory reaction will usually occur within 30minutes. This response will range from slight reddening of the skin to a full-blown hive (called "wheal and flare") in more sensitive patients similar to a mosquito bite. Interpretation of the results of the skin prick test is normally done by allergists on a scale of severity, with +/- meaning borderline reactivity, and 4+ being a large reaction. Increasingly, allergists are measuring and recording the diameter of the wheal and flare reaction. Interpretation by well-trained allergists is often guided by relevant literature.[60] Some patients may believe they have determined their own allergic sensitivity from observation, but a skin test has been shown to be much better than patient observation to detect allergy.[61]
If a serious life threatening anaphylactic reaction has brought a patient in for evaluation, some allergists will prefer an initial blood test prior to performing the skin prick test. Skin tests may not be an option if the patient has widespread skin disease or has taken antihistamines sometime the last several days.
Blood testing
An allergy blood test is quick and simple and can be ordered by a licensed health care provider e.g. an allergy specialist, GP or PED. Unlike skin-prick testing, a blood test can be performed irrespective of age, skin condition, medication, symptom, disease activity and pregnancy. Adults and children of any age can take an allergy blood test. For babies and very young children, a single needle stick for allergy blood testing is often more gentle than several skin tests. An allergy blood test is available through most laboratories, and a sample of the patients blood is sent to a laboratory for analysis and the results are sent back a few days later. Multiple allergens can be detected with a single blood sample. Allergy blood tests are very safe, since you are not exposed to any allergens during the testing procedure. How does the test work? The test measures the concentration of specific IgE antibodies in the blood. Quantitative IgE test results increases the possibility of ranking how different substances may affect your symptoms. A general rule of thumb is that the higher the IgE antibody value, the greater the likelihood of symptoms. Allergens found at low levels that today do not result in symptoms can nevertheless help predict future symptom development. The quantitative allergy blood result can help determine what a patient is allergic to, help predict and follow the disease development, estimate the risk of a severe reaction and explain cross-reactivity.[62][63]
Allergy A low total IgE level is not adequate to rule out sensitization to commonly inhaled allergens.[64] Statistical methods, such as ROC curves, predictive value calculations, and likelihood ratios have been used to examine the relationship of various testing methods to each other. These methods have shown that patients with a high total IgE have a high probability of allergic sensitization, but further investigation with allergy tests for specific IgE antibodies for a carefully chosen of allergens is often warranted. History Radiometric assays include the radioallergosorbent test (RAST) test method, which uses IgE-binding (anti-IgE) antibodies labeled with radioactive isotopes for quantifying the levels of IgE antibody in the blood.[65] Other newer methods use colorimetric or fluorescence-labeled technology in the place of radioactive isotopes. The market-leading RAST methodology was invented and marketed in 1974 by Pharmacia Diagnostics AB, Uppsala, Sweden, and the acronym RAST is actually a brand name. In 1989, Pharmacia Diagnostics AB replaced it with a superior test named the ImmunoCAP Specific IgE blood test, which uses the newer fluorescence-labeled technology. American College of Allergy Asthma and Immunology (ACAAI) and the American Academy of Allergy Asthma and Immunology (AAAAI) issued the Joint Task Force Report Pearls and pitfalls of allergy diagnostic testing in 2008, and is firm in its statement that the term RAST is now obsolete: The term RAST became a colloquialism for all varieties of (in vitro allergy) tests. This is unfortunate because it is well recognized that there are well-performing tests and some that do not perform so well, yet they are all called RASTs, making it difficult to distinguish which is which. For these reasons, it is now recommended that use of RAST as a generic descriptor of these tests be abandoned.[66] The new version, the ImmunoCAP Specific IgE blood test, is the only specific IgE assay to receive FDA approval to quantitatively report to its detection limit of 0.1kU/l.
Other
Challenge testing: Challenge testing is when small amounts of a suspected allergen are introduced to the body orally, through inhalation, or other routes. Except for testing food and medication allergies, challenges are rarely performed. When this type of testing is chosen, it must be closely supervised by an allergist. Elimination/Challenge tests: This testing method is utilized most often with foods or medicines. A patient with a particular suspected allergen is instructed to modify his/her diet to totally avoid that allergen for determined period of time. If the patient experiences significant improvement, he/she may then be challenged by reintroducing the allergen to see if symptoms can be reproduced. Patch testing: Patch testing is used to help ascertain the cause of skin contact allergy, or contact dermatitis. Adhesive patches, usually treated with a number of different commonly allergic chemicals or skin sensitizers, are applied to the back. The skin is then examined for possible local reactions at least twice, usually at 48 hours after application of the patch, and again two or three days later. Some "screening" test methods are intended to provide qualitative test results, giving a "yes" or "no" answer in patients with suspected allergic sensitization. One such method has a sensitivity of about 70.8% and a positive predictive value of 72.6% according to a large study.[67] Unreliable tests: There are other types of allergy testing methods that the American Academy of Allergy, Asthma, and Immunology considers to be unacceptable. These unreliable allergy testing methods are: Applied kinesiology (allergy testing through muscle relaxation), Cytotoxicity testing, Urine autoinjection, Skin titration (Rinkel method), and Provocative and neutralization (subcutaneous) testing or sublingual provocation[68]
Allergy
10
Management
In recent times, there have been enormous improvements in the medical practices used to treat allergic conditions. With respect to anaphylaxis and hypersensitivity reactions to foods, drugs, and insects and in allergic skin diseases, advances have included the identification of food proteins to which IgE binding is associated with severe reactions and development of low-allergen foods, improvements in skin prick test predictions; evaluation of the atopy patch test; in wasp sting outcomes predictions and a rapidly disintegrating epinephrine tablet, and anti-IL-5 for eosinophilic diseases.[69] Traditional treatment and management of allergies consisted simply of avoiding the allergen in question or otherwise reducing exposure. For instance, people with cat allergies were encouraged to avoid them. However, while avoidance of allergens may reduce symptoms and avoid life-threatening anaphylaxis, it is difficult to achieve for those with pollen or similar air-borne allergies. Nonetheless, strict avoidance of allergens is still considered a useful treatment method, and is often used in managing food allergies. New technology approaches to decreasing IgE overproduction, and regulating histimine release in allergic individuals have demonstrated statisitically significant reduction on Total Nasel Symptom Scores.[70][71]
Medication
Several antagonistic drugs are used to block the action of allergic mediators, or to prevent activation of cells and degranulation processes. These include antihistamines, glucocorticoids, epinephrine (adrenaline), theophylline and cromolyn sodium. Anti-leukotrienes, such as Montelukast (Singulair) or Zafirlukast (Accolate), are FDA approved for treatment of allergic diseases. Anti-cholinergics, decongestants, mast cell stabilizers, and other compounds thought to impair eosinophil chemotaxis, are also commonly used. These drugs help to alleviate the symptoms of allergy, and are imperative in the recovery of acute anaphylaxis, but play little role in chronic treatment of allergic disorders.
Immunotherapy
Desensitization or hyposensitization is a treatment in which the person is gradually vaccinated with progressively larger doses of the allergen in question. This can either reduce the severity or eliminate hypersensitivity altogether. It relies on the progressive skewing of IgG antibody production, to block excessive IgE production seen in atopys. In a sense, the person builds up immunity to increasing amounts of the allergen in question. Studies have demonstrated the long-term efficacy and the preventive effect of immunotherapy in reducing the development of new allergy.[72] Meta-analyses have also confirmed Anti-allergy immunotherapy efficacy of the treatment in allergic rhinitis in children[73] and in asthma.[74] A review by the Mayo Clinic in Rochester confirmed the safety and efficacy of allergen immunotherapy for allergic rhinitis and conjunctivitis, allergic forms of asthma, and stinging insect based on numerous well-designed scientific studies.[75] In addition, national and international guidelines confirm the clinical efficacy of injection immunotherapy in rhinitis and asthma, as well as the safety, provided that recommendations are followed.[76] A second form of immunotherapy involves the intravenous injection of monoclonal anti-IgE antibodies. These bind to free and B-cell associated IgE; signalling their destruction. They do not bind to IgE already bound to the Fc receptor on basophils and mast cells, as this would stimulate the allergic inflammatory response. The first agent of this class is Omalizumab. While this form of immunotherapy is very effective in treating several types of atopy, it should not be used in treating the majority of people with food allergies.
Allergy A third type, Sublingual immunotherapy, is an orally-administered therapy that takes advantage of oral immune tolerance to non-pathogenic antigens such as foods and resident bacteria. This therapy currently accounts for 40 percent of allergy treatment in Europe. In the United States, sublingual immunotherapy is gaining support among traditional allergists and is endorsed by doctors treating allergy.[77] Allergy shot treatment is the closest thing to a cure for allergic symptoms. This therapy requires a long-term commitment.
11
Other
An experimental treatment, enzyme potentiated desensitization (EPD), has been tried for decades but is not generally accepted as effective.[78] EPD uses dilutions of allergen and an enzyme, beta-glucuronidase, to which T-regulatory lymphocytes are supposed to respond by favouring desensitization, or down-regulation, rather than sensitization. EPD has also been tried for the treatment of autoimmune diseases but is not approved by the U.S. Food and Drug Administration or of proven effectiveness.[78] Systematic literature searches conducted by the Mayo Clinic through 2006, involving hundreds of articles studying multiple conditions, including asthma and upper respiratory tract infection, showed no effectiveness of homeopathic treatments and no difference compared with placebo. The authors concluded that, based on rigorous clinical trials of all types of homeopathy for childhood and adolescence ailments, there is no convincing evidence that supports the use of homeopathic treatments.[79]
Epidemiology
Many diseases related to inflammation such as type 1 diabetes, rheumatoid arthritis, and allergic diseases hay fever and asthma have increased in the Western world over the past 2-3 decades.[80] Rapid increases in allergic asthma and other atopic disorders in industrialized nations, it is estimated, began in the 1960s and 1970s, with further increases occurring during the 1980s and 1990s,[81] although some suggest that a steady rise in sensitization has been occurring since the 1920s.[82] The incidence of atopy in developing countries has, in general, remained much lower.[81]
Allergic conditions: Statistics and Epidemiology Allergytype Allergicrhinitis 35.9 million
[84]
United Kingdom )
[83]
3.3 million (about 5.5% of the [86] population ) 5.7 million (about 9.4%). In six and seven year olds asthma increased from 18.4% to 20.9% over five years, during the same time the rate decreased from 31% to 24.7% in 13 to 14 year olds. 5.8 million (about 1% severe).
Asthma
10 million suffer from allergic asthma (about 3% of the population). The prevalence of asthma increased 75% from 1980-1994. Asthma prevalence is 39% higher in [87] African Americans than in Europeans. About 9% of the population. Between 1960 and 1990 prevalence has increased from 3% to 10% in [88] children. At least 40 deaths per year due to insect venom. About 400 deaths due to penicillin anaphylaxis. About 220 cases of anaphylaxis and 3 deaths per year are due to [89] latex allergy. An estimated 150 people die annually [90] from anaphylaxis due to food allergy.
Atopic eczema
Anaphylaxis
Between 1999 and 2006, 48 deaths occurred in people ranging from five months to 85 years old.
Allergy
12
Unknown
Insect venom
Around 15% of adults have mild, localized allergic reactions. Systemic reactions occur in 3% of adults and [91] less than 1% of children.
Anaphylactic reactions to penicillin cause 400 deaths per Unknown year. About 6% of US children under age 3 and 3.5-4% of the overall US population. Peanut and/or tree nut (e.g. walnut) allergy affects about three million Americans, or [90] 1.1% of the population. Unknown 5-7% of infants and 1-2% of adults. A 117.3% increase in peanut allergies was observed from 2001 to 2005, an estimated 25,700 people in England are affected. 2.3 million (about 3.7%), prevalence has increased by 48.9% between 2001 and [92] 2005.
Although genetic factors fundamentally govern susceptibility to atopic disease, increases in atopy have occurred within too short a time frame to be explained by a genetic change in the population, thus pointing to environmental or lifestyle changes.[81] Several hypotheses have been identified to explain this increased prevalence; increased exposure to perennial allergens due to housing changes and increasing time spent indoors, and changes in cleanliness or hygiene that have resulted in the decreased activation of a common immune control mechanism, coupled with dietary changes, obesity and decline in physical exercise.[80] The hygiene hypothesis maintains[93] that high living standards and hygienic conditions exposes children to fewer infections. It is thought that reduced bacterial and viral infections early in life direct the maturing immune system away from TH1 type responses, leading to unrestrained TH2 responses that allow for an increase in allergy.[47][94] Changes in rates and types of infection alone however, have been unable to explain the observed increase in allergic disease, and recent evidence has focused attention on the importance of the gastrointestinal microbial environment. Evidence has shown that exposure to food and fecal-oral pathogens, such as hepatitis A, Toxoplasma gondii, and Helicobacter pylori (which also tend to be more prevalent in developing countries), can reduce the overall risk of atopy by more than 60%,[95] and an increased prevalence of parasitic infections has been associated with a decreased prevalence of asthma.[96] It is speculated that these infections exert their effect by critically altering TH1/TH2 regulation.[97] Important elements of newer hygiene hypotheses also include exposure to endotoxins, exposure to pets and growing up on a farm.[97]
History
The concept of "allergy" was originally introduced in 1906 by the Viennese pediatrician Clemens von Pirquet, after he noted that some of his patients were hypersensitive to normally innocuous entities such as dust, pollen, or certain foods.[98] Pirquet called this phenomenon "allergy" from the Ancient Greek words allos meaning "other" and ergon meaning "work".[99] All forms of hypersensitivity used to be classified as allergies, and all were thought to be caused by an improper activation of the immune system. Later, it became clear that several different disease mechanisms were implicated, with the common link to a disordered activation of the immune system. In 1963, a new classification scheme was designed by Philip Gell and Robin Coombs that described four types of hypersensitivity reactions, known as Type I to Type IV hypersensitivity.[100] With this new classification, the word "allergy" was restricted to type I hypersensitivities (also called immediate hypersensitivity), which are characterized as rapidly developing reactions. A major breakthrough in understanding the mechanisms of allergy was the discovery of the antibody class labeled immunoglobulin E (IgE) - Kimishige Ishizaka and co-workers were the first to isolate and describe IgE in the 1960s.[101]
Allergy
13
Medical specialty
An allergist is a physician specially trained to manage and treat allergies, asthma and the other allergic diseases. In the United States physicians holding certification by the American Board of Allergy and Immunology (ABAI) have successfully completed an accredited educational program and an evaluation process, including a secure, proctored examination to demonstrate the knowledge, skills, and experience to the provision of patient care in allergy and immunology.[102] Becoming an allergist/immunologist requires completion of at least nine years of training. After completing medical school and graduating with a medical degree, a physician will then undergo three years of training in internal medicine (to become an internist) or pediatrics (to become a pediatrician). Once physicians have finished training in one of these specialties, they must pass the exam of either the American Board of Pediatrics (ABP) or the American Board of Internal Medicine (ABIM). Internists or pediatricians wishing to focus on the sub-specialty of allergy-immunology then complete at least an additional two years of study, called a fellowship, in an allergy/immunology training program. Allergist/immunologists listed as ABAI-certified have successfully passed the certifying examination of the American Board of Allergy and Immunology (ABAI), following their fellowship.[103] In the United Kingdom, allergy is a subspecialty of general medicine or pediatrics. After obtaining postgraduate exams (MRCP or MRCPCH respectively), a doctor works for several years as a specialist registrar before qualifying for the General Medical Council specialist register. Allergy services may also be delivered by immunologists. A 2003 Royal College of Physicians report presented a case for improvement of what were felt to be inadequate allergy services in the UK.[104] In 2006, the House of Lords convened a subcommittee that reported in 2007. It concluded likewise that allergy services were insufficient to deal with what the Lords referred to as an "allergy epidemic" and its social cost; it made several other recommendations.[105]
References
[1] [2] [3] [4] [5] [6] [7] http:/ / apps. who. int/ classifications/ icd10/ browse/ 2010/ en#/ T78. 4 http:/ / www. icd9data. com/ getICD9Code. ashx?icd9=995. 3 http:/ / www. diseasesdatabase. com/ ddb33481. htm http:/ / www. nlm. nih. gov/ medlineplus/ ency/ article/ 000812. htm http:/ / www. emedicine. com/ med/ topic1101. htm http:/ / www. nlm. nih. gov/ cgi/ mesh/ 2011/ MB_cgi?field=uid& term=D006967 " allergy (http:/ / web. archive. org/ web/ 20090616022448/ http:/ / www. mercksource. com/ pp/ us/ cns/ cns_hl_dorlands_split. jsp?pg=/ ppdocs/ us/ common/ dorlands/ dorland/ one/ 000002984. htm)" at Dorland's Medical Dictionary [8] Kay AB (2000). "Overview of 'allergy and allergic diseases: with a view to the future'". Br. Med. Bull. 56 (4): 84364. doi:10.1258/0007142001903481. PMID11359624. [9] Bope, Edward T.; Rakel, Robert E. (2005). Conn's Current Therapy 2005. Philadelphia, PA: W.B. Saunders Company. p.880. ISBN0-7216-3864-3. [10] Holgate ST (1998). "Asthma and allergydisorders of civilization?". QJM 91 (3): 17184. doi:10.1093/qjmed/91.3.171. PMID9604069. [11] Rusznak C, Davies RJ (1998). "ABC of allergies. Diagnosing allergy". BMJ 316 (7132): 6869. PMC1112683. PMID9522798. [12] Golden DB (2007). "Insect sting anaphylaxis". Immunol Allergy Clin North Am 27 (2): 26172, vii. doi:10.1016/j.iac.2007.03.008. PMC1961691. PMID17493502. [13] Schafer JA, Mateo N, Parlier GL, Rotschafer JC (2007). "Penicillin allergy skin testing: what do we do now?". Pharmacotherapy 27 (4): 5425. doi:10.1592/phco.27.4.542. PMID17381381. [14] Tang AW (2003). "A practical guide to anaphylaxis". Am Fam Physician 68 (7): 132532. PMID14567487. [15] Brehler R, Ktting B (2001). "Natural rubber latex allergy: a problem of interdisciplinary concern in medicine". Arch. Intern. Med. 161 (8): 105764. doi:10.1001/archinte.161.8.1057. PMID11322839. [16] Muller BA (2004). "Urticaria and angioedema: a practical approach". Am Fam Physician 69 (5): 11238. PMID15023012. [17] Grammatikos AP (2008). "The genetic and environmental basis of atopic diseases". Ann. Med. 40 (7): 48295. doi:10.1080/07853890802082096. PMID18608118. [18] Janeway, Charles; Paul Travers, Mark Walport, and Mark Shlomchik (2001). Immunobiology; Fifth Edition (http:/ / www. ncbi. nlm. nih. gov/ books/ bv. fcgi?call=bv. View. . ShowTOC& rid=imm. TOC& depth=10). New York and London: Garland Science. pp.e-book. ISBN978-0-8153-4101-7. . [19] Sicherer 62 [20] Sicherer 63
Allergy
[21] Jrvinen KM, Beyer K, Vila L, Bardina L, Mishoe M, Sampson HA. (July 2007). "Specificity of IgE antibodies to sequential epitopes of hen's egg ovomucoid as a marker for persistence of egg allergy". J. Allergy. 2007 Jul;62(7):758-65. 62 (7): 75865. doi:10.1111/j.1398-9995.2007.01332.x. PMID17573723. [22] Sicherer 64 [23] Gordon L. Sussman, MD, FRCP; Donald H. Beezhold. "Allergy to Latex Rubber" (http:/ / www. annals. org/ content/ 122/ 1/ 43. full?ijkey=46e082703bf84e8d542fd6f767a7e39fe11c03e4& keytype2=tf_ipsecsha). Annals of Internal Medicine. vol. 122 no. 1 4346. [24] Fernndez de Corres L, Moneo I, Muoz D, et al. (January 1993). "Sensitization from chestnuts and bananas in patients with urticaria and anaphylaxis from contact with latex". Ann Allergy 70 (1): 359. PMID7678724. [25] C. Michael Hogan. Western poison-oak: Toxicodendron diversilobum (http:/ / globaltwitcher. auderis. se/ artspec_information. asp?thingid=82914). GlobalTwitcher, ed. Nicklas Stromberg. 2008. Retrieved 30 April 2010. [26] Keeler, Harriet L. (1900). Our Native Trees and How to Identify Them. New York: Charles Scriber's Sons. pp. 9496; Frankel, Edward, Ph.D. Poison Ivy, Poison Oak, Poison Sumac and Their Relatives; Pistachios, Mangoes and Cashews. The Boxwood Press. Pacific Grove, Calif. 1991. ISBN 978-0-940168-18-3. [27] DermAtlas -1892628434 (http:/ / dermatlas. med. jhmi. edu/ derm/ result. cfm?Diagnosis=-1892628434) [28] Armstrong W.P., Epstein W.L. (1995). Herbalgram (American Botanical Council) 34: 3642. cited in http:/ / waynesword. palomar. edu/ ww0802. htm [29] Galli SJ (2000). "Allergy". Curr. Biol. 10 (3): R935. doi:10.1016/S0960-9822(00)00322-5. PMID10679332. [30] De Swert LF (1999). "Risk factors for allergy". Eur. J. Pediatr. 158 (2): 8994. doi:10.1007/s004310051024. PMID10048601. [31] Croner S (1992). "Prediction and detection of allergy development: influence of genetic and environmental factors". J. Pediatr. 121 (5 Pt 2): S5863. doi:10.1016/S0022-3476(05)81408-8. PMID1447635. [32] Jarvis D, Burney P (1997). "Epidemiology of atopy and atopic disease". In Kay AB. Allergy and allergic diseases. 2. London: Blackwell Science. pp.120824. [33] Anderson HR, Pottier AC, Strachan DP (1992). "Asthma from birth to age 23: incidence and relation to prior and concurrent atopic disease". Thorax 47 (7): 53742. doi:10.1136/thx.47.7.537. PMC463865. PMID1412098. [34] Barnes KC, Grant AV, Hansel NN, Gao P, Dunston GM (2007). "African Americans with asthma: genetic insights" (http:/ / pats. atsjournals. org/ cgi/ content/ full/ 4/ 1/ 58). Proc Am Thorac Soc 4 (1): 5868. doi:10.1513/pats.200607-146JG. PMC2647616. PMID17202293. Archived (http:/ / www. webcitation. org/ 5uHp4cu2P) from the original on 2010-11-16. . [35] Folkerts G, Walzl G, Openshaw PJ (March 2000). "Do common childhood infections 'teach' the immune system not to be allergic?" (http:/ / linkinghub. elsevier. com/ retrieve/ pii/ S0167569900015826). Immunol. Today 21 (3): 11820. doi:10.1016/S0167-5699(00)01582-6. PMID10777250. . [36] The Hygiene Hypothesis Edward Willett (http:/ / edwardwillett. com/ 2000/ 05/ the-hygiene-hypothesis/ ) [37] Gibson PG, Henry RL, Shah S, Powell H, Wang H (September 2003). "Migration to a western country increases asthma symptoms but not eosinophilic airway inflammation". Pediatr. Pulmonol. 36 (3): 20915. doi:10.1002/ppul.10323. PMID12910582. [38] Addo-Yobo EO, Woodcock A, Allotey A, Baffoe-Bonnie B, Strachan D, Custovic A (February 2007). "Exercise-induced bronchospasm and atopy in Ghana: two surveys ten years apart" (http:/ / medicine. plosjournals. org/ perlserv/ ?request=get-document& doi=10. 1371/ journal. pmed. 0040070). PLoS Med. 4 (2): e70. doi:10.1371/journal.pmed.0040070. PMC1808098. PMID17326711. Archived (http:/ / www. webcitation. org/ 5uHp7R4nP) from the original on 2010-11-16. . Retrieved 2008-07-06. [39] Marra F, Lynd L, Coombes M "et al." (2006). "Does antibiotic exposure during infancy lead to development of asthma?: a systematic review and metaanalysis". Chest 129 (3): 6108. doi:10.1378/chest.129.3.610. PMID16537858. [40] Thavagnanam S, Fleming J, Bromley A, Shields MD, Cardwell, CR (2007). "A meta-analysis of the association between Caesarean section and childhood asthma". Clin. And Exper. Allergy 38 (4): 629. doi:10.1111/j.1365-2222.2007.02780.x. PMID18352976. [41] Zock JP, Plana E, Jarvis D "et al." (2007). "The use of household cleaning sprays and adult asthma: an international longitudinal study". Am J Respir Crit Care Med 176 (8): 73541. doi:10.1164/rccm.200612-1793OC. PMC2020829. PMID17585104. [42] Cooper PJ (2004). "Intestinal worms and human allergy". Parasite Immunol. 26 (1112): 45567. doi:10.1111/j.0141-9838.2004.00728.x. PMID15771681. [43] Braun-Fahrlnder C, Riedler J, Herz U, et al (2002). "Environmental exposure to endotoxin and its relation to asthma in school-age children". N. Engl. J. Med. 347 (12): 86977. doi:10.1056/NEJMoa020057. PMID12239255. [44] Garn H, Renz H (2007). "Epidemiological and immunological evidence for the hygiene hypothesis". Immunobiology 212 (6): 44152. doi:10.1016/j.imbio.2007.03.006. PMID17544829. [45] Macpherson CN, Gottstein B, Geerts S (2000). "Parasitic food-borne and water-borne zoonoses". Rev. - Off. Int. Epizoot. 19 (1): 24058. PMID11189719. [46] Carvalho EM, Bastos LS, Arajo MI (2006). "Worms and allergy". Parasite Immunol. 28 (10): 52534. doi:10.1111/j.1365-3024.2006.00894.x. PMID16965288. [47] Yazdanbakhsh M, Kremsner PG, van Ree R (2002). "Allergy, parasites, and the hygiene hypothesis". Science 296 (5567): 4904. doi:10.1126/science.296.5567.490. PMID11964470. [48] Emanuelsson C, Spangfort MD (2007). "Allergens as eukaryotic proteins lacking bacterial homologues". Mol. Immunol. 44 (12): 325660. doi:10.1016/j.molimm.2007.01.019. PMID17382394. [49] Falcone FH, Pritchard DI (2005). "Parasite role reversal: worms on trial". Trends Parasitol. 21 (4): 15760. doi:10.1016/j.pt.2005.02.002. PMID15780835.
14
Allergy
[50] Grimbaldeston MA, Metz M, Yu M, Tsai M, Galli SJ (2006). "Effector and potential immunoregulatory roles of mast cells in IgE-associated acquired immune responses". Curr. Opin. Immunol. 18 (6): 75160. doi:10.1016/j.coi.2006.09.011. PMID17011762. [51] Holt PG, Sly PD (2007). "Th2 cytokines in the asthma late-phase response". Lancet 370 (9596): 13968. doi:10.1016/S0140-6736(07)61587-6. PMID17950849. [52] Allergic and Environmental Asthma (http:/ / www. emedicine. com/ med/ topic3390. htm#) at eMedicine - Includes discussion of differentials [53] Wheeler PW, Wheeler SF (2005). "Vasomotor rhinitis" (http:/ / www. aafp. org/ afp/ 20050915/ 1057. html). American Family Physician 72 (6): 105762. PMID16190503. . [54] Portnoy, JM, et al. Evidence-based Allergy Diagnostic Tests, Current Allergy and Asthma Reports 2006, 6:455-461 [55] NICE Diagnosis and assessment of food allergy in children and young people in primary care and community settings, 2011 [56] Boyce J et al. Guidelines for the Diagnosis and Management of Food Allergy in the United States: Report of NIAID-Sponsored Expert Panel. J Allergy Clin Immunol 2010; 126: S1S58 [57] Cox, L. Overview of Serological-Specific IgE Antibody Testing in Children. Pediatric Allergy and Immunology. 2011. [58] NIH Guidelines for the Diagnosis and Management of Food Allergy in the United States. Report of the NIAID- Sponsored Expert Panel, 2010, NIH Publication no. 11-7700. [59] Food Allergy in children and young people. Costing report. Implementing NICE guidance, 2011. http:/ / guidance. nice. org. uk/ CG116/ CostingReport/ pdf/ English [60] Verstege A, Mehl A, Rolinck-Werninghaus C, et al (2005). "The predictive value of the skin prick test weal size for the outcome of oral food challenges". Clin. Exp. Allergy 35 (9): 12206. doi:10.1111/j.1365-2222.2005.2324.x. PMID16164451. [61] Li JT, Andrist D, Bamlet WR, Wolter TD (2000). "Accuracy of patient prediction of allergy skin test results". Ann. Allergy Asthma Immunol. 85 (5): 3824. doi:10.1016/S1081-1206(10)62550-1. PMID11101180. [62] Yunginger J et alQuantitative IgE antibody assays in allergic disease. J Allergy Clin Immunol 2000; 105: 107784. [63] Sampson H et al. Utility of food-specific IgE concentrations in predictin symptomatic food allergy. J Allergy Clin Immunol 2001; 107: 8916. [64] Kerkhof M, Dubois AE, Postma DS, Schouten JP, de Monchy JG (2003). "Role and interpretation of total serum IgE measurements in the diagnosis of allergic airway disease in adults". Allergy 58 (9): 90511. doi:10.1034/j.1398-9995.2003.00230.x. PMID12911420. [65] Ten RM, Klein JS, Frigas E (1995). "Allergy skin testing" (http:/ / www. mayoclinicproceedings. com/ inside. asp?AID=3978& UID=). Mayo Clin. Proc. 70 (8): 7834. PMID7630219. . [66] Cox, et al. Pearls and pitfalls of allergy diagnostic testing. Annals of Allergy, Asthma & Immunology. 2008. 101(6): 580-592 [67] Vidal C, Gude F, Boquete O, et al (2005). "Evaluation of the phadiatop test in the diagnosis of allergic sensitization in a general adult population". Journal of Investigational Allergology and Clinical Immunology 15 (2): 12430. PMID16047713. [68] "Allergy Diagnosis" (http:/ / www. theonlineallergist. com/ index. php/ article/ allergy_diagnosis/ ). Archived (http:/ / www. webcitation. org/ 5uHp4q48S) from the original on 2010-11-16. .The Online Allergist. Retrieved 2010-10-25. [69] Sicherer SH, Leung DY (2007). "Advances in allergic skin disease, anaphylaxis, and hypersensitivity reactions to foods, drugs, and insects". J. Allergy Clin. Immunol. 119 (6): 14629. doi:10.1016/j.jaci.2007.02.013. PMID17412401. [70] Funada, U.; Wada, M.; Kawata, T.; Tanaka, N.; Tadokoro, T.; Maekawa, A. (2000). "Effect of Cobalamin on the Allergic Response in Mice". Bioscience, Biotechnology, and Biochemistry 64 (10): 2053. doi:10.1271/bbb.64.2053. [71] Funada, U.; Wada, M.; Kawata, T.; Mori, K.; Tamai, H.; Isshiki, T.; Onoda, J.; Tanaka, N. et al (2001). "Vitamin B-12-Deficiency Affects Immunoglobulin Production and Cytokine Levels in Mice". International Journal for Vitamin and Nutrition Research 071: 0060. doi:10.1024/0300-9831.71.1.60. [72] Ross RN, Nelson HS, Finegold I (2000). "Effectiveness of specific immunotherapy in the treatment of allergic rhinitis: an analysis of randomized, prospective, single- or double-blind, placebo-controlled studies". Clinical therapeutics 22 (3): 34250. doi:10.1016/S0149-2918(00)80038-7. PMID10963288. [73] Penagos, M; Compalati, E, Tarantini, F, Baena-Cagnani, R, Huerta, J, Passalacqua, G, Canonica, GW (August 2006). "Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years of age: a meta-analysis of randomized, placebo-controlled, double-blind trials.". Annals of Allergy, Asthma & Immunology 97 (2): 1418. PMID16937742. [74] Abramson, MJ; Puy, RM, Weiner, JM (April 1995). "Is allergen immunotherapy effective in asthma? A meta-analysis of randomized controlled trials.". American Journal of Respiratory and Critical care Medicine 151 (4): 96974. PMID7697274. [75] Rank MA, Li JT (September 2007). "Allergen immunotherapy". Mayo Clin. Proc. 82 (9): 111923. doi:10.4065/82.9.1119. PMID17803880. [76] Passalacqua G, Durham SR (2007). "Allergic rhinitis and its impact on asthma update: allergen immunotherapy". J. Allergy Clin. Immunol. 119 (4): 88191. doi:10.1016/j.jaci.2007.01.045. PMID17418661. [77] Canonica GW, Bousquet J, Casale T, Lockey R, Baena-Cagnani C et al (December 2009). "Sublingual Immunotherapy: World Allergy Organization Position Paper 2009" (http:/ / www. worldallergy. org/ publications/ slit-wao-pp_final. pdf). Allergy 64 (Suppl. 91): 159. doi:10.1111/j.1398-9995.2009.02309.x. PMID20041860. . [78] Terr AI (2004). "Unproven and controversial forms of immunotherapy". Clinical allergy and immunology 18: 70310. PMID15042943. [79] Altun U, Pittler MH, Ernst E (2007). "Homeopathy for childhood and adolescence ailments: systematic review of randomized clinical trials". Mayo Clin. Proc. 82 (1): 6975. doi:10.4065/82.1.69. PMID17285788.
15
Allergy
[80] Platts-Mills TA, Erwin E, Heymann P, Woodfolk J (2005). "Is the hygiene hypothesis still a viable explanation for the increased prevalence of asthma?". Allergy 60 Suppl 79: 2531. doi:10.1111/j.1398-9995.2005.00854.x. PMID15842230. [81] Bloomfield SF, Stanwell-Smith R, Crevel RW, Pickup J (2006). "Too clean, or not too clean: the hygiene hypothesis and home hygiene". Clin. Exp. Allergy 36 (4): 40225. doi:10.1111/j.1365-2222.2006.02463.x. PMC1448690. PMID16630145. [82] Isolauri E, Huurre A, Salminen S, Impivaara O (2004). "The allergy epidemic extends beyond the past few decades". Clin. Exp. Allergy 34 (7): 100710. doi:10.1111/j.1365-2222.2004.01999.x. PMID15248842. [83] "Chapter 4: The Extent and Burden of Allergy in the United Kingdom" (http:/ / www. publications. parliament. uk/ pa/ ld200607/ ldselect/ ldsctech/ 166/ 16607. htm). House of Lords - Science and Technology - Sixth Report. 2007-07-24. Archived (http:/ / www. webcitation. org/ 5uHp5735j) from the original on 2010-11-16. . Retrieved 2007-12-03. [84] "AAAAI - rhinitis, sinusitis, hay fever, stuffy nose, watery eyes, sinus infection" (http:/ / www. aaaai. org/ patients/ gallery/ rhinitissinusitis. asp?item=1a). Archived (http:/ / www. webcitation. org/ 5uHp3eXFl) from the original on 2010-11-16. . Retrieved 2007-12-03. [85] Based on an estimated population of 303 million in 2007 U.S. POPClock (http:/ / www. census. gov/ population/ www/ popclockus. html). U.S. Census Bureau. [86] Based on an estimated population of 60.6 million UK population grows to 60.6 million (http:/ / www. statistics. gov. uk/ cci/ nugget. asp?id=6) [87] "AAAAI - asthma, allergy, allergies, prevention of allergies and asthma, treatment for allergies and asthma" (http:/ / www. aaaai. org/ patients/ gallery/ prevention. asp?item=1a). Archived (http:/ / www. webcitation. org/ 5uHp3Vl6G) from the original on 2010-11-16. . Retrieved 2007-12-03. [88] "AAAAI - skin condition, itchy skin, bumps, red irritated skin, allergic reaction, treating skin condition" (http:/ / www. aaaai. org/ patients/ gallery/ skinallergies. asp?item=1a). Archived (http:/ / www. webcitation. org/ 5uHp44ryd) from the original on 2010-11-16. . Retrieved 2007-12-03. [89] "AAAAI - anaphylaxis, cause of anaphylaxis, prevention, allergist, anaphylaxis statistics" (http:/ / www. aaaai. org/ patients/ gallery/ anaphylaxis. asp?item=1a). Archived (http:/ / www. webcitation. org/ 5uHp2tbzO) from the original on 2010-11-16. . Retrieved 2007-12-03. [90] "AAAAI - food allergy, food reactions, anaphylaxis, food allergy prevention" (http:/ / www. aaaai. org/ patients/ gallery/ foodallergy. asp?item=1a). Archived (http:/ / www. webcitation. org/ 5uHp6IGEJ) from the original on 2010-11-16. . Retrieved 2007-12-03. [91] "AAAAI - stinging insect, allergic reaction to bug bite, treatment for insect bite" (http:/ / www. aaaai. org/ patients/ gallery/ insect. asp?item=1a). Archived (http:/ / www. webcitation. org/ 5uHp4Ecxt) from the original on 2010-11-16. . Retrieved 2007-12-03. [92] Simpson CR, Newton J, Hippisley-Cox J, Sheikh A (2008). "Incidence and prevalence of multiple allergic disorders recorded in a national primary care database". J Roy Soc Med 101 (11): 558563. doi:10.1258/jrsm.2008.080196. PMC2586863. PMID19029357. [93] Strachan DP (1989). "Hay fever, hygiene, and household size". BMJ 299 (6710): 125960. doi:10.1136/bmj.299.6710.1259. PMC1838109. PMID2513902. [94] Renz H, Blmer N, Virna S, Sel S, Garn H (2006). "The immunological basis of the hygiene hypothesis". Chem Immunol Allergy. Chemical Immunology and Allergy 91: 3048. doi:10.1159/000090228. ISBN3-8055-8000-2. PMID16354947. [95] Matricardi PM, Rosmini F, Riondino S, et al (2000). "Exposure to foodborne and orofecal microbes versus airborne viruses in relation to atopy and allergic asthma: epidemiological study". BMJ 320 (7232): 4127. doi:10.1136/bmj.320.7232.412. PMC27285. PMID10669445. [96] Masters S, Barrett-Connor E (1985). "Parasites and asthmaredictive or protective?". Epidemiol Rev 7: 4958. PMID4054238. [97] Sheikh A, Strachan DP (2004). "The hygiene theory: fact or fiction?". Curr Opin Otolaryngol Head Neck Surg 12 (3): 2326. doi:10.1097/01.moo.0000122311.13359.30. PMID15167035. [98] Clemens Peter Pirquet von Cesenatico (http:/ / www. whonamedit. com/ Doctor. cfm/ 2382. html) at Who Named It? [99] Von Pirquet C (1906). "Allergie". Munch Med Wochenschr 53 (5): 1457. PMID20273584. [100] Gell PGH, Coombs RRA. (1963). Clinical Aspects of Immunology. London: Blackwell. [101] Ishizaka K, Ishizaka T, Hornbrook MM (1966). "Physico-chemical properties of human reaginic antibody. IV. Presence of a unique immunoglobulin as a carrier of reaginic activity". J. Immunol. 97 (1): 7585. PMID4162440. [102] "ABAI: American Board of Allergy and Immunology" (http:/ / www. abai. org/ training. asp). Archived (http:/ / www. webcitation. org/ 5uHp4Xiak) from the original on 2010-11-16. . Retrieved 2007-08-05. [103] "AAAAI - What is an Allergist?" (http:/ / www. aaaai. org/ media/ resources/ allergist. asp). Archived (http:/ / www. webcitation. org/ 5uHp3JDDM) from the original on 2010-11-16. . Retrieved 2007-08-05. [104] Royal College of Physicians (2003). Allergy: the unmet need. London, UK: Royal College of Physicians. ISBN 978-1-86016-183-4. PDF version (http:/ / www. rcplondon. ac. uk/ pubs/ contents/ 81e384d6-0328-4653-9cc2-2aa7baa3c56a. pdf)PDF(1.03MB) [105] House of Lords - Science and Technology Committee (2007). Allergy - HL 166-I, 6th Report of Session 2006-07 - Volume 1: Report (http:/ / www. publications. parliament. uk/ pa/ ld200607/ ldselect/ ldsctech/ 166/ 16602. htm). London, UK: TSO (The Stationery Office). ISBN978-0-10-401149-2. .
16
Allergy
17
External links
American Academy of Allergy, Asthma & Immunology (http://www.aaaai.org)
Allergen
An allergen is any substance that can cause an allergy. In technical terms, an allergen is an antigen capable of stimulating a type-I hypersensitivity reaction in atopic individuals through Immunoglobulin E (IgE) responses.[1]. Most humans mount significant Immunoglobulin E responses only as a defense against parasitic infections. However, some individuals may respond to many common environmental antigens. This hereditary predisposition is called atopy. In atopic individuals, non-parasitic antigens stimulate inappropriate IgE production, leading to type I hypersensitivity. Sensitivities vary widely from one person (or other animal) to another. A very broad range of substances can be allergens to sensitive individuals.
Types of allergies
Allergens can be found in a variety of sources, such as dust mite excretion, pollen, pet dander or even royal jelly.[2] Food allergies are not as common as food sensitivity, but some foods such as peanuts (a legume), nuts, seafood and shellfish are the cause of serious allergies in many people. Officially, the United States Food and Drug Administration does recognize eight foods as being common for allergic reactions in a large segment of the sensitive population. These include peanuts, tree nuts, eggs, milk, shellfish, fish, wheat and their derivatives, and soy and their derivatives, as well as sulfites (chemical based, often found in flavors and colors in foods) at 10ppm and over. See the FDA website for complete details. It should be noted that other countries, in view of the differences in the genetic profiles of their citizens and different levels of exposure to specific foods due to different dietary habits, the "official" allergen list will change. Canada recognizes all eight of the allergens recognized by the US, and also recognizes sesame seeds,[3] and mustard.[4] The European Union additionally recognizes celery. Another type of allergen is urushiol, a resin produced by poison ivy and poison oak. It causes the skin rash condition known as urushiol-induced contact dermatitis by changing a skin cell's configuration so that it is no longer recognized by the immune system as part of the body. A little over half of North Americans are known to be allergic to urushiol and repeated exposure can increase one's sensitivity to the allergen. An allergic reaction can be caused by any form of direct contact with the allergenconsuming food or drink one is sensitive to (ingestion), breathing in pollen, perfume or pet dander (inhalation), or brushing a body part against an allergy-causing plant (direct contact, generally resulting in hives). Other common causes of serious allergy are wasp, fire ant and bee stings, penicillin, and latex. An extremely serious form of an allergic reaction is called anaphylaxis. One form of treatment is the administration of sterile epinephrine to the person experiencing anaphylaxis, which suppresses the body's overreaction to the allergen, and allows for the patient to be transported to a medical facility.
Fungal allergens
In 1952 basidiospores were described as being possible airborne allergens[5] and were linked to asthma in 1969.[6] Basidiospores are the dominant airborne fungal allergens. Fungal allergies are associated with seasonal asthma.[7][8] They are considered to be a major source of airborne allergens.[9] The basidospore family include mushrooms, rusts, smuts, brackets, and puffballs. The airborne spores from mushrooms reach levels comparable to those of mold and pollens. The levels of mushroom respiratory allergy are as high as 30 percent of those with allergic disorder, but it is believed to be less than 1 percent of food allergies.[10][11] Heavy rainfall (which increases fungal spore release) is associated with increased hospital admissions of children with asthma.[12] A study in New Zealand found that 22
Allergen percent of patients with respiratory allergic disorders tested positive for basidiospores allergies.[13] Mushroom spore allergies can cause either immediate allergic symptomatology or delayed allergic reactions. Those with asthma are more likely to have immediate allergic reactions and those with allergic rhinitis are more likely to have delayed allergic responses.[14] A study found that 27 percent of patients were allergic to basidiomycete mycelia extracts and 32 percent were allergic to basidiospore extracts, thus demonstrating the high incidence of fungal sensitisation in individuals with suspected allergies.[15] It has been found that of basidiomycete cap, mycelia, and spore extracts that spore extracts are the most reliable extract for diagnosing basidiomycete allergy.[16][17] In Canada, 8% of children attending allergy clinics were found to be allergic to Ganoderma, a basidiospore.[18] Pleurotus ostreatus,[19] cladosporium,[20] and calvatia cyathiformis are significant airborne spores.[9] Other significant fungal allergens include aspergillus and alternaria-penicillin families.[21] In India fomes pectinatis is a predominant air-borne allergen affecting up to 22 percent of patients with respiratory allergies.[22] Some fungal air-bourne allergens such as coprinus comatus are associated with worsening of eczematous skin lesions.[23] Children who are born during autumn months (during fungal spore season) are more likely to develop asthmatic symptoms later in life.[24]
18
Common allergens
In addition to foreign proteins found in foreign serum (from blood transfusions) and vaccines, common allergens include: Animal products Fel d 1 (cat allergy) fur and dander cockroach calyx wool dust mite excretion Drugs penicillin sulfonamides salicylates (also found naturally in numerous fruits) Foods celery and celeriac [25] corn or maize eggs (typically albumen, the white) fruit pumpkin legumes beans peas peanuts soybeans milk seafood sesame soy
The house dust mite, its feces and chitin are common allergens around the home
Allergen tree nuts pecans almonds wheat Insect stings bee sting venom wasp sting venom mosquito stings Mold spores Other latex metal Plant pollens (hay fever) grass ryegrass, timothy-grass weeds ragweed, plantago, nettle, artemisia vulgaris, chenopodium album, sorrel trees birch, alder, hazel, hornbeam, aesculus, willow, poplar, platanus, tilia, olea, Ashe juniper
19
Seasonal allergies
Seasonal allergy symptoms are commonly experienced part of the year, usually during spring, summer or fall when certain trees or grasses pollinate. This depends on the kind of tree or grass. For instance, some trees such as oak, elm, and maple pollinate in the spring, while grasses such as Bermuda, timothy and orchard pollinate in the summer. Grass allergy is generally linked to hay fever because their symptoms and causes are somehow similar to each other. Symptoms include rhinitis, which causes sneezing and a runny nose, as well as allergic conjunctivitis, which includes watering and itchy eyes.[26] Also an initial tickle on the roof of the mouth or in the back of the throat may be experienced. Also, depending on the season, the symptoms may be more severe and people may experience coughing, wheezing, and irritability. A few people even become depressed, lose their appetite, or have problems sleeping. Moreover, since the sinuses may also become congested, some people experience headaches.[27] If both parents suffered from allergies in the past, there is a 66% chance for the individual to suffer from seasonal allergies, and the risk lowers to 60% if just one parent had suffered from allergies. The immune system also has strong influence on seasonal allergies, since it reacts differently to diverse allergens like pollen. When an allergen enters the body of an individual that is predisposed to allergies, it triggers an immune reaction and the production of antibodies. These allergen antibodies migrate to mast cells lining the nose, eyes and lungs. When an allergen drifts into the nose more than once, mast cells release a slew of chemicals or histamines that irritate and inflame the moist membranes lining the nose and produce the symptoms of an allergic reaction: scratchy throat, itching, sneezing and watery eyes. Some symptoms that differentiate allergies from a cold include[28]: No fever or muscle ache. Mucous secretions are runny and clear. Sneezes occurring in rapid and several sequences. Itchy throat, ears and nose. These symptoms usually last longer than 710 days.
Among seasonal allergies, there are some allergens that fuse together and produce a new type of allergy. For instance, grass pollen allergens cross-react with food allergy proteins in vegetables such as onion, lettuce, carrots, celery and corn. Besides, the cousins of birch pollen allergens, like apples, grapes, peaches, celery and apricots, produce severe itching in the ears and throat. The cypress pollen allergy brings a cross reactivity between diverse
Allergen species like olive, privet, ash and Russian olive tree pollen allergens. In some rural areas there is another form of seasonal grass allergy, combining airborne particles of pollen mixed with mold.[29] Recent research has suggested that humans might develop allergies as a defense to fight off parasites. According to Yale University Immunologist Dr Ruslan Medzhitov, protease allergens cleave the same sensor proteins that evolved to detect proteases produced by the parasitic worms.[30] Additionally, a new report on seasonal allergies called Extreme allergies and Global Warming, have found that many allergy triggers are worsening due to climate change. 16 states in the United States were named as Allergen Hotspots for large increases in allergenic tree pollen if global warming pollution keeps increasing. Therefore, researchers on this report claimed that global warming is bad news for millions of asthmatics in the United States whose asthma attacks are triggered by seasonal allergies.[31] Indeed, seasonal allergies are one of the main triggers for asthma, along with colds or flu, cigarette smoke and exercise. In Canada, for example, up to 75% of asthmatics also have seasonal allergies.[32]
20
Treatment
Treatment includes over-the-counter medications, antihistamines, nasal decongestants, allergy shots, and alternative medicine. In the case of nasal symptoms, antihistamines are normally the first option. They may be taken together with pseudoephedrine to help relieve a stuffy nose and they can stop the itching and sneezing. Some over-the-counter options are Benadryl and Tavist. However, these antihistamines may cause extreme drowsiness, therefore, people are advised to not operate heavy machinery or drive while taking this kind of medication. Other side effects include dry mouth, blurred vision, constipation, difficulty with urination, confusion, and light-headedness.[35] There is also a newer second generation of antihistamines that are generally classified as the "non-sedating antihistamines" or anti-drowsy, which include cetirizine, loratadine, and fexofenadine.[36] An example of nasal decongestants is pseudoephedrine and its side-effects include insomnia, restlessness, and difficulty urinating. Some other nasal sprays are available by prescription, including Azelastine and Ipratropium. Some of their side-effects include drowsiness. For eye symptoms, it is important to first bath the eyes with plain eyewashes to reduce the irritation. People should not wear contact lenses during episodes of conjunctivitis. Allergy shots, also called immunotherapy, are also available and are especially recommended for people who cannot tolerate allergy medications or who severe symptoms, and also for those who develop asthma during pollen season.
Allergen Immunotherapy contains a small amount of the substance that triggers the allergic reactions after the pollen season to get prepared for the next season.
[37]
Natural remedies are another option that patients look to for relief. One of the most popular recently is the European herb butterbur (Petasites hybridus). The British Medical Journal published a study in which Swiss researchers proved how one tablet of butterbur four times daily was as effective as an antihistamine in controlling symptoms of hay fever. On a second study, a group of British researchers gave their approval to butterbur's effectiveness in battling symptoms of grass allergy. Other herbal supplements that function as remedies include freeze-dried nettles (Urtica) and a tonic made from the goldenseal herb (Hydrastis candiensis), which doctors recommend in addition to saline nasal spray (another natural remedy).[38]
Links
General information on allergy and allergens [39] Allermatch - Sequence comparison to allergenic proteins [40] SDAP - Structural database of allergenic proteins [41] Allergome Database [42] Allergen Nomenclature [43]
References
[1] Goldsby, Richard A., et al.,Immunology. 5th ed. New York: W.H. Freeman [2] Rosmilah, M; et al. (December 2008). "Characterization of major allergens of royal jelly Apis mellifera". Trop Biomed 25 (3): 24351. PMID19287364. [3] "Health Canada: Food Allergies" (http:/ / www. hc-sc. gc. ca/ fn-an/ securit/ allerg/ index_e. html). . Retrieved 2007-06-09. [4] "CFIA: Revised Labelling Regulations for Food Allergens, Gluten Sources and Sulphites (Amendments to the Food and Drug Regulations)" (http:/ / www. inspection. gc. ca/ english/ fssa/ labeti/ allerg/ 20110216inde. shtml). . Retrieved 2011-02-28. [5] GREGORY, PH.; HIRST, JM. (Sep 1952). "Possible role of basidiospores as air-borne allergens". Nature 170 (4323): 414414. doi:10.1038/170414a0. PMID12993181. [6] Herxheimer, H.; Hyde, HA.; Williams, DA. (Jul 1969). "Allergic asthma caused by basidiospores". Lancet 2 (7612): 1313. PMID4183245. [7] Hasnain, SM.; Wilson, JD.; Newhook, FJ. (May 1985). "Fungal allergy and respiratory disease". N Z Med J 98 (778): 3426. PMID3858721. [8] Levetin, E. (Apr 1989). "Basidiospore identification". Ann Allergy 62 (4): 30610. PMID2705657. [9] Horner, WE.; Lopez, M.; Salvaggio, JE.; Lehrer, SB. (1991). "Basidiomycete allergy: identification and characterization of an important allergen from Calvatia cyathiformis". Int Arch Allergy Appl Immunol 94 (14): 359361. doi:10.1159/000235403. PMID1937899. [10] Sprenger, JD.; Altman, LC.; O'Neil, CE.; Ayars, GH.; Butcher, BT.; Lehrer, SB. (Dec 1988). "Prevalence of basidiospore allergy in the Pacific Northwest". J Allergy Clin Immunol 82 (6): 10761080. doi:10.1016/0091-6749(88)90146-7. PMID3204251. [11] Koivikko, A.; Savolainen, J. (Jan 1988). "Mushroom allergy". Allergy 43 (1): 110. doi:10.1111/j.1398-9995.1988.tb02037.x. PMID3278649. [12] Khot, A.; Burn, R.; Evans, N.; Lenney, W.; Storr, J. (Jul 1988). "Biometeorological triggers in childhood asthma". Clin Allergy 18 (4): 351358. doi:10.1111/j.1365-2222.1988.tb02882.x. PMID3416418. [13] Hasnain, SM.; Wilson, JD.; Newhook, FJ.; Segedin, BP. (May 1985). "Allergy to basidiospores: immunologic studies". N Z Med J 98 (779): 3936. PMID3857522. [14] Santilli, J.; Rockwell, WJ.; Collins, RP. (Sep 1985). "The significance of the spores of the Basidiomycetes (mushrooms and their allies) in bronchial asthma and allergic rhinitis". Ann Allergy 55 (3): 46971. PMID4037433. [15] Lehrer, SB.; Lopez, M.; Butcher, BT.; Olson, J.; Reed, M.; Salvaggio, JE. (Sep 1986). "Basidiomycete mycelia and spore-allergen extracts: skin test reactivity in adults with symptoms of respiratory allergy". J Allergy Clin Immunol 78 (3 Pt 1): 478485. doi:10.1016/0091-6749(86)90036-9. PMID3760405. [16] Weissman, DN.; Halmepuro, L.; Salvaggio, JE.; Lehrer, SB. (1987). "Antigenic/allergenic analysis of basidiomycete cap, mycelia, and spore extracts". Int Arch Allergy Appl Immunol 84 (1): 5661. doi:10.1159/000234398. PMID3623711. [17] Liengswangwong, V.; Salvaggio, JE.; Lyon, FL.; Lehrer, SB. (May 1987). "Basidiospore allergens: determination of optimal extraction methods". Clin Allergy 17 (3): 191198. doi:10.1111/j.1365-2222.1987.tb02003.x. PMID3608137. [18] Tarlo, SM.; Bell, B.; Srinivasan, J.; Dolovich, J.; Hargreave, FE. (Jul 1979). "Human sensitization to Ganoderma antigen". J Allergy Clin Immunol 64 (1): 4349. doi:10.1016/0091-6749(79)90082-4. PMID447950. [19] Lopez, M.; Butcher, BT.; Salvaggio, JE.; Olson, JA.; Reed, MA.; McCants, ML.; Lehrer, SB. (1985). "Basidiomycete allergy: what is the best source of antigen?". Int Arch Allergy Appl Immunol 77 (12): 169170. doi:10.1159/000233775. PMID4008070.
Allergen
[20] Stephen, E.; Raftery, AE.; Dowding, P. (Aug 1990). "Forecasting spore concentrations: a time series approach". Int J Biometeorol 34 (2): 8789. doi:10.1007/BF01093452. PMID2228299. [21] Dhillon, M. (May 1991). "Current status of mold immunotherapy". Ann Allergy 66 (5): 38592. PMID2035901. [22] Gupta, SK.; Pereira, BM.; Singh, AB. (Mar 1999). "Fomes pectinatis: an aeroallergen in India". Asian Pac J Allergy Immunol 17 (1): 17. PMID10403002. [23] Fischer, B.; Yawalkar, N.; Brander, KA.; Pichler, WJ.; Helbling, A. (Oct 1999). "Coprinus comatus (shaggy cap) is a potential source of aeroallergen that may provoke atopic dermatitis". J Allergy Clin Immunol 104 (4 Pt 1): 836841. doi:10.1016/S0091-6749(99)70295-2. PMID10518829. [24] Harley, KG.; Macher, JM.; Lipsett, M.; Duramad, P.; Holland, NT.; Prager, SS.; Ferber, J.; Bradman, A. et al (Apr 2009). "Fungi and pollen exposure in the first months of life and risk of early childhood wheezing". Thorax 64 (4): 353358. doi:10.1136/thx.2007.090241. PMID19240083. [25] Bublin M; Radauer C; Wilson IBH; Kraft D; Scheiner O; Breiteneder H; Hoffmann-Sommergruber K (2003). "Cross-reactive N-glycans of Api g 5, a high molecular weight glycoprotein allergen from celery, are required for immunoglobulin E binding and activation of effector cells from allergic patients" (http:/ / www. fasebj. org/ cgi/ content/ full/ 17/ 12/ 1697). FASEB 17 (12): 16971699. doi:10.1096/fj.02-0872fje. PMID12958180. [26] "Seasonal Allergy - What to Know" (http:/ / seasonalallergies. us/ ). . Retrieved 2010-04-09. [27] "Seasonal Allergies" (http:/ / www. merck. com/ mmhe/ sec16/ ch185/ ch185b. html). . Retrieved 2010-04-09. [28] Seasonal allergies: Something to sneeze at (http:/ / www. cbc. ca/ health/ story/ 2010/ 03/ 19/ f-seasonal-allergies-symptoms. html/ ) CBS News. Retrieved on 2010-08-31 [29] Seasonal Allergies: What to know (http:/ / www. seasonalallergies. us/ ) Seasonal Allergy. Retrieved on 2010-08-31 [30] Parasites behind seasonal allergies (http:/ / www. abc. net. au/ science/ articles/ 2010/ 04/ 12/ 2870397. htm/ ) ABC Science. Retrieved on 2010-08-31 [31] Weinmann, Aileo (2010-04-14) Seasonal allergies getting worse from Climate Change (http:/ / www. nwf. org/ News-and-Magazines/ Media-Center/ News-by-Topic/ Global-Warming/ 2010/ 04-14-10-Seasonal-Allergies-Getting-Worse-From-Climate-Change. aspx/ ) National Wildlife Federation. Media Center. Retrieved on 2010-08-31 [32] Asthma and Allergies: The Symptoms (http:/ / www. asthma. ca/ allergies/ asthmaandallergiessymptoms. html/ ) Asthma & Allergies. Retrieved on 2010-08-31 [33] Seasonal Allergies (http:/ / kidshealth. org/ parent/ medical/ allergies/ seasonal_allergies. html/ ) Kids Health. Retrieved on 2010-08-31 [34] Allergic Rhinitis (http:/ / health. nytimes. com/ health/ guides/ disease/ allergic-rhinitis/ diagnosis. html/ ) New York Times Health Guide. Retrieved on 2010-08-31 [35] "Seasonal Allergies" (http:/ / www. pdrhealth. com/ disease/ disease-mono. aspx?contentFileName=BHG01AL10. xml& contentName=Seasonal+ allergies& contentId=134& sectionMonograph=ht4). . Retrieved 2010-04-09. [36] "Non-Sedating or Anti-Drowsy Antihistamine Tablets" (http:/ / www. hayfeverpharmacy. co. nz/ products/ antihistamine-tablets). . Retrieved 2010-04-09. [37] "Allergy shots" (http:/ / www. mayoclinic. com/ health/ allergy-shots/ MY01158). . Retrieved 2010-04-09. [38] Relieve Allergies the Natural Way (http:/ / www. webmd. com/ allergies/ guide/ relieve-allergies-natural-way) Web MD. Retrieved on 2010-08-31 [39] http:/ / www. hon. ch/ Library/ Theme/ Allergy/ Glossary/ allergy. html [40] http:/ / www. allermatch. org [41] http:/ / fermi. utmb. edu/ SDAP/ [42] http:/ / www. allergome. org/ script/ about. php [43] http:/ / www. allergen. org
22
Aeroallergen
23
Aeroallergen
An Aeroallergen (pronounced aeroallergen) is any airborne substance, such as pollen or spores, which triggers an allergic reaction.
Pollens
Aeroallergens include the pollens of specific seasonal plants is commonly known as "hay fever", because it is most prevalent during haying season, from late May to the end of June in the Northern Hemisphere; but it is possible to suffer from hay fever throughout the year. The pollen which causes hay fever varies from person to person and from region to region; generally speaking, the tiny, hardly visible pollens of wind-pollinated plants are the predominant cause. Pollens of insect-pollinated plants are too large to remain airborne and pose no risk. Examples of plant pollen commonly responsible for hay fever include: Trees: such as birch (Betula), alder (Alnus), cedar (Cedrus), hazel (Corylus), hornbeam (Carpinus), horse chestnut (Aesculus), willow (Salix), poplar (Populus), plane (Platanus), linden/lime (Tilia) and olive (Olea). In northern latitudes birch is considered to be the most important allergenic tree pollen, with an estimated 1520% of hay fever sufferers sensitive to birch pollen grains. Olive pollen is most predominant in Mediterranean regions. Grasses (Family Poaceae): especially ryegrass (Lolium sp.) and timothy (Phleum pratense). An estimated 90% of hay fever sufferers are allergic to grass pollen. Weeds: ragweed (Ambrosia), plantain (Plantago), nettle/parietaria (Urticaceae), mugwort (Artemisia), Fat hen (Chenopodium) and sorrel/dock (Rumex) The time of year at which hay fever symptoms manifest themselves varies greatly depending on the types of pollen to which an allergic reaction is produced. The pollen count, in general, is highest from mid-spring to early summer. As most pollens are produced at fixed periods in the year, a long-term hay fever sufferer may also be able to anticipate when the symptoms are most likely to begin and end, although this may be complicated by an allergy to dust particles.
Spores
In fungi, both asexual and sexual spores or sporangiospores of many fungal species are actively dispersed by forcible ejection from their reproductive structures, which travel through the air over long distances. Many fungi thereby possess specialized mechanical and physiological mechanisms as well as spore-surface structures, such as hydrophobins, for spore ejection. These mechanisms include, for example, forcible discharge of ascospores enabled by the structure of the ascus and accumulation of osmolytes in the fluids of the ascus that lead to explosive discharge of the ascospores into the air.[1] The forcible discharge of single spores termed ballistospores involves formation of a small drop of water (Buller's drop), which upon contact with the spore leads to its projectile release with an initial acceleration of more than 10,000 g.[2] Other fungi rely on alternative mechanisms for spore release, such as external mechanical forces, exemplified by puffballs.
Aeroallergen
24
Foodstuffs
It is thought that peanuts and other allergic foodstuffs may become airborne, thus triggering allergic reactions in susceptible individuals, especially children.[3][4][5] However, one report notes: Recently concern has been raised that peanut protein in the air will trigger a full-blown anaphylaxis since respiratory exposure can occur in the school setting as food proteins aerosolize into vapors during cooking at high temperatures, even in well-ventilated cafeterias. When airborne peanut protein exposure and reactions of children with known peanut allergies were explored, no allergic symptoms or anaphylaxis were observed when peanut allergic children were not aware of the airborne exposure. Interestingly, when aware of the exposure, symptoms of itchy eyes, sneezing, and runny nose resulted. In a research article by Perry, et al. (2004), no peanut allergen was detected in the air after subjects consumed peanut butter, shelled peanuts, and unshelled peanuts. As Dr. Michael Young notes in his 2006 book, The Peanut Allergy Answer Book, predicting who will have a life-threatening anaphylactic response to airborne allergy is very unpredictable and the likelihood of it is very, very small. ... There remains no evidence that exposure to airborne peanut protein worsens allergy or results in anaphylaxis for the majority of peanut allergic individuals. There always remains the possibility that someone who is exceptionally sensitive will experience a severe reaction, however, protecting them from all possible exposures to peanut protein is extremely difficult. NetWellness website[6]
Eosinophilic gastroenteritis
Eosinophilic gastroenteritis (EG) is a rare and heterogeneous condition characterized by patchy or diffuse eosinophilic infiltration of gastrointestinal (GI) tissue, first described by Kaijser in 1937 [7] .[8] Aeroallergens can cause EG.[9][10] The stomach is the organ most commonly affected, followed by the small intestine and the colon .[11][12] As a part of host defense mechanism, eosinophil is normally present in gastrointestinal mucosa, though finding in deeper tissue is almost always pathologic .[13] What triggers such dense infiltration in EG is not clear. It is possible that different pathogenetic mechanisms of disease is involved in several subgroups of patients. Food allergy and variable IgE response to food substances has been observed in some patients which implies role of hypersensitive response in pathogenesis. Many patients indeed have history of other atopic conditions like eczema, asthma etc. Eosinophil recruitment into inflammatory tissue is a complex process, regulated by a number of inflammatory cytokines. In EG cytokines IL-3, IL-5 and granulocyte macrophage colony stimulating factor (GM-CSF) may be behind the recruitement and activation. They have been observed immunohistochemically in diseased intestinal wall .[14] In addition eotaxin has been shown to have an integral role in regulating the homing of eosinophils into the lamina propria of stomach and small intestine .[10] In the allergic subtype of disease, it is thought that food allergens cross the intestinal mucosa and trigger an inflammatory response that includes mast cell degranulation and recruitment of eosinophils.[9] EG is "managed" (treated) with corticosteroids, with a 90% response rate in some studies. Various steroid sparing agents e.g. sodium cromoglycate (a stabilizer of mast cell membranes), ketotifen (an antihistamine), and montelukast (a selective, competitive leukotriene receptor antagonist) have been proposed, centering around an allergic hypothesis, with mixed results.[9][15] An elimination diet may be successful if a limited number of food allergies are identified.[16]
Aeroallergen
25
References
[1] Trail F. (2007). "Fungal cannons: explosive spore discharge in the Ascomycota". FEMS Microbiology Letterrs 276 (1): 128. doi:10.1111/j.1574-6968.2007.00900.x. PMID17784861. [2] Pringle A, Patek SN, Fischer M, Stolze J, Money NP. (2005). "The captured launch of a ballistospore". Mycologia 97 (4): 86671. doi:10.3852/mycologia.97.4.866. PMID16457355. [3] The Michael C. Young, M.D., "Common Beliefs About Peanut Allergy: Fact or Fiction?" (reprinted with permission of the Food Allergy & Anaphylaxis Network, in Anaphylaxis Canada, September newsletter) found at allergysafecommunities.ca (http:/ / www. allergysafecommunities. ca/ assets/ common_beliefs_faan_2003. pdf). (.pdf) Accessed March 19, 2009. [4] "Passengers with the condition, which can be deadly, can try to ensure a peanut-free flight. But even the best plans sometimes don't work." See "Out of the Blue: Peanut allergies are a little-known danger." Elliott Hester, St. Petersburg Times, December 30, 2001, St. Petersburg Times (http:/ / www. sptimes. com/ News/ 123001/ Travel/ Out_of_the_Blue__Pean. shtml). Accessed March 19, 2009. [5] Constance Hays, "Ideas & Trends: Airborne Allergies; A New Fear of Flying: Peanuts," New York Times, Sunday, May 10, 1998, found at NY Times archives (http:/ / query. nytimes. com/ gst/ fullpage. html?sec=health& res=9E03E2D61031F933A25756C0A96E958260). Accessed March 19, 2009. [6] Jill F. Kilanowski & Ann Stalter (College of Nursing, The Ohio State University), "Children's Health: Peanut Allergy in the School Environment: Myths and Facts: Part 1 of a 2-Part Series," at NetWellness website (http:/ / www. netwellness. org/ healthtopics/ ch/ peanut1. cfm), citing Perry, T., Conover-Walker, M., Pomes, A., Chapman, M., & Wood, R. (2004). "Distribution of peanut allergen in the environment." Journal of Allergy and Clinical Immunology, 113, 973-976. Accessed March 19, 2009. [7] Kaijser R. Zur Kenntnis der allergischen Affektionen des Verdauugskanals vom Standpunkt des Chirurgen aus. Arch Klin Chir 1937; 188:3664. [8] Whitaker I, Gulati A, McDaid J, Bugajska-Carr U, Arends M (2004). "Eosinophilic gastroenteritis presenting as obstructive jaundice". European journal of gastroenterology & hepatology 16 (4): 4079. doi:10.1097/00042737-200404000-00007. PMID15028974. [9] Prez-Milln A, Martn-Lorente J, Lpez-Morante A, Yuguero L, Sez-Royuela F (1997). "Subserosal eosinophilic gastroenteritis treated efficaciously with sodium cromoglycate". Dig. Dis. Sci. 42 (2): 3424. doi:10.1023/A:1018818003002. PMID9052516. [10] Mishra A, Hogan S, Brandt E, Rothenberg M (2001). "An etiological role for aeroallergens and eosinophils in experimental esophagitis". J. Clin. Invest. 107 (1): 8390. doi:10.1172/JCI10224. PMC198543. PMID11134183. [11] Naylor A (1990). "Eosinophilic gastroenteritis". Scottish medical journal 35 (6): 1635. PMID2077646. [12] Jimenez-Saenz M, Villar-Rodriguez J, Torres Y, Carmona I, Salas-Herrero E, Gonzalez-Vilches J, Herrerias-Gutierrez J (2003). "Biliary tract disease: a rare manifestation of eosinophilic gastroenteritis". Dig. Dis. Sci. 48 (3): 6247. doi:10.1023/A:1022521707420. PMID12757181. [13] Blackshaw A, Levison D (1986). "Eosinophilic infiltrates of the gastrointestinal tract". J. Clin. Pathol. 39 (1): 17. doi:10.1136/jcp.39.1.1. PMC499605. PMID2869055. [14] Desreumaux P, Bloget F, Seguy D, Capron M, Cortot A, Colombel J, Janin A (1996). "Interleukin 3, granulocyte-macrophage colony-stimulating factor, and interleukin 5 in eosinophilic gastroenteritis". Gastroenterology 110 (3): 76874. doi:10.1053/gast.1996.v110.pm8608886. PMID8608886. [15] Barbie D, Mangi A, Lauwers G (2004). "Eosinophilic gastroenteritis associated with systemic lupus erythematosus". J. Clin. Gastroenterol. 38 (10): 8836. doi:10.1097/00004836-200411000-00010. PMID15492606. [16] Katz A, Twarog F, Zeiger R, Falchuk Z (1984). "Milk-sensitive and eosinophilic gastroenteropathy: similar clinical features with contrasting mechanisms and clinical course". J. Allergy Clin. Immunol. 74 (1): 728. doi:10.1016/0091-6749(84)90090-3. PMID6547462.
Allergic inflammation
26
Allergic inflammation
Allergic inflammation is an important pathophysiological feature of several disabilities or medical conditions including allergic asthma, atopic dermatitis, allergic rhinitis and several ocular allergic diseases. Allergic reactions may generally be divided into two components; the early phase reaction, and the late phase reaction. While the contribution to the development of symptoms from each of the phases varies greatly between diseases, both are usually present and provide us a framework for understanding allergic disease [1][2][3][4] .
Tissues affected in allergic inflammation.
The early phase of the allergic reaction typically occurs within minutes, or even seconds, following allergen exposure and is also commonly referred to as the immediate allergic reaction or as a Type I allergic reaction [5]. The reaction is caused by the release of histamine and mast cell granule proteins by a process called degranulation, as well as the production of leukotrienes, prostaglandins and cytokines, by mast cells following the cross-linking of allergen specific IgE molecules bound to mast cell FcRI receptors [3]. These mediators affect nerve cells causing itching [6], smooth muscle cells causing contraction (leading to the airway narrowing seen in allergic asthma) [4], goblet cells causing mucus production [1], and endothelial cells causing vasodilatation and edema [6]. The late phase of a Type 1 reaction (which develops 8-12 hours and is mediated by mast cells)[5] should not be confused with delayed hypersensitivity Type IV allergic reaction (which takes 48-72 hours to develop and is mediated by T cells)[7]. The products of the early phase reaction include chemokines and molecules that act on endothelial cells and cause them to express Intercellular adhesion molecule (such as vascular cell adhesion molecule and selectins), which together result in the recruitment and activation of leukocytes from the blood into the site of the allergic reaction [3]. Typically, the infiltrating cells observed in allergic reactions contain a high proportion of lymphocytes, and especially, of eosinophils. The recruited eosinophils will degranulate releasing a number of cytotoxic molecules (including Major Basic Protein and eosinophil peroxidase) as well as produce a number of cytokines such as IL-5 [8]. The recruited T-cells are typically of the Th2 variety and the cytokines they produce lead to further recruitment of mast cells and eosinophils, and in plasma cell isotype switching to IgE which will bind to the mast cell FcRI receptors and prime the individual for further allergic responses.
Allergic inflammation
27
References
[1] Fireman P (2003). "Understanding asthma pathophysiology" (http:/ / openurl. ingenta. com/ content/ nlm?genre=article& issn=1088-5412& volume=24& issue=2& spage=79& aulast=Fireman). Allergy Asthma Proc 24 (2): 7983. PMID12776439. . [2] Leung DY (1998). "Molecular basis of allergic diseases" (http:/ / linkinghub. elsevier. com/ retrieve/ pii/ S1096-7192(98)92682-8). Mol. Genet. Metab. 63 (3): 15767. doi:10.1006/mgme.1998.2682. PMID9608537. . [3] Hansen I, Klimek L, Msges R, Hrmann K (2004). "Mediators of inflammation in the early and the late phase of allergic rhinitis" (http:/ / meta. wkhealth. com/ pt/ pt-core/ template-journal/ lwwgateway/ media/ landingpage. htm?issn=1528-4050& volume=4& issue=3& spage=159). Curr Opin Allergy Clin Immunol 4 (3): 15963. doi:10.1097/00130832-200406000-00004. PMID15126935. . [4] Katelaris CH (2003). "Ocular allergy: implications for the clinical immunologist". Ann. Allergy Asthma Immunol. 90 (6 Suppl 3): 237. doi:10.1016/S1081-1206(10)61656-0. PMID12839109. [5] Janeway, Charles (2001). Immunobiology: the immune system in health and disease (5th ed.). New York: Garland. ISBN0-8153-3642-X. [6] Trocme SD, Sra KK (2002). "Spectrum of ocular allergy" (http:/ / meta. wkhealth. com/ pt/ pt-core/ template-journal/ lwwgateway/ media/ landingpage. htm?issn=1528-4050& volume=2& issue=5& spage=423). Curr Opin Allergy Clin Immunol 2 (5): 4237. doi:10.1097/00130832-200210000-00010. PMID12582327. . [7] Hinshaw WD, Neyman GP, Olmstead SM. "Hypersensitivity Reactions, Delayed" (http:/ / emedicine. medscape. com/ article/ 136118-overview). eMedicine. . [8] Rothenberg ME; Rothenberg, Marc E. (1998). "Eosinophilia" (http:/ / content. nejm. org/ cgi/ pmidlookup?view=short& pmid=9603798& promo=ONFLNS19). N. Engl. J. Med. 338 (22): 1592600. doi:10.1056/NEJM199805283382206. PMID9603798. .
Anaphylaxis
28
Anaphylaxis
Anaphylaxis
Classification and external resources
Angioedema of the face such that the boy is unable to open his eyes. This reaction was due to an allergen exposure. ICD-10 ICD-9 DiseasesDB MedlinePlus eMedicine MeSH T78.2 995.0 29153 [1] [2] [3] [4] [5] [6]
000844
med/128 D000707
Anaphylaxis is defined as "a serious allergic reaction that is rapid in onset and may cause death".[7] It typically results in a number of symptoms including an itchy rash, throat swelling, and low blood pressure. Common causes include insect bites, foods, and medications. On a pathophysiologic level, anaphylaxis is due to the release of mediators from certain types of white blood cells triggered either by immunologic or non-immunologic mechanisms. It is diagnosed based on the presenting symptoms and signs. The primary treatment is injection of epinephrine, with other measures being complementary. Worldwide 0.052% of people are estimated to have anaphylaxis at some point in their life and rates appear to be increasing. The term comes from the Greek words ana, against, and phylaxis, protection.
Anaphylaxis
29
Skin
Symptoms typically include generalized hives, itchiness, flushing or swelling of the lips.[12] Those with swelling or angioedema may describe a burning sensation of the skin rather than itchiness.[10] Swelling of the tongue or throat occurs in up to about 20% of cases.[13] Other features may include a runny nose and swelling of the conjunctiva.[14] The skin may also be blue tinged due to a lack of oxygen.[14]
Respiratory symptoms and signs that may be present, including shortness of breath, wheezes or stridor.[12] The wheezing is typically due to spasms of the bronchial muscles[15] while stridor is related to upper airway obstruction secondary to swelling.[14] Hoarseness, pain with swallowing, or a cough may also occur.[10]
Respiratory
Cardiac
Coronary artery spasm may occur with subsequent myocardial infarction, dysrhythmia, or cardiac arrest.[9][11] Those with underlying coronary disease are at greater risk of cardiac effects from anaphylaxis.[15] The coronary spasm is related to the presence of histamine-releasing cells in the heart.[15] While a fast heart rate due to low blood pressure is more common,[14] a BezoldJarisch reflex has been described in 10% of cases, where a slow heart rate is associated with low blood pressure.[16] A drop in blood pressure or shock (either distributive or cardiogenic) may result in the feeling of lightheadedness or loss of consciousness.[15] Rarely very low blood pressure may be the only sign of anaphylaxis.[13]
Anaphylaxis
30
Other
Gastrointestinal symptoms may include crampy abdominal pain, diarrhea, and vomiting.[12] There may be confusion, a loss of bladder control or pelvic pain similar to that of uterine cramps.[12][14] Dilation of blood vessels around the brain may cause headaches.[10] A feeling of anxiety or of "impending doom" has also be described.[11]
Causes
Anaphylaxis can occur in response to almost any foreign substance.[17] Common triggers include venom from insect bites or stings, foods, and medication.[16][18] Foods are the most common trigger in children and young adults while medications and insect bites and stings are more common in older adults.[11] Less common causes include: physical factors, biological agents such as semen, latex, hormonal changes, food additives such as monosodium glutamate and food colors, and topical medications.[14] Physical factors such as exercise (known as exercise-induced anaphylaxis) or temperature (either hot or cold) may also act as triggers through their direct effects on mast cells.[11][19] Exercise induced events are frequently associated with the ingestion of certain foods.[10] During anesthesia, neuromuscular blocking agents, antibiotics, and latex are the most common causes.[20] The cause remains unknown in 32-50% of cases, referred to as "idiopathic anaphylaxis".[21]
Food
Many foods can trigger anaphylaxis; this may occur upon the first known ingestion.[16] Common triggering foods vary around the world. In Western cultures, ingestion of or exposure to peanuts, wheat, tree nuts, shellfish, fish, milk, and eggs are the most prevalent causes.[9][11] Sesame is common in the Middle East, while rice and chickpea are frequently encountered as sources of anaphylaxis in Asia.[11] Severe cases are usually the result of ingesting the allergen,[16] but some people experience a severe reaction upon contact. Children can outgrow their allergies. By age 16, 80% of children with anaphylaxis to milk or eggs and 20% who experience isolated anaphylaxis to peanuts are able to tolerate these foods.[17]
Medication
Any medication may potentially trigger anaphylaxis. The most common are -lactam antibiotics (such as penicillin) followed by aspirin and NSAIDs.[9][22] Other antibiotics are implicated less frequently and the reactions to NSAIDs are agent specific meaning that if one is allergic to one NSAID they can typically tolerate a different one.[22] Other relatively common causes include chemotherapy, vaccines, protamine and herbal preparations.[11][22] Some medications (vancomycin, morphine, x-ray contrast among others) cause anaphylaxis by directly triggering mast cell degranulation.[16] The frequency of a reaction to an agent partly depends on the frequency of its use and partly on its intrinsic properties.[23] Anaphylaxis to penicillins or cephalosporins only occurs after they bind to proteins inside the body with some agents binding more easily than other.[10] Anaphylaxis to penicillin occurs once in every 2,000 to 10,000 courses of treatment, with death occurring in less than one in every 50,000 courses of treatment.[10] Anaphylaxis to aspirin and NSAIDs occurs in about one in every 50,000 persons.[10] If someone has a reaction to penicillins their risk of a reaction to cephalosporins is greater but still less than one in 1000.[10] The old radiocontrast agents caused reactions in 1% of cases while the newer lower osmolar agents cause reactions in 0.04% of cases.[23]
Anaphylaxis
31
Venom
Venom from stinging or biting insects such as Hymenoptera (bees and wasps) or Triatominae (kissing bugs) may induce anaphylaxis in susceptible people.[9][24] Previous systemic reactions, which are anything more than a local reaction around the site of the sting, are a risk factor for future anaphylaxis;[25][26] however, half of fatalities have had no previous systemic reaction.[27]
Risk factors
People with atopic diseases such as asthma, eczema, or allergic rhinitis are at high risk of anaphylaxis from food, latex, and radiocontrast but not injectable medications or stings.[11][16] One study in children found that 60% had a history of previous atopic diseases, and of those who die from anaphylaxis more than 90% have asthma.[16] Those with mastocytosis or of a higher socioeconomic status are at increased risk.[11][16] The longer the time since the last exposure to the agent in question the lower the risk.[10]
Pathophysiology
Anaphylaxis is a severe allergic reaction of rapid onset affecting many body systems.[7][28] It is due to the release of inflammatory mediators and cytokines from mast cells and basophils, typically due to an immunologic reaction but sometimes non-immunologic mechanism.[28]
Immunologic
In the immunologic mechanism, immunoglobulin E (IgE) binds to the antigen (the foreign material that provokes the allergic reaction). Antigen-bound IgE then activates FcRI receptors on mast cells and basophils. This leads to release of inflammatory mediators such as histamine. These mediators subsequently increase the contraction of bronchial smooth muscles, trigger vasodilation, increase the leakage of fluid from blood vessels, and cause heart muscle depression.[10][28] There is also an immunologic mechanism that does not rely on IgE, but it is not known if this occurs in humans.[28]
Non-immunologic
Non-immunologic mechanisms involved substances that directly cause the degranulation of mast cells and basophils. These include agents such as contrast medium, opioids, temperature (hot or cold), and vibration.[19][28]
Diagnosis
Anaphylaxis is diagnosed based on clinical criteria.[11] When any one of the following three occurs within minutes/hours of exposure to an allergen there is a high likelihood of anaphylaxis:[11] 1. Involvement of the skin or mucosal tissue plus either respiratory difficulty or a low blood pressure 2. Two or more of the following symptoms:a. Involvement of the skin or mucosa b. Respiratory difficulties c. Low blood pressure d. Gastrointestinal symptoms 3. Low blood pressure after exposure to a known allergen During an attack, blood tests for tryptase or histamine (released from mast cells) might be useful in diagnosing anaphylaxis due to insect stings or medications. However these tests are of limited utility if the cause is food or if the person has a normal blood pressure,[11] and they are not specific for the diagnosis.[17]
Anaphylaxis
32
Classification
There are three main classifications of anaphylaxis. Anaphylactic shock is associated with systemic vasodilation that results in low blood pressure which is by definition 30% lower than the person's baseline or below standard values.[13] Biphasic anaphylaxis is the recurrence of symptoms within 172 hours with no further exposure to the allergen.[11] Reports of incidence vary, with some studies claiming as many as 20% of cases.[29] The recurrence typically occurs within 8 hours.[16] It is managed in the same manner as anaphylaxis.[9] Pseudoanaphylaxis or anaphylactoid reactions are a type of anaphylaxis that does not involve an allergic reaction but is due to direct mast cell degranulation.[16][30] Non-immune anaphylaxis is the current term use by the World Allergy Organization[30] with some recommending that the old terminology no longer be used.[16]
Allergy testing
Allergy testing may help in determining the trigger. Skin allergy testing (such as patch testing) is available for certain foods and venoms.[17] Blood testing for specific IgE can be useful to confirm milk, egg, peanut, tree nut and fish allergies.[17] Skin testing is available to confirm penicillin allergies but is not available for other medications.[17] Non-immune forms of anaphylaxis can only be determined by history or exposure to the allergen in question, and not by skin or blood testing.[30]
Differential diagnosis
It can sometimes be difficult to distinguish anaphylaxis from asthma, syncopy, and panic attacks.[11] Asthma however typically does not have itching or gastrointestinal symptoms, syncope presents with pallor rather than a rash, and a panic attack may have flushing but does not have hives.[11] Other conditions that may present similarly include: scrombroidosis and anisakiasis.[16]
Post-mortem findings
In a person who died from anaphylaxis, autopsy may show an "empty heart" attributed to reduced venous return from vasodilation and redistribution of intravascular volume from the central to the peripheral compartment.[31] Other signs are laryngeal edema, eosinophilia in lungs, heart and tissues, and evidence of myocardial hypoperfusion.[32] Laboratory findings could detect increased levels of serum tryptase, increase in total and specific IgE serum levels.[32]
Prevention
Avoidance of the trigger of anaphylaxis is recommended. In cases where this may not be possible, desensitization may be an option. Immunotherapy with Hymenoptera venoms is effective at desensitizing 8090% of adults and 98% of children against allergies to bees, wasps, hornets, yellowjackets, and fire ants. Oral immunotherapy may be effective at desensitizing some people to certain food including milk, eggs, nuts and peanuts; however adverse effects are common. Desensitization is also possible for many medications, however it is advised that most people simply avoid the agent in question. In those who react to latex it may be important to avoid cross-reactive foods such as avocados, bananas, and potatoes among others.[11]
Anaphylaxis
33
Management
Anaphylaxis is a medical emergency that may require resuscitation measures such as airway management, supplemental oxygen, large volumes of intravenous fluids, and close monitoring.[9] Administration of epinephrine is the treatment of choice with antihistamines and steroids often used as adjuncts.[11] A period of in hospital observation for between 2 and 24 hours is recommended for people once they have returned to normal due to concerns of biphasic anaphylaxis.[16][29][33][10]
Epinephrine
Epinephrine (adrenaline) is the primary treatment for anaphylaxis with no absolute contraindication to its use.[9] It is recommended that an epinephrine solution be given intramuscularly into the mid anterolaterial thigh as soon as the diagnosis is suspected. The injection An old version of an EpiPen auto-injector may be repeated every 5 to 15 minutes if there is insufficient response.[11] A second dose is needed in 16 to 35% of episodes[16] with more than two doses rarely required.[11] The intramuscular route is preferred over subcutaneous administration because the latter may have delayed absorption.[34] Minor adverse effects from epinephrine include tremors, anxiety, headaches, and palpitations.[11] People on -blockers may be resistant to the effects of epinephrine.[16] In this situation if epinephrine is not effective intravenous glucagon can be administered which has a mechanism of action independent of -receptors.[16] If necessary, it can also be given intravenously using a dilute epinephrine solution. Intravenous epinephrine however has been associated both with dysrhythmia and myocardial infarction.[35] Epinephrine autoinjector used for self-administration typically in two doses, one for adults or children who weight more than 25kg and one for children who weigh 10 to 25kg.[36]
Adjuncts
Antihistamines (both H1 and H2), while commonly used and assumed effective based on theoretical reasoning, are poorly supported by evidence. A 2007 Cochrane review did not find any good-quality studies upon which to base recommendations[37] and they are not believed to have an effect on airway edema or spasm.[16] Corticosteroids are unlikely to make a difference in the current episode of anaphylaxis, but may be used in the hope of decreasing the risk of biphasic anaphylaxis. Their prophylactic effectiveness in these situations is uncertain.[29] Nebulized salbutamol may be effective for bronchospasm that does not resolve with epinephrine.[16] Methylene blue has been used in those not responsive to other measures due to its presumed effect of relaxing smooth muscle.[16]
Preparedness
People prone to anaphylaxis are advised to have an "allergy action plan", and parents are advised to inform schools of their children's allergies and what to do in case of an anaphylactic emergency.[38] The action plan usually includes use of epinephrine auto-injectors, the recommendation to wear a medical alert bracelet, and counseling on avoidance of triggers.[38] Immunotherapy is available for certain triggers to prevent future episodes of anaphylaxis. A multi-year course of subcutaneous desensitization has been found effective against stinging insects, while oral desensitization is effective for many foods.[9]
Anaphylaxis
34
Prognosis
In those in whom the cause is known and prompt treatment is available, the prognosis is good.[39] Even if the cause is unknown, if appropriate preventative medication is available, the prognosis is generally good.[10] If death occurs, it is usually due to either respiratory (typically asphyxia) or cardiovascular causes (shock),[16][28] with 0.720% of cases resulting in death.[10][15] There have been cases of death occurring within minutes.[11] Outcomes in those with exercise-induced anaphylaxis are typically good, with fewer and less severe episodes as people get older.[40]
Epidemiology
The incidence of anaphylaxis is 45 per 100,000 persons per year,[16] with a lifetime risk of 0.52%.[11] Rates appear to be increasing: incidence in the 1980s was approximately 20 per 100,000 per year, while in the 1990s it was 50 per 100,000 per year.[9] The increase appears to be primarily for food-induced anaphylaxis.[41] The risk is greatest in young people and females.[9][16] Currently, anaphylaxis leads to 5001,000 deaths per year (2.4 per million) in the United States, 20 deaths per year in the United Kingdom (0.33 per million), and 15 deaths per year in Australia (0.64 per million).[16] Mortality rates have decreased between the 1970s and 2000s.[42] In Australia, death from food-induced anaphylaxis occur primarily in women while deaths due to insect bites primarily occur in males.[16] Death from anaphylaxis is most commonly triggered by medications.[16]
History
The term "aphylaxis" was coined by Charles Richet in 1902 and later changed to "anaphylaxis" due to its nicer quality of speech.[17] He was subsequently awarded the Nobel Prize in Medicine and Physiology for his work on anaphylaxis in 1913.[10] The phenomenon itself however has been described since ancient times.[30] The term comes from the Greek words ana, against, and phylaxis, protection.[43]
Research
There are ongoing efforts to develop sublingual epinephrine to treat anaphylaxis.[16] Subcutaneous injection of the anti-IgE antibody omalizumab is being studied as a method of preventing recurrence, but it is not yet recommended.[11][44]
References
[1] [2] [3] [4] [5] [6] [7] http:/ / apps. who. int/ classifications/ icd10/ browse/ 2010/ en#/ T78. 2 http:/ / www. icd9data. com/ getICD9Code. ashx?icd9=995. 0 http:/ / www. diseasesdatabase. com/ ddb29153. htm http:/ / www. nlm. nih. gov/ medlineplus/ ency/ article/ 000844. htm http:/ / www. emedicine. com/ med/ topic128. htm http:/ / www. nlm. nih. gov/ cgi/ mesh/ 2011/ MB_cgi?field=uid& term=D000707 Tintinalli, Judith E. (2010). Emergency Medicine: A Comprehensive Study Guide (Emergency Medicine (Tintinalli)). New York: McGraw-Hill Companies. pp.177182. ISBN0-07-148480-9. [8] Oswalt ML, Kemp SF (May 2007). "Anaphylaxis: office management and prevention". Immunol Allergy Clin North Am 27 (2): 17791, vi. doi:10.1016/j.iac.2007.03.004. PMID17493497. "Clinically, anaphylaxis is considered likely to be present if any one of three criteria is satisfied within minutes to hours" [9] Simons FE (October 2009). "Anaphylaxis: Recent advances in assessment and treatment" (https:/ / secure. muhealth. org/ ~ed/ students/ articles/ JAClinImmun_124_p0625. pdf). J. Allergy Clin. Immunol. 124 (4): 62536; quiz 6378. doi:10.1016/j.jaci.2009.08.025. PMID19815109. . [10] Marx, John (2010). Rosen's emergency medicine: concepts and clinical practice 7th edition. Philadelphia, PA: Mosby/Elsevier. p.15111528. ISBN978-0-323-05472-0. [11] Simons, FE; World Allergy, Organization (2010 May). "World Allergy Organization survey on global availability of essentials for the assessment and management of anaphylaxis by allergy-immunology specialists in health care settings." (http:/ / www. csaci. ca/ include/ files/
Anaphylaxis
WAO_Anaphylaxis_Guidelines_2011. pdf). Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 104 (5): 40512. PMID20486330. . [12] Sampson HA, Muoz-Furlong A, Campbell RL, et al. (February 2006). "Second symposium on the definition and management of anaphylaxis: summary reportSecond National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium". J. Allergy Clin. Immunol. 117 (2): 3917. doi:10.1016/j.jaci.2005.12.1303. PMID16461139. [13] Limsuwan, T; Demoly, P (2010 Jul). "Acute symptoms of drug hypersensitivity (urticaria, angioedema, anaphylaxis, anaphylactic shock)." (http:/ / smschile. cl/ documentos/ cursos2010/ MedicalClinicsNorthAmerica/ Acute Symptoms of Drug Hypersensitivity (Urticaria, Angioedema, Anaphylaxis, Anaphylactic Shock). pdf). The Medical clinics of North America 94 (4): 691710, x. PMID20609858. . [14] Brown, SG; Mullins, RJ, Gold, MS (2006 Sep 4). "Anaphylaxis: diagnosis and management.". The Medical journal of Australia 185 (5): 2839. PMID16948628. [15] Triggiani, M; Patella, V, Staiano, RI, Granata, F, Marone, G (2008 Sep). "Allergy and the cardiovascular system." (http:/ / www. ncbi. nlm. nih. gov/ pmc/ articles/ PMC2515352/ ?tool=pubmed). Clinical and experimental immunology 153 Suppl 1: 711. PMC2515352. PMID18721322. . [16] Lee, JK; Vadas, P (2011 Jul). "Anaphylaxis: mechanisms and management.". Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 41 (7): 92338. PMID21668816. [17] Boden, SR; Wesley Burks, A (2011 Jul). "Anaphylaxis: a history with emphasis on food allergy.". Immunological reviews 242 (1): 24757. PMID21682750. [18] Worm, M (2010). "Epidemiology of anaphylaxis.". Chemical immunology and allergy 95: 1221. PMID20519879. [19] editors, Marianne Gausche-Hill, Susan Fuchs, Loren Yamamoto, (2007). The pediatric emergency medicine resource (http:/ / books. google. ca/ books?id=lLVfDC2dh54C& pg=PA69) (Rev. 4. ed. ed.). Sudbury, Mass.: Jones & Bartlett. pp.69. ISBN978-0-7637-4414-4. . [20] Dewachter, P; Mouton-Faivre, C, Emala, CW (2009 Nov). "Anaphylaxis and anesthesia: controversies and new insights.". Anesthesiology 111 (5): 114150. doi:10.1097/ALN.0b013e3181bbd443. PMID19858877. [21] editor, Mariana C. Castells, (2010). Anaphylaxis and hypersensitivity reactions (http:/ / books. google. ca/ books?id=bEvnfm7V-LIC& pg=PA223). New York: Humana Press. pp.223. ISBN978-1-60327-950-5. . [22] Volcheck, Gerald W. (2009). Clinical allergy : diagnosis and management (http:/ / books. google. ca/ books?id=pWZLkZB7EW8C& pg=PA442). Totowa, N.J.: Humana Press. pp.442. ISBN978-1-58829-616-0. . [23] Drain, KL; Volcheck, GW (2001). "Preventing and managing drug-induced anaphylaxis.". Drug safety : an international journal of medical toxicology and drug experience 24 (11): 84353. PMID11665871. [24] Klotz, JH; Dorn, PL, Logan, JL, Stevens, L, Pinnas, JL, Schmidt, JO, Klotz, SA (2010 Jun 15). ""Kissing bugs": potential disease vectors and cause of anaphylaxis.". Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 50 (12): 162934. PMID20462351. [25] Bil, MB (2011 Jul). "Anaphylaxis caused by Hymenoptera stings: from epidemiology to treatment.". Allergy 66 Suppl 95: 357. PMID21668850. [26] Cox, L; Larenas-Linnemann, D, Lockey, RF, Passalacqua, G (2010 Mar). "Speaking the same language: The World Allergy Organization Subcutaneous Immunotherapy Systemic Reaction Grading System.". The Journal of allergy and clinical immunology 125 (3): 56974, 574.e1-574.e7. PMID20144472. [27] Bil, BM; Bonifazi, F (2008 Aug). "Epidemiology of insect-venom anaphylaxis.". Current opinion in allergy and clinical immunology 8 (4): 3307. PMID18596590. [28] Khan, BQ; Kemp, SF (2011 Aug). "Pathophysiology of anaphylaxis.". Current opinion in allergy and clinical immunology 11 (4): 31925. PMID21659865. [29] Lieberman P (September 2005). "Biphasic anaphylactic reactions". Ann. Allergy Asthma Immunol. 95 (3): 21726; quiz 226, 258. doi:10.1016/S1081-1206(10)61217-3. PMID16200811. [30] Ring, J; Behrendt, H, de Weck, A (2010). "History and classification of anaphylaxis." (http:/ / media. wiley. com/ product_data/ excerpt/ 42/ 04708611/ 0470861142. pdf). Chemical immunology and allergy 95: 111. PMID20519878. . [31] Anaphylaxis, Author: Stephen F Kemp, MD, FACP; Chief Editor: Michael A Kaliner, MD;http:/ / emedicine. medscape. com/ article/ 135065-overview#showall [32] Da Broi, U; Moreschi, C (2011 Jan 30). "Post-mortem diagnosis of anaphylaxis: A difficult task in forensic medicine.". Forensic science international 204 (1-3): 15. PMID20684869. [33] "Emergency treatment of anaphylactic reactions Guidelines for healthcare providers" (http:/ / www. resus. org. uk/ pages/ reaction. pdf) (PDF). Resuscitation Council (UK). January 2008. . Retrieved 2008-04-22. [34] Simons, KJ; Simons, FE (2010 Aug). "Epinephrine and its use in anaphylaxis: current issues.". Current opinion in allergy and clinical immunology 10 (4): 35461. PMID20543673. [35] Mueller, UR (2007 Aug). "Cardiovascular disease and anaphylaxis.". Current opinion in allergy and clinical immunology 7 (4): 33741. PMID17620826. [36] Sicherer, SH; Simons, FE, Section on Allergy and Immunology, American Academy of, Pediatrics (2007 Mar). "Self-injectable epinephrine for first-aid management of anaphylaxis.". Pediatrics 119 (3): 63846. PMID17332221. [37] Sheikh A, Ten Broek V, Brown SG, Simons FE (August 2007). "H1-antihistamines for the treatment of anaphylaxis: Cochrane systematic review". Allergy 62 (8): 8307. doi:10.1111/j.1398-9995.2007.01435.x. PMID17620060.
35
Anaphylaxis
[38] Martelli, A; Ghiglioni, D, Sarratud, T, Calcinai, E, Veehof, S, Terracciano, L, Fiocchi, A (2008 Aug). "Anaphylaxis in the emergency department: a paediatric perspective.". Current opinion in allergy and clinical immunology 8 (4): 3219. PMID18596589. [39] Harris, edited by Jeffrey; Weisman, Micheal S. (2007). Head and neck manifestations of systemic disease (http:/ / books. google. ca/ books?id=31yUl-V90XoC& pg=PA325). London: Informa Healthcare. pp.325. ISBN978-0-8493-4050-5. . [40] editor, Mariana C. Castells, (2010). Anaphylaxis and hypersensitivity reactions (http:/ / books. google. ca/ books?id=bEvnfm7V-LIC& pg=PA223). New York: Humana Press. pp.223. ISBN978-1-60327-950-5. . [41] Koplin, JJ; Martin, PE, Allen, KJ (2011 Oct). "An update on epidemiology of anaphylaxis in children and adults.". Current opinion in allergy and clinical immunology 11 (5): 4926. PMID21760501. [42] Demain, JG; Minaei, AA, Tracy, JM (2010 Aug). "Anaphylaxis and insect allergy.". Current opinion in allergy and clinical immunology 10 (4): 31822. PMID20543675. [43] "anaphylaxis" (http:/ / www. merriam-webster. com/ dictionary/ anaphylaxis). merriam-webster.com. . Retrieved 2009-11-21. [44] Vichyanond, P (2011 Sep). "Omalizumab in allergic diseases, a recent review.". Asian Pacific journal of allergy and immunology / launched by the Allergy and Immunology Society of Thailand 29 (3): 20919. PMID22053590.
36
External links
Anaphylaxis (http://www.dmoz.org/Health/Conditions_and_Diseases/Allergies/Anaphylaxis//) at the Open Directory Project
37
Food Allergies
Food allergy
Food allergy
Classification and external resources ICD-10 ICD-9 OMIM T78.0 [1] [2] -V15.05 [3]
V15.01 147050
[4]
A food allergy is an adverse immune response to a food protein.[8][9] They are distinct from other adverse responses to food, such as food intolerance, pharmacological reactions, and toxin-mediated reactions. The protein in the food is the most common allergic component. These kinds of allergies occur when the body's immune system mistakenly identifies a protein as harmful. Some proteins or fragments of proteins are resistant to digestion and those that are not broken down in the digestive process are tagged by the Immunoglobulin E (IgE). These tags fool the immune system into thinking that the protein is harmful. The immune system, thinking the organism (the individual) is under attack, triggers an allergic reaction. These reactions can range from mild to severe. Allergic responses include dermatitis, gastrointestinal and respiratory distress, including such life-threatening anaphylactic responses as biphasic anaphylaxis and vasodilation; these require immediate emergency intervention. Individuals with protein allergies commonly avoid contact with the problematic protein. Some medications may prevent, minimize or treat protein allergy reactions. Treatment consists of either immunotherapy (desensitisation) or avoidance, in which the allergic person avoids all forms of contact with the food to which they are allergic. Areas of research include anti-IgE antibody (omalizumab, or Xolair) and specific oral tolerance induction (SOTI), which have shown some promise for treatment of certain food allergies. People diagnosed with a food allergy may carry an injectable form of epinephrine such as an EpiPen, or wear some form of medical alert jewelry, or develop an emergency action plan, in accordance with their doctor. The scope of problem, particularly for young people, is a significant public health issue.
Food allergy
38
Classification
Food allergy is thought to develop more easily in patients with the atopic syndrome, a very common combination of diseases: allergic rhinitis and conjunctivitis, eczema and asthma.[10] The syndrome has a strong inherited component; a family history of allergic diseases can be indicative of the atopic syndrome. Conditions caused by food allergies are classified into 3 groups according to the mechanism of the allergic response: 1. IgE-mediated (classic): Type-I immediate hypersensitivity reaction (symptoms described above) Oral allergy syndrome 2. IgE and/or non-IgE-mediated: Allergic eosinophilic esophagitis Allergic eosinophilic gastritis Allergic eosinophilic gastroenteritis 3. Non-IgE mediated: Food protein-induced Enterocolitis syndrome (FPIES) Food protein proctocolitis/proctitis Food protein-induced enteropathy. An important example is Celiac disease, which is an adverse immune response to the protein gluten. Milk-soy protein intolerance (MSPI) is a non-medical term used to describe a non-IgE mediated allergic response to milk and/or soy protein during infancy and early childhood. Symptoms of MSPI are usually attributable to food protein proctocolitis or FPIES. Heiner syndrome lung disease due to formation of milk protein/IgG antibody immune complexes (milk precipitins) in the blood stream after it is absorbed from the GI tract. The lung disease commonly causes bleeding into the lungs and results in pulmonary hemosiderosis.
Symptoms of allergies vary from person to person. The amount of food needed to trigger a reaction also varies from person to person.
Food allergy
39
Cardiopulmonary
Serious danger regarding allergies can begin when the respiratory tract or blood circulation is affected. The latter can be indicated through wheezing and cyanosis. Poor blood circulation leads to a weak pulse, pale skin, and fainting.[12] A severe case of an allergic reaction, caused by symptoms affecting the respiratory tract and blood circulation, is called anaphylaxis. When symptoms are shown where breathing is impaired and circulation is affected, the person is said to be in anaphylactic shock. Anaphylaxis occurs when IgE Antibodies are involved, and areas of the body that are not in direct contact with the food become affected and show symptoms.[13] This occurs because no nutrients are circulated throughout the body, causing the widening of blood vessels. This vasodilation causes blood pressure to decrease, which leads to the loss of consciousness. Those with asthma or an allergy to peanuts, tree nuts, or seafood are at greater risk for anaphylaxis.[14]
Cause
One of the most common food allergies is a sensitivity to peanuts, a member of the bean family. Peanut allergies may be severe, but children with peanut allergies sometimes outgrow them.[15] Tree nuts, including pecans, pistachios, pine nuts, and walnuts, are also common allergens. Sufferers may be sensitive to one particular tree nut or to many different tree nuts.[16] Also seeds, including sesame seeds and poppy seeds, contain oils where protein is present, which may elicit an allergic reaction.[16] Egg allergies affect about one in fifty children but are frequently outgrown by children when they reach age five.[17] Typically the sensitivity is to proteins in the white, rather than the yolk.[16] Milk, from cows, goats or sheep, is another common food allergen, and many sufferers are also unable to tolerate dairy products such as cheese. A very small portion of children with a milk allergy, roughly ten percent, will have a reaction to beef. Beef contains a small amount of protein that is present in cow's milk.[18] Other foods containing allergenic proteins include soy, wheat, fish, shellfish, fruits, vegetables, spices, synthetic and natural colors, and chemical additives. Although sensitivity levels vary by country, the most common food allergies are allergies to milk, eggs, peanuts, tree nuts, seafood, shellfish, soy and wheat.[19] These are often referred to as "the big eight."[20] Allergies to seeds especially sesame seem to be increasing in many countries.[21] An example of allergies more common to a particular region is the surplus rice allergies in East Asia where rice forms a large part of the diet.[22]
Cross reactivity
Some children who are allergic to cow's milk protein also show a cross sensitivity to soy-based products.[23] There are infant formulas in which the milk and soy proteins are degraded so when taken by an infant, their immune system does not recognize the allergen and they can safely consume the product. Hypoallergenic infant formulas can be based on hydrolyzed proteins, which are proteins partially predigested in a less antigenic form. Other formulas, based on free amino acids, are the least antigenic and provide complete nutrition support in severe forms of milk allergy. People with latex allergy often also develop allergies to bananas, kiwi, avocados, and some other foods.[24]
Food allergy
40
Pathophysiology
Allergic reactions are hyperactive responses of the immune system to generally innocuous substances. When immune cells encounter the allergenic protein, IgE antibodies are produced; this is similar to the immune system's reaction to foreign pathogens. The IgE antibodies identify the allergenic proteins as harmful and initiate the allergic reaction. The harmful proteins are those that do not break down due to the strong bonds of the protein. IgE antibodies bind to a receptor on the on the surface of the protein, creating a tag, just as a virus or parasite becomes tagged. It is not entirely clear why some proteins do not denature and subsequently trigger allergic reactions and hypersensitivity while others do not.[25]
A histamine, the structure shown, is what causes a person to feel itchy during an allergic reaction. A common medication to stop this is an antihistamine, which fights the histamines in the person's system.
Hypersensitivities are categorized according to the parts of the immune system that are attacked and the amount of time it takes for the response to occur. There are four types of Hypersensitivity reaction: Type 1, Immediate IgE-mediated, Type 2, Cytotoxic, Type 3, Immune complex-mediated, and Type 4, Delayed cell-mediated.[26] The pathophysiology of allergic responses can be divided into two phases. The first is an acute response that occurs immediately after exposure to an allergen. This phase can either subside or progress into a "late phase reaction" which can substantially prolong the symptoms of a response, and result in tissue damage. Many food allergies are caused by hypersensitivities to particular proteins in different foods. Proteins have unique properties that allow them to become allergens, such as stabilizing forces in the tertiary and quaternary structure which prevent degradation during digestion. Many theoretically allergenic proteins cannot survive the destructive environment of the digestive tract and thus don't trigger hypersensitive reactions.[27]
Acute response
In the early stages of allergy, a type I hypersensitivity reaction against an allergen, encountered for the first time, causes a response in a type of immune cell called a TH2 lymphocyte, which belongs to a subset of T cells that produce a cytokine called interleukin-4 (IL-4). These TH2 cells interact with other lymphocytes called B cells, whose role is the production of antibodies. Coupled with signals provided by IL-4, this interaction stimulates the B cell to begin production of a large amount of a particular type of antibody known as IgE. Secreted IgE circulates in the blood and binds to an IgE-specific receptor (a kind of Fc receptor called FcRI) on the surface of other kinds of immune cells called mast cells and basophils, which are both involved in the acute inflammatory response. The IgE-coated cells, at this stage are sensitized to the allergen.[28]
If later exposure to the same allergen occurs, the allergen can bind to the IgE molecules held on the surface of the mast cells or basophils. Cross-linking of the IgE and Fc receptors occurs when more than one IgE-receptor complex interacts with the same allergenic molecule, and activates the sensitized cell. Activated mast cells and basophils undergo a process called degranulation, during which they release histamine and other inflammatory chemical mediators (cytokines, interleukins, leukotrienes, and
Degranulation process in allergy. 1 antigen 2 IgE antibody 3 FcRI receptor 4 preformed mediators (histamine, proteases, chemokines, heparine) 5 granules 6 mast cell 7 newly formed mediators (prostaglandins, leukotrienes, thromboxanes, PAF)
Food allergy prostaglandins) from their granules into the surrounding tissue causing several systemic effects, such as vasodilation, mucous secretion, nerve stimulation and smooth muscle contraction. This results in rhinorrhea, itchiness, dyspnea, and anaphylaxis. Depending on the individual, the allergen, and the mode of introduction, the symptoms can be system-wide (classical anaphylaxis), or localized to particular body systems; asthma is localized to the respiratory system and eczema is localized to the dermis.[28]
41
Late-phase response
After the chemical mediators of the acute response subside, late phase responses can often occur. This is due to the migration of other leukocytes such as neutrophils, lymphocytes, eosinophils, and macrophages to the initial site. The reaction is usually seen 224 hours after the original reaction.[29] Cytokines from mast cells may also play a role in the persistence of long-term effects. Late phase responses seen in asthma are slightly different from those seen in other allergic responses, although they are still caused by release of mediators from eosinophils, and are still dependent on activity of TH2 cells.[30]
Protein function
Protein folding is essential to the overall function of the individual protein; some protein structures allow them to resist degradation in the acidic environment of the digestive tract.Polypeptide chains are often very long and flexible, which leads to a wide variety of ways for a protein to fold. Non-covalent interactions control the shape and structure of the nascent protein. A protein's proper amino acid sequence is absolutely required to induce proper folding into the quaternary structure. Two common folding patterns seen in proteins are the alpha helix and beta sheets.
Food allergy
42
Diagnosis
There are three common types of allergy testing: skin prick test, blood test, and food challenges. An allergist can perform these tests, and they can also go into further depth depending on the results. For skin prick tests, a tiny board with protruding needles is used. The allergens are placed either on the board or directly on the skin. The board is then placed on the skin, in order to puncture the skin and for the allergens to enter the body. If a hive appears, the person will be considered positive for the allergy. This test only works for IgE antibodies. Allergic reactions caused by other antibodies cannot be detected through skin prick tests.[34] Blood testing is another way to test for allergies; however, it poses the same disadvantage and only detects IgE allergens and does not Skin testing on arm is a common way for work for every possible allergen. RAST, RadioAllergoSorbent Test, detecting an allergy, however, it is not as is used to detect IgE antibodies present to a certain allergen. The effective as other tests. score taken from the RAST test is compared to predictive values, taken from a specific type of RAST test. If the score is higher than the predictive values, there is a great chance the allergy is present in the person. One advantage of this test is that it can test many allergens at one time.[35] Food challenges test for allergens other than those caused by IgE allergens. The allergen is given to the person in the form of a pill, so the person can ingest the allergen directly. The person is watched for signs and symptoms. The problem with food challenges is that they must be performed in the hospital under careful watch, due to the possibility of anaphylaxis.[36] The best method for diagnosing food allergy is to be assessed by an allergist. The allergist will review the patient's history and the symptoms or reactions that have been noted after food ingestion. If the allergist feels the symptoms or reactions are consistent with food allergy, he/she will perform allergy tests. Examples of allergy testing include: Skin prick testing is easy to do and results are available in minutes. Different allergists may use different devices for skin prick testing. Some use a "bifurcated needle", which looks like a fork with 2 prongs. Others use a "multi-test", which may look like a small board with several pins sticking out of it. In these tests, a tiny amount of the suspected allergen is put onto the skin or into a testing device, and the device is placed on the skin to prick, or break through, the top layer of skin. This puts a small amount of the allergen under the skin. A hive will form at any spot where the person is allergic. This test generally yields a positive or negative result. It is good for quickly learning if a person is allergic to a particular food or not, because it detects allergic antibodies known as IgE. Skin tests cannot predict if a reaction would occur or what kind of reaction might occur if a person ingests that particular allergen. They can however confirm an allergy in light of a patient's history of reactions to a particular food. Non-IgE mediated allergies cannot be detected by this method. Blood tests are another useful diagnostic tool for evaluating IgE-mediated food allergies. For example, the RAST (RadioAllergoSorbent Test) detects the presence of IgE antibodies to a particular allergen. A CAP-RAST test is a specific type of RAST test with greater specificity: it can show the amount of IgE present to each allergen.[37] Researchers have been able to determine "predictive values" for certain foods. These predictive values can be compared to the RAST blood test results. If a persons RAST score is higher than the predictive value for that food, then there is over a 95% chance the person will have an allergic reaction (limited to rash and anaphylaxis reactions) if they ingest that food. Currently, predictive values are available for the following foods: milk, egg, peanut, fish, soy, and wheat.[38][39][40] Blood tests allow for hundreds of allergens to be screened from a single sample, and cover food allergies as well as inhalants. However, non-IgE mediated allergies cannot be detected by this method. Other widely promoted tests such as the antigen leukocyte cellular antibody test (ALCAT) and the
Food allergy Food Allergy Profile are considered unproven methods, the use of which is not advised.[41] Food challenges, especially double-blind placebo-controlled food challenges (DBPCFC), are the gold standard for diagnosis of food allergies, including most non-IgE mediated reactions. Blind food challenges involve packaging the suspected allergen into a capsule, giving it to the patient, and observing the patient for signs or symptoms of an allergic reaction. Due to the risk of anaphylaxis, food challenges are usually conducted in a hospital environment in the presence of a doctor. Additional diagnostic tools for evaluation of eosinophilic or non-IgE mediated reactions include endoscopy, colonoscopy, and biopsy.
43
Differential diagnosis
Important differential diagnoses are: Lactose intolerance; this generally develops later in life but can present in young patients in severe cases. This is due to an enzyme deficiency (lactase) and not allergy. It occurs in many non-Western people. Celiac disease; this is an autoimmune disorder triggered by gluten proteins such as gliadin (present in wheat, rye and barley). It is a non-IgE mediated food allergy by definition. Irritable bowel syndrome (IBS) C1 esterase inhibitor deficiency (hereditary angioedema); this rare disease generally causes attacks of angioedema, but can present solely with abdominal pain and occasional diarrhea.
Prevention
According to a report issued by the American Academy of Pediatrics, "There is evidence that breastfeeding for at least 4 months, compared with feeding infants formula made with intact cow milk protein, prevents or delays the occurrence of atopic dermatitis, cow milk allergy, and wheezing in early childhood."[42] In order to avoid an allergic reaction, a strict diet can be followed. It is difficult to determine the amount of allergenic food required to elicit a reaction, so complete avoidance should be attempted unless otherwise suggested by a qualified medical professional. In some cases, hypersensitive reactions can be triggered by exposures to allergens though skin contact, inhalation, kissing, participation in sports, blood transfusions, cosmetics, and alcohol.[43] When avoiding certain foods in order to lessen the risk of reaction, it can be hard to maintain the proper amounts of nutrients. Some allergens are also common sources of vitamins and minerals, as well as macronutrients such as fat and protein; healthcare providers will often suggest alternate food sources of essential vitamins and minerals which are less allergenic.
Treatment
The mainstay of treatment for food allergy is avoidance of the foods that have been identified as allergens. For people who are extremely sensitive, this may involve the total avoidance of any exposure with the allergen, including touching or inhaling the problematic food as well as touching any surfaces that may have come into contact with it. If the food is accidentally ingested and a systemic reaction (anaphylaxis) occurs, then epinephrine should be used. It is possible that a second dose of epinephrine may be required for severe reactions. There are treatments for an allergic reaction. Among the first time the reaction occurs, it is most beneficial to take the person to the emergency room, where proper action may be taken. Other treatments include: epinephrine, antihistamines, and steroids.
Food allergy
44
Epinephrine
Epinephrine, also known as adrenaline, is a common medication used to treat allergic reactions. Epinephrine reverses the allergic reaction by improving blood circulation. This is done by tightening blood vessels in order to increase the heart beat and circulation to bodily organs. EpiPens are portable epinephrine-dispensing devices which can be used to alleviate the Epinephrine is produced naturally in the body. It is produced during symptoms of severe, acute allergies. "flight-or-fight" response. When a person is presented with a dangerous situation, the adrenal gland is triggered to release adrenaline; this gives the person an increased heart rate and more energy to try to fight off the danger being imposed on the individual. Epinephrine is also prescribed by a physician in a form that is self-injectable. This is what is called an epi-pen.[44]
Antihistamines
Antihistamines are also used to treat allergic reactions. Antihistamines block the action of histamine, which causes blood vessels to dilate and become leaky to plasma proteins. Histamine also causes itchiness by acting on sensory nerve terminals. The most common antihistamine given for food allergies is diphenhydramine, also known as Benedryl. Antihistamines relieve symptoms. When it comes to dealing with anaphylaxis, however, they do not completely improve the dangerous symptoms that affect breathing.[45]
Steroids
Steroids are used to calm down the immune system cells that are attacked by the chemicals released during an allergic reaction. This form of treatment in the form of a nasal spray should not be used to treat anaphylaxis, for it only relieves symptoms in the area in which the steroid is in contact. Another reason steroids should not be used to treat anaphylaxis is due to the long amount of time it takes to reduce inflammation and start to work. Steroids can also be taken orally or through injection. By taking a steroid in these manners, every part of the body can be reached and treated, but a long time is usually needed for these to take effect.[46]
Desensitisation
Desensitisation may be a cure for food allergies.[47] If the major precipitating allergen is a pollen then this is targeted by current protocols for desensitisation, not the food analogue allergen. Injections are used, as sublingual drops are not suitable for sufferers of oral allergy. Prof. Dr. Ronald van Ree of The University of Amsterdam and The Academic Medical Center expects that vaccines can in theory be created using genetic engineering to cure allergies. If this can be done, food allergies could be eradicated in about ten years.[48]
Epidemiology
The most common food allergens include peanuts, milk, eggs, tree nuts, fish, shellfish, soy, and wheat these foods account for about 90% of all allergic reactions.[49] The most common food allergies in adults are shellfish, peanuts, tree nuts, fish, and egg.[50] The most common food allergies in children are milk, eggs, peanuts, and tree nuts.[50] Six to eight percent of children under the age of three have food allergies and nearly four percent of adults have food allergies.[50] For reasons that are not entirely understood, the diagnosis of food allergies has apparently become more common in Western nations in recent times.[51] In the United States, food allergy affects as many as 5% of infants less than three years of age[52] and 3% to 4% of adults.[53] There is a similar prevalence in Canada.[54]
Food allergy Seventy-five percent of children who have allergies to milk protein are able to tolerate baked-in milk products, i.e., muffins, cookies, cake. About 50% of children with allergies to milk, egg, soy, and wheat will outgrow their allergy by the age of 6. Those that are still allergic by the age of 12 or so have less than an 8% chance of outgrowing the allergy.[55] Peanut and tree nut allergies are less likely to be outgrown, although evidence now shows[56] that about 20% of those with peanut allergies and 9% of those with tree nut allergies will outgrow them.[57] In Central Europe, celery allergy is more common. In Japan, allergy to buckwheat flour, used for soba noodles, is more common. Meat allergy is extremely rare in the general population, but a geographic cluster of people allergic to meat has been observed in Sydney, Australia.[58] There appears to be a possible association between localised reaction to tick bite and the development of meat allergy. Fruit allergies exist, such as to apples, peaches, pears, jackfruit, strawberries, etc. Corn allergy may also be prevalent in many populations, although it may be difficult to recognize in areas such as the United States and Canada where corn derivatives are common in the food supply.[59] Protein allergies or intolerance of seeds, nuts, meat, and milk are especially common among children.[60]
45
Footnotes
[1] [2] [3] [4] [5] [6] [7] [8] [9] http:/ / apps. who. int/ classifications/ icd10/ browse/ 2010/ en#/ T78. 0 http:/ / www. icd9data. com/ getICD9Code. ashx?icd9=V15. 01 http:/ / www. icd9data. com/ getICD9Code. ashx?icd9=V15. 05 http:/ / omim. org/ entry/ 147050 http:/ / www. nlm. nih. gov/ medlineplus/ ency/ article/ 000817. htm http:/ / www. emedicine. com/ med/ topic806. htm http:/ / www. nlm. nih. gov/ cgi/ mesh/ 2011/ MB_cgi?field=uid& term=D005512 "Frequently Asked Questions" (http:/ / www. foodallergy. org/ questions. html). Food Allergy & Anaphylaxis Network. . "Allergy Glossary of Terms" (http:/ / www. revolutionhealth. com/ conditions/ asthma-allergies/ hay-fever-seasonal-allergies/ introduction/ allergy-glossary). Revolution Health. . [10] "Other atopic dermatitis and related conditions" (http:/ / www. icd9data. com/ 2007/ Volume1/ 680-709/ 690-698/ 691/ 691. 8. htm). ICD9. . [11] MedlinePlus Encyclopedia Food allergy (http:/ / www. nlm. nih. gov/ medlineplus/ ency/ article/ 000817. htm) [12] van Ree 1 [13] Sicherer 2006, p.12 [14] Food Allergies (http:/ / www. foodallergyinitiative. org). Food Allergy Initiative. 2009. Accessed 27 Mar 2010. [15] Sicherer 2006, p.62 [16] Sicherer 2006, p.63 [17] Savage JH, Matsui EC, Skripak JM, Wood RA (December 2007). "The natural history of egg allergy" (http:/ / linkinghub. elsevier. com/ retrieve/ pii/ S0091-6749(07)01834-9). J Allergy Clin Immunol 120 (6): 14137. doi:10.1016/j.jaci.2007.09.040. PMID18073126. . [18] Sicherer 2006, p.64 [19] "Food Allergy Facts & Figures" (http:/ / www. aafa. org/ display. cfm?id=9& sub=30). Asthma and Allergy Foundation of Americs. March 28, 2007. . [20] "Food allergy and intolerance" (http:/ / www. faia. org. uk/ html/ food_sensitivity. php). Allergy & Intolerance. Food Additives and Ingredients Association. . Retrieved 2010-06-08. [21] "About Food Allergies" (http:/ / www. faiusa. org/ ?page=aboutFoodAllergies). Food Allergy Initiative. 2008. . Retrieved 2008-12-08. [22] "Rice Allergy" (http:/ / allergy. healthcentersonline. com/ foodallergyintolerance/ riceallergy2. cfm). HealthCentersOnline. 2006. pp.2. . Retrieved 2006-10-26. [23] "Policy Statement: Hypoallergenic Infant Formulas" (http:/ / aappolicy. aappublications. org/ cgi/ content/ full/ pediatrics;106/ 2/ 346). American Academy of Pediatrics. August 2, 2000. .
Food allergy
[24] "Other Common Allergens" (http:/ / www. foodallergy. org/ page/ other). The Food Allergy & Anaphylaxis Network. . [25] Food Reactions. Allergies (http:/ / www. foodreactions. org/ allergy/ ). Foodreactions.org. Kent, England. 2005. Accessed 27 Apr 2010. [26] Nester 2009, p.414 [27] Mayo Clinic. Causes of Food Allergies. (http:/ / www. mayoclinic. com/ health/ food-allergy/ AN00179) April 2010. [28] Janeway, Charles; Paul Travers, Mark Walport, and Mark Shlomchik (2001). Immunobiology; Fifth Edition (http:/ / www. ncbi. nlm. nih. gov/ books/ bv. fcgi?call=bv. View. . ShowTOC& rid=imm. TOC& depth=10). New York and London: Garland Science. pp.e-book. ISBN0-8153-4101-6. .. [29] Grimbaldeston MA, Metz M, Yu M, Tsai M, Galli SJ (2006). "Effector and potential immunoregulatory roles of mast cells in IgE-associated acquired immune responses". Curr. Opin. Immunol. 18 (6): 75160. doi:10.1016/j.coi.2006.09.011. PMID17011762. [30] Holt PG, Sly PD (2007). "Th2 cytokines in the asthma late-phase response". Lancet 370 (9596): 13968. doi:10.1016/S0140-6736(07)61587-6. PMID17950849. [31] Freeman 2008, p.53 [32] Alberts 2010, p.121 [33] Freeman 2008, p.54 [34] Sicherer 2006, p.185 [35] Sicherer 2006, pp.1878 [36] Sicherer 2006, p.189 [37] "What is a RAST test ? What is a CAP-RAST test?" (http:/ / www. kidswithfoodallergies. org/ resourcespre. php?id=48& title=What is a RAST test ? What is a CAP-RAST test?). kidswithfoodallergies.org. . [38] Sampson, HA; Ho DG (October 1997). "Relationship between food-specific IgE concentrations and the risk of positive food challenges in children and adolescents". J Allergy Clin Immunol 100 (4): 44451. doi:10.1016/S0091-6749(97)70133-7. PMID9338535. [39] Sampson, HA (May 2001). "Utility of food-specific IgE concentrations in predicting symptomatic food allergy". J Allergy Clin Immunol 107 (5): 8916. doi:10.1067/mai.2001.114708. PMID11344358. [40] Garcia-Ara, C; Boyano-Martinez T, Diaz-Pena JM, et al. (January 2001). "Specific IgE levels in the diagnosis of immediate hypersensitivity to cows' milk protein in the infant". Allergy Clin Immunol 107 (1): 18590. doi:10.1067/mai.2001.111592. PMID11150010. [41] Wthrich B (2005). "Unproven techniques in allergy diagnosis". J Investig Allergol Clin Immunol 15 (2): 8690. PMID16047707. [42] Greer, F. R.; Sicherer, SH; Burks, AW; American Academy of Pediatrics Committee on Nutrition; American Academy of Pediatrics Section on Allergy and Immunology (2008). "Effects of early nutritional interventions on the development of atopic disease in infants and children: the role of maternal dietary restriction, breastfeeding, timing of introduction of complementary foods, and hydrolyzed formulas" (http:/ / pediatrics. aappublications. org/ cgi/ content/ full/ 121/ 1/ 183?submit. y=5& submit. x=110& submit=sendit& gca=121/ 1/ 183& ). Pediatrics (American Academy of Pediatrics) 121 (1): 183. doi:10.1542/peds.2007-3022. PMID18166574. . Retrieved 2008-01-09. [43] Sicherer 2006, pp.1518 [44] Sicherer 2006, p.133 [45] Sicherer 2006, p.131 [46] Sicherer 2006, p.134 [47] "Studies Show Children Can Complete Treatment for Peanut Allergies and Achieve Long-Term Tolerance" (http:/ / www. dukehealth. org/ HealthLibrary/ News/ studies_show_children_can_complete_treatment_for_peanut_allergies_and_achieve_long_term_tolerance). Duke University Medicine News and Communications. 2009-03-15. . Retrieved Mar. 15, 2009. [48] "Food allergies 'gone in 10 years'" (http:/ / news. bbc. co. uk/ 2/ hi/ health/ 5329572. stm). BBC News. 2006-09-09. . Retrieved 2006-09-09. [49] "About Food Allergies" (http:/ / www. faiusa. org/ ?fuseaction=home. viewpage& page_id=5556A2E8-E081-2F43-D4153C0689F035F6). Food Allergy Initiative. . Retrieved 2010-08-06. [50] National Institute of Allergy and Infectious Diseases (July 2004). "Food Allergy: An Overview" (http:/ / www. niaid. nih. gov/ publications/ pdf/ foodallergy. pdf) (PDF). National Institutes of Health. pp.35. . [51] Kagan RS (February 2003). "Food allergy: an overview" (http:/ / www. ehponline. org/ members/ 2003/ 5702/ 5702. html). Environ Health Perspect 111 (2): 2235. doi:10.1289/ehp.5702. PMC1241355. PMID12573910. . [52] Sampson H (2004). "Update on food allergy" (http:/ / www. jacionline. org/ article/ PIIS0091674904011455/ fulltext). J Allergy Clin Immunol 113 (5): 805819. doi:10.1016/j.jaci.2004.03.014. PMID15131561. . [53] Sicherer S, Sampson H (2006). "9. Food allergy". J Allergy Clin Immunol 117 (2 Suppl MiniPrimer): S4705. doi:10.1016/j.jaci.2005.05.048. PMID16455349. [54] "Food Allergies and Intolerance" (http:/ / www. hc-sc. gc. ca/ fn-an/ securit/ allerg/ index_e. html). Health Canada. December 6, 2007. . [55] "What Are Food Allergies? Food Allergy Summary" (http:/ / www. aafa. org/ display. cfm?id=9& sub=15& cont=78). Asthma and Allergy Foundation of America. March 28, 2007. . [56] "Outgrowing food allergies" (http:/ / www. childrensmemorial. org/ depts/ allergy/ outgrow. asp). Children's Memorial Hospital. . [57] Fleischer DM, Conover-Walker MK, Matsui EC, Wood RA (November 2005). "The natural history of tree nut allergy". J Allergy Clin Immunol 116 (5): 108793. doi:10.1016/j.jaci.2005.09.002. PMID16275381. [58] "One tick red meat could do without" (http:/ / www. theaustralian. news. com. au/ story/ 0,25197,23667445-23289,00. html). The Australian. . [59] Parker, Cherry (February 1980). "Food Allergies". The American Journal of Nursing (Lippincott Williams &) 80 (2): 2625. doi:10.2307/3470059. JSTOR3470059. PMID6898386.
46
Food allergy
[60] Sicherer, Scott H. M.D., Understanding and Managing Your Child's Food Allergy. Baltimore: The Johns Hopkins University Press, 2006.
47
References
Alberts, Bruce; Bray, Dennis; Hopkin, Karen; Johnson, Alexander; Lewis, Julian; Raff, Martin; Roberts, Keith; Walter, Peter (2010). "Protein Structure and Function". Essential Cell Biology (3rd ed.). New York: Garland Science, Taylor and Francis Group. pp.120170. Fernndez de Corres L, Moneo I, Muoz D, Bernaola G, Fernndez E, Audicana M, Urrutia I (January 1993). "Sensitization from chestnuts and bananas in patients with urticaria and anaphylaxis from contact with latex". Ann Allergy 70 (1): 359. PMID7678724. Frankel, Edward (1991). Poison Ivy, Poison Oak, Poison Sumac and Their Relatives; Pistachios, Mangoes and Cashews. Pacific Grove CA: Boxwood Press. ISBN0-940168-18-9. Freeman, Scott (2008). "Protein Structure and Function". Biological Science (3rd ed.). San Francisco CA: Pearson Education. pp.4365. Food Allergy and Anaphylaxis Network. Network (http://foodallergy.org). 2008. Accessed 25 Mar 2010. Hogan, C.Michael. Western poison-oak: Toxicodendron diversilobum (http://globaltwitcher.auderis.se/ artspec_information.asp?thingid=82914). GlobalTwitcher, ed. Nicklas Stromberg. 2008. Accessed 30 April 2010. Keeler, Harriet L. Our Native Trees and How to Identify Them. New York: Charles Scriber's Sons. 1900. Medic Alert Foundation. Medic Alert (http://medicalert.org). California. 2010. Accessed 25 Mar 2010. American Academy of Allergy, Asthma and Immunology. Allergies (http://www.aaaai.org). 2010. Accessed 25 Mar 2010. Food and Drug Administration. USFDA: Allergies (http://www.cfsan.fda.gov). United States Department of Health and Human Services. 2010. Accessed 27 Mar 2010. Food Allergies (http://www.foodallergyinitiative.org). Food Allergy Initiative. 2009. Accessed 27 Mar 2010. Food Reactions. Allergies (http://www.foodreactions.org/allergy/). foodreactions.org Kent, England. 2005. Accessed 27 Apr 2010. Mayo Clinic Food Allergy (http://www.mayoclinic.com/health/food-allergy/AN00179). 2010. Accessed 27 Apr 2010. High Protein foods. Foods (http://www.highproteinfoods.net). High Protein Foods.net, 2004. Accessed 21 Mar 2010. Mount Sinai School of Medicine. Food allergy (http://www.mssm.edu/jaffe_food_allergy). 2010. Accessed 25 Mar 2010. Nester, Eugene W.; Anderson, Denise G.; Roberts, Jr, C. Evans; Nester, Martha T. (2009). "Immunologic Disorders". Microbiology: A Human Perspective (6th ed.). New York: McGraw-Hill. pp.414428. Sicherer, Scott H. (2006). Understanding and Managing Your Child's Food Allergy. Baltimore: Johns Hopkins University Press. Zuidmeer L, van Ree R (June 2007). "Lipid transfer protein allergy: primary food allergy or pollen/food syndrome in some cases" (http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/ landingpage.htm?issn=1528-4050&volume=7&issue=3&spage=269). Curr Opin Allergy Clin Immunol 7 (3): 26973. doi:10.1097/ACI.0b013e32814a5401. PMID17489047.
Food allergy
48
Further reading
"Food Allergies and Intolerances Resource List for Consumers" (http://www.nal.usda.gov/fnic/pubs/bibs/ allergy.pdf). Food and Nutrition Information Center, National Agricultural Library. December 2010. - a collection of resources on the topic of food allergies and intolerances Weissman, Susan, Feeding Eden: The Trials and Triumphs of a Food Allergy Family, New York : Sterling Publishing Co., Inc., March 6, 2012. ISBN 978-1-4027-8122-3
External links
Why Risk It (http://www.whyriskit.ca) - support for Canadian teenagers suffering from anaphylaxis The Anaphylaxis Campaign (http://www.anaphylaxis.org.uk) UK support charity The Food Allergy & Anaphylaxis Network (http://www.foodallergy.org) - US x20051103230534239900 (http://www.gpnotebook.co.uk/simplepage.cfm?ID=x20051103230534239900) at GPnotebook General Practice Notebook 16-182d. (http://www.merck.com/mmhe/sec16/ch182/ch182d.html) at Merck Manual of Diagnosis and Therapy Home Edition
Corn allergy
Corn/Maize allergy is a type of food allergy. It can be a difficult allergy to manage, particularly in the United States, due to the high number of food products which contain various forms of corn, such as corn starch, citric acid, modified food starch, vinegar, and vanilla, among many others. [1] However, it is an allergy that often goes unrecognized.[2]
Symptoms
As a result of a possible IgE allergy to corn, symptoms can resemble that of any other recognized allergy, including anaphylaxis. Reactions to corn derivatives, such as corn syrup, are also possible.
Notes
[1] "Food Allergies", The American Journal of Nursing, Vol. 80, No. 2 (Feb., 1980), pp. 262-265 [2] "Allergy to Corn Often Remains Unrecognized", Science News 89:331 May 7, 1966
24
Egg allergy
49
Egg allergy
Egg allergy
Classification and external resources
D021181
Egg allergy is a type of food allergy. It is a hypersensitivity to dietary substances from the yolk or whites of eggs, causing an overreaction of the immune system which may lead to severe physical symptoms for millions of people around the world.[3] Egg allergy appears mainly, but not exclusively, in children. In fact, it is the second most common food allergy in children.[4] (The most common is cows' milk allergy.) It is usually treated with an exclusion diet and vigilant avoidance of foods that may be contaminated with egg. The most severe food allergy reaction is called anaphylaxis[5] and is an emergency situation requiring immediate attention and treatment with epinephrine. The Asthma and Allergy Foundation of America estimates that most children outgrow egg allergy by the age of five, but some people remain allergic for a lifetime.[6]
Antigens
Most people who are allergic to hen's eggs have antibodies which react to one of four proteins in the egg white:[7] ovomucoid, ovalbumin, ovotransferrin, and lysozyme; ovomucoid, also called Gal d 1, is the most common target of immune system attack.[7] The egg yolk contains several potential antigens: livetin, apovitillin, and vosvetin. A person who reacts only to a protein in the egg yolk may be able to easily tolerate egg whites, and vice versa. Some people will be allergic to proteins in both the egg white and the egg yolk. Egg yolk allergies may be somewhat more common in adults.[7] A small number of people who are allergic to eggs will develop an allergy to chicken or other poultry meats.[7]
Egg allergy
50
Diagnosis
Diagnosis is generally made through a combination of skin prick testing or blood testing and detailed records of all foods and drink the person regularly intakes.
Treatment
There is currently no cure for egg allergy. Most people who are allergic to eggs avoid eating any form of egg or egg component. For people with a more serious allergic reaction to eggs, urticaria (hives) and inflammation can occur and as such, doctors suggest that the person carries around an EpiPen.
Prognosis
In a study presented at the 2007 American Academy of Allergy, Asthma, and Immunology (AAAAI) meeting, 50% of patients outgrew egg allergy by age 17. Of those patients who outgrew it, 45% did so by age 5. Children who outgrew the allergy tended to have peak IgE levels at around age one, which then decline.[8]
Vaccine hazard
The flu vaccine is typically made using chicken embryo, and as a result the final vaccine does contain egg proteins. Egg-allergic individuals may react to egg protein(s) in the vaccine (or to gelatin or neomycin if they are allergic to that). If an individual is unable to take the vaccine, vaccinating all other members of their family can help protect them from the flu. Different brands and even individual batches of flu vaccine do vary in their egg protein content. Allergist formerly used skin testing with flu vaccine to predict if receiving the flu shot might be safe, but the results of this type of testing are totally unpredictive and this type of testing should be abandoned. Instead, the age-appropriate immunization material containing the lowest amount of egg proteins should be chosen, then a 1/10 dose should be given followed by a 30 minute observation period in a medical setting fully equipped to treat any possible reaction. Ovalbumin is usually used as a marker for the egg proteins. Vaccines available as recently as 2010 in the US contained up to 21 mcg of ovalbumin per 0.5 mL dose. In 2011 the ovalbumin content varies from less than 5.0 mcg/dose down to less than 0.05 mcg/dose, depending on the brand. One study done on 83 egg allergic patients resulted in a lack of serious reactions at doses of ovalbumin ranging from 0.10 mcg to 0.60 mcg. Thus so some brands available in the US in 2011 are probably safe for most egg allergic patients (administered with caution), but others may not be. For reference modern MMR vaccine (which is generally accepted now to be well tolerated by egg allergic patients, but which is still given with caution) was shown in a 2009 study reported in the BMJ to contain 0.0005 to 0.0010 mcg/dose [0.5 to 1.0 ng/dose). REFERENCE: June 2011 UPTODATE.com monograph on "influenza vaccine and egg allergy" and the NIH Expert Panel Report on Food Allergy, December 2010. Egg proteins can also be found in yellow fever vaccine and MMR vaccine.[9] The quantity of egg protein in a dose of MMR vaccine is approximately 40 picograms (much lower than in influenza vaccine, which contains approximately 0.02-1.0micrograms), and this is believed to be associated with a much lower risk.[10]
Egg allergy Albumin Apovitellin Cholesterol-free egg substitute (e.g. Eggbeaters) Dried egg solids, dried egg Egg, egg white, egg yolk Egg wash Eggnog Fat substitutes (some) Globulin Livetin Lysozyme Mayonnaise Meringue or meringue powder Ovalbumin Ovoglobulin Ovomucin Ovomucoid Ovotransferrin Ovovitelia Ovovitellin Powdered eggs Silici albuminate Simplesse Trailblazer Vitellin Whole egg
51
Ingredients that sometimes include egg are: Artificial flavoring Lecithin Natural flavoring Nougat
Egg allergy
52
References
[1] [2] [3] [4] [5] http:/ / www. icd9data. com/ getICD9Code. ashx?icd9=V15. 03 http:/ / www. nlm. nih. gov/ cgi/ mesh/ 2011/ MB_cgi?field=uid& term=D021181 National Institutes of Health, NIAID Allergy Statistics 2005 http:/ / www. niaid. nih. gov/ factsheets/ allergystat. htm "Egg Allergy" (http:/ / www. faiusa. org/ ?page=egg). Food Allergy Initiative. 2008. . Retrieved 12-11-2008. National Report of the Expert Panel on Food Allergy Research, NIH-NIAID 2003 http:/ / www3. niaid. nih. gov/ about/ organization/ dait/ PDF/ june30_2003. pdf [6] Egg Allergy Facts (http:/ / www. aafa. org/ display. cfm?id=9& sub=20& cont=523) Asthma and Allergy Foundation of America [7] Thomas Platts-Mills; Ring, Johannes (2005). Allergy in Practice. Berlin: Springer. p.106. ISBN3-540-00219-7. [8] The Natural History of Egg Allergy by J. H. Rabe, E. C. Matsui, K. E. Mudd, J. M. Skripak, R. A. Wood; http:/ / www. abstractsonline. com/ viewer/ viewAbstract. asp?CKey={DD35189B-AC3C-4320-AAD4-6A60AB84247B}& MKey={ADB9F23F-599E-4E3C-8BFE-532DF96F148F}& AKey={3B788255-C10D-411E-A96E-F2E03408D278}& SKey={2DF953E8-793B-4112-8FE0-58A9F4495EC0} [9] Romero GL, Kumar S (December 2006). "Case 1: The case of the cookie, the rash and the flu vaccine". Paediatr Child Health 11 (10): 6757. PMC2528595. PMID19030254. [10] "Egg Allergies : Vaccine Education Center - Children's Hospital of Philadelphia" (http:/ / www. chop. edu/ consumer/ jsp/ division/ generic. jsp?id=75811). . [11] "Egg Avoidance List" (http:/ / www. kidswithfoodallergies. org/ resourcespre. php?id=36& title=Egg_allergy_avoidance_list). . [12] Arnaldo Cantani (2008). Pediatric Allergy, Asthma and Immunology. Berlin: Springer. pp.710713. ISBN3-540-20768-6. [13] Joris, Isabelle; Majno, Guido (2004). Cells, tissues, and disease: principles of general pathology. Oxford [Oxfordshire]: Oxford University Press. pp.538. ISBN0-19-514090-7. [14] Carina Venter; Isabel Skypala (2009). Food Hypersensitivity: Diagnosing and Managing Food Allergies and Intolerance. Wiley-Blackwell. pp.129131. ISBN1-4051-7036-0. [15] "NFL Workout: Strapped In A system designed by a Navy SEAL got the Saints' Drew Brees in shape to succeed" (http:/ / sportsillustrated. cnn. com/ 2007/ players/ 01/ 09/ nfl. workout0115/ index. html). CNN. 2007-01-09. . Retrieved 2008-10-01.
Milk allergy
53
Milk allergy
Milk allergy
Classification and external resources
A milk allergy is a food allergy, an adverse immune reaction to one or more of the constituents of milk from any animal (most commonly alpha S1-casein, a protein in cow's milk). This milk-induced allergic reaction can involve anaphylaxis, a potentially life-threatening condition. It is important to note that a milk allergy is a separate and distinct condition from lactose intolerance.
Allergen
A person with milk allergy can be reactive to one of dozens of the proteins within milk. The most common one is alpha S1-casein.[2] Alpha S1-caseins differ between species. This explains why someone with an allergic reaction to sheep's milk cannot drink goat's milk but can drink breast milk without an allergic reaction.[3]
Symptoms
The principal symptoms are gastrointestinal, dermatological and respiratory. These can translate to: skin rash, hives, vomiting, and gastric distress such as diarrhea, constipation, stomach pain or flatulence. The clinical spectrum extends to diverse disorders: anaphylactic reactions, atopic dermatitis, wheeze, infantile colic, gastroesophageal reflux (GER), oesophagitis, allergic colitis, headache/migraine, oral irritation, and constipation. The symptoms may occur within a few minutes after exposure in immediate reactions, or after hours (and in some cases after several days) in delayed reactions.
Milk allergy
54
Milk allergy
55
Accidental exposure
Treatment for accidental ingestion of milk products by allergic individuals varies depending on the sensitivity of the allergic person. Frequently medications such as an Epinephrine pen or an Antihistamine such as Diphenhydramine (Benadryl) are prescribed by an allergist in case of accidental ingestion. Milk allergy can cause anaphylaxis, a severe, life threatening allergic reaction. Milk allergies are common in infants but are usually outgrown within the first 23 years of life.
Statistics
Milk allergy is the most common food allergy in early childhood. It affects somewhere between 2% and 3% of infants in developed countries, but approximately 8590% of affected children lose clinical reactivity to milk once they surpass 3 years of age.[9] Between 13% and 20% of children allergic to milk are also allergic to beef.[10]
References
[1] [2] [3] [4] [5] [6] [7] [8] http:/ / www. icd9data. com/ getICD9Code. ashx?icd9=V15. 02 http:/ / www. dynamicchiropractic. com/ mpacms/ dc/ article. php?id=38646 http:/ / foodallergens. ifr. ac. uk/ biochemical. lasso?selected_food=5000& allergenID=1041 http:/ / kidshealth. org/ parent/ medical/ allergies/ milk_allergy. html MSPI Overview (http:/ / mspikids. info/ ) Go Dairy Free | Dairy Ingredient List (http:/ / www. godairyfree. org/ Food-to-Eat/ Food-Label-Info/ Dairy-Ingredient-List. html) http:/ / www. fussybaby. ca/ breastfeedingdairy. html Brill H (September 2008). "Approach to milk protein allergy in infants" (http:/ / www. cfp. ca/ cgi/ pmidlookup?view=long& pmid=18791102). Can Fam Physician 54 (9): 125864. PMC2553152. PMID18791102. . [9] Hst A (December 2002). "Frequency of cow's milk allergy in childhood". Ann. Allergy Asthma Immunol. 89 (6 Suppl 1): 337. doi:10.1016/S1081-1206(10)62120-5. PMID12487202. [10] Martelli A, De Chiara A, Corvo M, Restani P, Fiocchi A (December 2002). "Beef allergy in children with cow's milk allergy; cow's milk allergy in children with beef allergy". Ann. Allergy Asthma Immunol. 89 (6 Suppl 1): 3843. doi:10.1016/S1081-1206(10)62121-7. PMID12487203.
Milk allergy
56
External links
A muffin a day could keep milk allergy at bay (http://www.aboutkidshealth.ca/En/News/NewsAndFeatures/ Pages/muffins-milk-allergy.aspx) Eating without Casein (http://web.mit.edu/kevles/www/nomilk.html) Practical guide to milk-free eating Milk Allergy (http://www.faiusa.org/?page=milk) at Food Allergy Initiative Milk Allergy Symptoms (http://milkallergy.info/)
Fruit allergy
Fruit allergy is a food allergy. Fruit allergies make up about 10 percent of all food related allergies[1]
Symptoms
Allergic reactions to fruit and vegetables are usually mild and often just affect the mouth, causing itching, a rash, or blisters where the food touches the lips and mouth. This is called oral allergy syndrome. (A number of people who react in this way to fruit or vegetables will also react to pollen from some trees and weeds. So, for example, people who are allergic to birch pollen are also likely to be allergic to apples.[2]) Another symptom may include slight swelling in the throat, making it feel like it is closing. The ability to breathe is still present though, so it is not fatal.
Diagnostic
Skin prick testing is a common way of testing for an allergy. Other ways to test for allergies can be challenge testing, which consists in feeding a very small and measured amount of the allergen to the patient and monitor the reaction (O'Neil, Zanovec and Nickla). This should only be done by a doctor under surveillance.
Allergy or Intolerance
An allergy is different from an intolerance. Food allergies and food intolerances should not be confused because they do not contain the same risks and are not diagnosed the same way. Allergies can be fatal after only a small consumption, while intolerance, although uncomfortable, are not as deadly. An intolerance may lead to a nutrient deficiency which could cause death if untreated but the intolerance itself is not enough to cause rapid death. Allergies, with their varying symptoms, could cause instantaneous death if there is inflammation in the throat and
57
Mitigation
For those allergic to fruits, cooking may help reduce or eliminate the reaction to some fruits.[2] People with this allergy might not necessarily be allergic to citrus fruits.
References
[1] Asthma and Allergy Foundation of America - Information About Asthma, Allergies, Food Allergies and More! (http:/ / www. aafa. org/ display. cfm?id=9& sub=20& cont=286) [2] Food Standards Agency - Eat well, be well - Fruit and vegetable allergy (http:/ / www. eatwell. gov. uk/ healthissues/ foodintolerance/ foodintolerancetypes/ fruitandveg/ )
Sareen and Shah. (2011). Hypersensitivity manifestations to the fruit mango. Asia Pacific Allergy. (44-49). Retrieved from http:/ / www-ncbi-nlm-nih-gov. login. ezproxy. library. ualberta. ca/ pmc/ articles/ PMC3206236/ pdf/apa-1-43.pdf O'Neil, Zanovec and Nicklas. (2010). A Review of Food Allergy and Nutritional Considerations in the Food-Allergic Adult. American Journal of Lifestyle Medicine. (49-62). Retrieved from http:/ / ajl. sagepub. com. login. ezproxy. library.ualberta.ca/content/5/1/49.full.pdf+html
External links
Asthma and Allergy Foundation of America (http://www.aafa.org)
Peanut allergy
58
Peanut allergy
Peanut allergy
Classification and external resources
A peanut allergy warning ICD-10 ICD-9 DiseasesDB MeSH T78.4 [1] [1] [2] [3] , V15.01 [2]
995.61 29154
D021183
Peanut allergy is a type of food allergy distinct from nut allergies. It is a type 1 hypersensitivity reaction to dietary substances from peanuts causing an overreaction of the immune system which in a small percentage of people may lead to severe physical symptoms. It is estimated to affect 0.4-0.6% of the population.[4] In England, an estimated 4,000 people are newly diagnosed with peanut allergy per year (11 per day); 25,700 having been diagnosed with peanut allergy by a clinician at some point in their lives.[5] The most severe allergies in general can result in anaphylaxis,[6] an emergency situation requiring immediate attention and treatment with epinephrine. It is usually treated with an exclusion diet and vigilant avoidance of foods that may contain whole peanuts or peanut particles and/or oils.
Symptoms
Symptoms of peanut allergy are related to the action of Immunoglobulin E (IgE) and other anaphylatoxins, which act to release histamine and other mediator substances from mast cells (degranulation). In addition to other effects, histamine induces vasodilation of arterioles and constriction of bronchioles in the lungs, also known as bronchospasm (constriction of the airways). Symptoms can include the following:[7] vomiting diarrhea urticaria (hives) angioedema (swelling of the lips, face, throat and skin)
Peanut allergy asthma anaphylactic shock The British Dietetic Association warns that: "If untreated, anaphylactic shock can result in death due to obstruction of the upper or lower airway (bronchospasm) or hypotension and heart failure. This happens within minutes to hours of eating the peanuts. The first symptoms may include sneezing and a tingling sensation on the lips, tongue and throat followed by pallor, feeling unwell, warm and light headed. Severe reactions may return after an apparent resolution of 16 hours. Asthmatics with peanut sensitivity are more likely to develop life threatening reactions".[7]
59
Causes
The exact cause of someone developing a peanut allergy is unknown. A 2003 study found no link to maternal exposure to peanuts during pregnancy or during breast-feeding,[8] though the data show a linkage to the amount of time a child is breastfed. The same study indicated that exposure to soy milk or soy products was correlated with peanut allergies. However, an analysis of a larger group in Australia found no linkage to consumption of soy milk, and that the appearance of linkage is likely due to preference to using soy milk among families with known milk allergies.[9][10] It's possible that exposure to peanut oils in lotions may be implicated with development of the allergy.[11][12] Another hypothesis for the increase in peanut allergies (and other immune and auto-immune disorders) in recent decades is the hygiene hypothesis. Comparative studies have found that delaying introduction of peanut products significantly increases the risks of development of peanut allergies,[13][14] and the American Academy of Pediatrics, in response to ongoing studies that showed no reduction in risk of atopic disease, rescinded their recommendation to delay exposure to peanuts along with other foods. They also found no reason to avoid peanuts during pregnancy or while breastfeeding.[15] A study conducted jointly in Israel and United Kingdom in 8600 children noted a nearly 10 fold increase in incidence of peanut allergy among U.K. children compared to Israeli children. It was found that Israeli children were given peanut at a much younger age than those in the U.K. following recommendation of pediatricians in the U.K.[16] Pediatric Associations in Britain and Australia recommend delaying introduction until age 3 and have not changed their recommendations as of March 2009.
Prevalence
The Asthma and Allergy Foundation of America estimates that peanut allergy is one of the most common causes of food-related death.[17] However, there is an increasing body of medical opinion that, while there definitely are food sensitivities, the dramatic uptake in frequency of nut allergies and more particularly the measures taken in response to the threat show elements of mass psychogenic illness, hysterical reactions grossly out of proportion to the level of danger:[18] "Dr. Christakis points out that about 3.3 million Americans are allergic to nuts, and even more 6.9 million are allergic to seafood. But of 30 million hospitalizations each year, just 2,000 are due to food allergies, and about 150 people die annually from serious allergic food reactions. Thats the same number of people killed by bee stings and lightning strikes combined. About 10,000 children are hospitalized annually with traumatic brain injuries from sports, 2,000 children drown each year, and about 1,300 die in gun accidents, he writes." Media sensationalism has also been blamed.[19] Prevalence among adults and children is similararound 1%but at least one study shows it to be on the rise in children in the United States.[20] The number of young children affected doubled between 1997 and 2002.[21] 25% of children with a peanut allergy outgrow it.[22] In America, about 10 people per year die from peanut allergies.[23] One study has shown that peanut allergies also correlate with ethnicity; in particular, Native Americans are less prone to be allergic to peanuts.[24]
Peanut allergy
60
Routes of Exposure
While the most obvious and dangerous route for an allergic individual is unintentional ingestion, some reactions are possible through external exposure. However some of these are controversial, exaggerated, or have been discredited through empirical testing. Common beliefs are that anaphylaxis can be triggered by touching peanuts or products, smelling the odor of peanuts, and simple proximity to peanut products. Many of these beliefs have resulted in controversial bans on all peanut products from entire facilities such as schools and medical facilities. Harvard pediatrician Dr. Michael C. Young notes in his book The Peanut Allergy Answer Book that while such secondary contact might pose a risk to an allergic individual, the occurrence of a reaction is rare and limited to minor symptoms.[25] Some reactions have been noted to be psychogenic in nature, the result of conditioning and belief rather than a true chemical reaction. Blinded, placebo-controlled studies by Sicherer et al. were unable to produce any reactions using the odor of peanut butter or its mere proximity.[25] That said, some activities such as cooking or large-scale shelling or crushing of peanuts (such as in a farming or factory production environment) can cause particles to become airborne, and can have respiratory effects to allergic individuals who are nearby. Similarly, residue on surfaces has been known to cause minor skin rashes, though not anaphylaxis.[25]
Treatments
Currently there is no confirmed treatment to prevent or cure allergic reactions to peanuts; however some children have been recently participating in a method of treating the allergy to peanuts. This method consists of feeding the children minuscule peanut traces which gradually become larger and larger in order to desensitize the immune system to the peanut allergens.[21] Strict avoidance of peanuts is the only way to avoid an allergic reaction. Children and adults are advised to carry epinephrine injectors to treat anaphylaxis. In order to diagnose allergies one must be prepared to first tell their doctor about their symptoms. These symptoms should include any time intervals between the ingestion of the product and the time that the symptoms began. A person should also include the exact type of symptoms and any other history of the symptoms that may have also occurred from this same product. The time interval from the person's last reaction will also be helpful to the doctor to determine the specific allergy or medical issue. One of the first and easiest ways a doctor is able to diagnose the food allergy is by means of something called a Food Challenge. During this challenge, the patient will be asked to eliminate the peanut allergen completely from their diet for a time span from 10 to 14 days from start to finish. This type of elimination food challenge time span if for the IgE mediated allergy. There will be a time span as long as 8 weeks for the reaction called the cell mediated allergic reaction. By running these Food Challenges, doctors are able to determine whether or not the suspicion of the peanut allergy is accurate. The doctor will look at the results after the given time and if the symptoms have not changed, even after the peanuts have been eliminated completely for such a long period of time, that the allergy is probably not the likely cause. If the symptoms go away after the challenge then the allergy is probably the cause of the symptoms. While several companies have developed promising drugs to counteract peanut allergies, trials have been mired in legal battles.[26]
Peanut allergy
61
Oral desensitization
A desensitization study at Duke University was done with escalating doses of peanut protein. Eight children with known peanut allergy were given escalating doses of peanut protein in the form of a ground flour mixed into apple sauce or other food. To enter the study peanut IgE level > 7 kU/L and a positive skin prick test. The first day, they are given 0.1mg of peanut protein, then the amount of peanut is increased gradually to 50mg, if tolerated, over that first day. About of the kids tolerated 50mg dose by the end of the day, while the others were able to reach 12.5mg or 25mg. The children continued taking daily doses of peanut at home, returning to the hospital every two weeks for dose increases until they reached 300mg peanut protein a day, or the equivalent of a single peanut. The maintenance phase follows lasted up to 18 months, depending on how much peanut protein the child tolerated. Seven children completed the study. These children were given a "food challenge" to peanut flour, exposing them to up to nearly 8grams, or the equivalent of more than 13 peanuts. Five of the seven children tolerated the equivalent of 13 peanuts at the food challenge at the end of the study.[30] The childrens immunologic findings were similar to those seen with other types of immunotherapyan initial rise followed by a decline in peanut-specific IgE and IgG. They also had a rise in peanut-specific IgG4 throughout the study, which is thought to be a marker of protection in other forms of immunotherapy.[31] In February 2009 a successful desensitization study was announced by Addenbrooke's Hospital in Cambridge, England.[32] An example of the oral rush immunotherapy protocol is the administration of diluted peanut at a dose of 0.1mg (1 mL of a 1gram/10L solution), and escalating by 10 fold every 30 minutes. Once a maximum dose of 50mg is reached (1 mL of a 5gram/100 mL solution), or when systemic or local reaction occurs, the escalation is stopped.[27][33] The patient is maintained on this maximum day one dose daily and the dose is escalated by a less rapid twofold increase each week, or each month, depending on tolerance or protocol used. Reactions are treated with antihistamines, and if needed anaphylactic drugs. Standard protocols are being developed by several clinical trials being conducted in the United States.[34] Pre- and post-study serum anti-peanut IgE levels are measured, and varying doses and escalation schedules are being compared to placebo in blinded study protocols. Actual desensitization treatments are being carried out in the community using modified protocols.[35] Success has been reported in both rapid (short duration of weeks) to slow rush protocol (spread over months) with minimal systemic reactions. The first day of the protocol often required inpatient hospital admission, or observation in a physician's office equipped with resuscitative drugs and with IV access). Frequent follow up is required during the desensitization trials to treat reactions and modify the protocol if needed.[36] Because of the relative safety of oral rush immunotherapy, some in the medical community have questioned if desensitization is better than living with peanut allergy.[37]
Allergen-free peanuts
On July 20, 2007, the North Carolina Agricultural and Technical State University announced that one of its scientists, Dr. Mohamed Ahmedna, had developed a process to make allergen-free peanuts. Initial testing showed a 100 percent deactivation of peanut allergens in whole roasted kernels, and human serums from severely allergic individuals showed no reaction when exposed to the processed peanuts. Food companies have expressed an interest in licensing the process, which purportedly does not degrade the taste or quality of treated peanuts, and even results in easier processing to use as an ingredient in food products.[38]
Peanut allergy
62
References
[1] [2] [3] [4] http:/ / www. icd9data. com/ getICD9Code. ashx?icd9=995. 61 http:/ / www. diseasesdatabase. com/ ddb29154. htm http:/ / www. nlm. nih. gov/ cgi/ mesh/ 2011/ MB_cgi?field=uid& term=D021183 National Institutes of Health, NIAID Allergy Statistics 2005 (http:/ / www3. niaid. nih. gov/ topics/ foodAllergy/ understanding/ quickFacts. htm) [5] Kotz D, Simpson CR, Sheikh A (2011). "Incidence, prevalence, and trends of general practitioner-recorded diagnosis of peanut allergy in England, 2001-5". Journal of Allergy and Clinical Immunology 127 (3): 623630.e1. doi:10.1016/j.jaci.2010.11.021. PMID21236479. [6] National Report of the Expert Panel on Food Allergy Research, NIH-NIAID 2003 (http:/ / www3. niaid. nih. gov/ about/ organization/ dait/ PDF/ june30_2003. pdf) [7] The British Dietetic Association. Peanut Allergy Information for Dietitians. 1999 (http:/ / www. bda. uk. com/ Downloads/ peanutallergy. pdf) [8] "Interesting causes for peanut allergy identified" (http:/ / www. cincinnatichildrens. org/ svc/ alpha/ e/ eosinophilic/ doctors_comment1. htm). Cincinnatichildrens.org. 2007-09-26. . Retrieved 2010-07-08. [9] Soy milk allergy myth debunked (http:/ / www. smh. com. au/ news/ health/ soy-milk-allergy-myth-debunked/ 2008/ 06/ 18/ 1213770721239. html), Sydney Morning Herald, June 18, 2008 [10] Soy milk study results (http:/ / scienceinpublic. com/ sciencenow/ 2008/ jennifer_koplin. htm) [11] "Factors Associated with the Development of Peanut Allergy in Childhood" (http:/ / content. nejm. org/ cgi/ content/ short/ 348/ 11/ 977). NEJM. 2003-07-17. doi:10.1056/NEJMoa013536. . Retrieved 2010-07-08. [12] "Peanut allergy may be linked to peanut oil skin preparations and soy milk consumption" (http:/ / www. highbeam. com/ doc/ 1P3-340612661. html). Community Practitioner. 2003-05-01. . Retrieved 2010-07-08. [13] Food allergy advice may be peanuts (http:/ / www. sciencenews. org/ view/ generic/ id/ 38370/ title/ Food_allergy_advice_may_be_peanuts), Science News magazine, Dec 6 2008 [14] Hst A, Halken S, Muraro A, et al'.' (February 2008). "Dietary prevention of allergic diseases in infants and small children" (http:/ / www3. interscience. wiley. com/ resolve/ openurl?genre=article& sid=nlm:pubmed& issn=0905-6157& date=2008& volume=19& issue=1& spage=1). Pediatr Allergy Immunol 19 (1): 14. doi:10.1111/j.1399-3038.2007.00680.x. PMID18199086. . [15] Greer FR, Sicherer SH, Burks AW (January 2008). "Effects of early nutritional interventions on the development of atopic disease in infants and children: the role of maternal dietary restriction, breastfeeding, timing of introduction of complementary foods, and hydrolyzed formulas" (http:/ / pediatrics. aappublications. org/ cgi/ content/ full/ 121/ 1/ 183). Pediatrics 121 (1): 18391. doi:10.1542/peds.2007-3022. PMID18166574. . [16] Du Toit, G. et.al. The Journal of Allergy and Clinical Immunology. November 2008, Volume 122, Pages 978-985 "Early consumption of peanuts in infancy is associated with a low prevalence of peanut allergy" [17] "Allergy Facts and Figures", Asthma and Allergy Foundation of America http:/ / www. aafa. org/ display. cfm?id=9& sub=20& cont=517 [18] http:/ / well. blogs. nytimes. com/ 2008/ 12/ 15/ are-nut-bans-promoting-hysteria/ [19] Colver A (September 2006). "Are the dangers of childhood food allergy exaggerated?" (http:/ / www. bmj. com/ cgi/ content/ full/ 333/ 7566/ 494#TBL1). BMJ 333 (7566): 4946. doi:10.1136/bmj.333.7566.494. PMC1557974. PMID16946341. . [20] Prevalence of peanut and tree nut allergy in the United States determined by means of a random digit dial telephone survey: A 5-year follow-up study http:/ / www. allerg. qc. ca/ peanutallergy. htm#pressreldec903 [21] "Expert sees peanut allergy solution within 5 years" (http:/ / www. reuters. com/ article/ latestCrisis/ idUSN01401804). Reuters. 2008-05-01. . Retrieved 2008-10-30. [22] http:/ / www. ich. ucl. ac. uk/ factsheets/ families/ F000279/ [23] http:/ / www. aaaai. org/ patients/ advocate/ 2003/ fall/ reactions. stm [24] "peanut allergy" (http:/ / www. allerg. qc. ca/ peanutallergy. htm). Allerg.qc.ca. . Retrieved 2010-07-08. [25] Young, Michael C.. The Peanut Allergy Answer Book: 2nd Edition. Fair Winds Press. ISBN1-59233-233-1. [26] "Trials of an allergy drug Remedy against peanuts is mired in legal battles" (http:/ / www. nytimes. com/ 2003/ 03/ 13/ business/ wrangling-may-delay-peanut-allergy-drug. html). International Herald Tribune. 2003-03-14. . Retrieved 2010-07-08. [27] Robert A. Wood, MD. "Peanut Allergy: Presentations and Prospects for a Cure" (http:/ / www. childrensnational. org/ files/ PDF/ ForDoctors/ cme/ GrandRounds/ Wood-_Peanut_Allergy_DC_Childrens. pdf) (PDF). . Retrieved 2010-07-08. [28] "Answers from Dr. Greene | Allergy Care Guide" (http:/ / www. pennmedicine. org/ health_info/ allergy/ 000067. html). Pennmedicine.org. 2007-10-07. . Retrieved 2010-07-08. [29] Nelson HS, Lahr J, Rule R, Bock A, Leung D (June 1997). "Treatment of anaphylactic sensitivity to peanuts by immunotherapy with injections of aqueous peanut extract" (http:/ / linkinghub. elsevier. com/ retrieve/ pii/ S0091674997001528). J. Allergy Clin. Immunol. 99 (6 Pt 1): 74451. doi:10.1016/S0091-6749(97)80006-1. PMID9215240. . [30] "Progress Against Peanut Allergies" (http:/ / www. webmd. com/ allergies/ news/ 20070226/ progress-against-peanut-allergies). Webmd.com. . Retrieved 2010-07-08. [31] Terry Murray (2007-03-20). "AAAAI: Peanut desensitization program for kids shows promise" (http:/ / www. medicalpost. com/ medicine/ meeting/ article. jsp?content=20070321_101113_6224). Medicalpost.com. . Retrieved 2010-07-08.
Peanut allergy
[32] "News from Cambridge UK" (http:/ / www. cambridgenetwork. co. uk/ news/ article/ default. aspx?objid=56692). Cambridgenetwork.co.uk. . Retrieved 2010-07-08. [33] Clark AT, Islam S, King Y, Deighton J, Anagnostou K, Ewan PW (August 2009). "Successful oral tolerance induction in severe peanut allergy" (http:/ / www3. interscience. wiley. com/ resolve/ openurl?genre=article& sid=nlm:pubmed& issn=0105-4538& date=2009& volume=64& issue=8& spage=1218). Allergy 64 (8): 121820. doi:10.1111/j.1398-9995.2009.01982.x. PMID19226304. . [34] "Peanut Sublingual Immunotherapy" (http:/ / clinicaltrials. gov/ ct2/ show/ NCT00580606). ClinicalTrials.gov. . Retrieved 2010-07-08. [35] "Dallas Allergy" (http:/ / dallasallergy. net/ ). Dallas Allergy. . Retrieved 2010-07-08. [36] Beyer K, Wahn U (December 2008). "Oral immunotherapy for food allergy in children" (http:/ / meta. wkhealth. com/ pt/ pt-core/ template-journal/ lwwgateway/ media/ landingpage. htm?issn=1528-4050& volume=8& issue=6& spage=553). Curr Opin Allergy Clin Immunol 8 (6): 5536. doi:10.1097/ACI.0b013e32831952c8. PMID18978471. . [37] Brown HM (February 2007). "Would oral desensitization for peanut allergy be safer than avoidance?". Ann. Allergy Asthma Immunol. 98 (2): 203. doi:10.1016/S1081-1206(10)60701-6. PMID17304895. [38] North Carolina A & T State University Press Release, July 23, 2007
63
External links
The "Peanut Patch": The future of peanut allergy treatments? (http://www.aboutkidshealth.ca/En/News/ NewsAndFeatures/Pages/Peanut-patch-future-of-peanut-allergy-treatments.aspx) "Are Nut Bans Promoting Hysteria?" (http://well.blogs.nytimes.com/2008/12/15/ are-nut-bans-promoting-hysteria/) by Tara Parker-Pope at The New York Times (15 Dec 2008) This allergies hysteria is just nuts (http://christakis.med.harvard.edu/pdf/publications/misc/023.pdf) by Nicholas A. Christakis (British Medical Journal, December 2008) Peanut Allergy (http://peanut.dy.fi) (Finnish) Allergy Aware.org. "Peanut Allergy". 2009. Web, 20 July 2011. Goodman, Brenda. WebMD Health News. "Food Allergies in Kids More Common Than Thought." 20 June 2011. Web 2 July 2011. <http://children.webmd.com/news/20110620/food-allergies-in-kids-more-common-than-thought>. Laino, Charlene. Web MD. "New Therapy May Knock Out Peanut Allergy". 16 March 2009. Web 31 July 2011. <http://www.webmd.com/allergies/news/20090316/new-therapy-may-knock-out-peanut-allergy>.
Seafood allergy
64
Seafood allergy
Seafood allergy
Classification and external resources ICD-9 V15.04 [1]
Seafood allergy is a type of food allergy. It is a hypersensitivity to dietary substances from shellfish, scaly fish or crustaceans, causing an overreaction of the immune system, which may lead to severe physical symptoms for millions of people.[2] The Asthma and Allergy Foundation of America estimates that the majority of pediatric and adult food allergy patients have a seafood allergy.[3] It occurs mainly (but not exclusively) in adults. Allergic reactions may result when the susceptible person is not consuming the allergenic substance, by exposure to vapours resulting from cooking of seafood or even preparation or handling.[4]
Treatment
Seafood allergies are usually treated with an exclusion diet and vigilant avoidance of foods that may be contaminated with shellfish or fish ingredients and/or oils. The most severe seafood allergy reaction is called anaphylaxis,[5] which is an emergency, requiring immediate attention. It is treated with Epinephrine, which can be administered with an EpiPen.
References
[1] [2] [3] [4] http:/ / www. icd9data. com/ getICD9Code. ashx?icd9=V15. 04 National Institutes of Health, NIAID Allergy Statistics 2005 http:/ / www. niaid. nih. gov/ factsheets/ allergystat. htm Allergy Facts and Figures, Asthma and Allergy Foundation of America http:/ / www. aafa. org/ display. cfm?id=9& sub=20& cont=518 "Seafood* (Fish, Crustaceans and Shellfish) - One of the nine most common food allergens" (http:/ / www. inspection. gc. ca/ english/ fssa/ labeti/ allerg/ fispoie. shtml). Canadian Food Inspection Agency. 2009-06-12. . Retrieved 2009-06-21. [5] National Report of the Expert Panel on Food Allergy Research, NIH-NIAID 2003 http:/ / www3. niaid. nih. gov/ about/ organization/ dait/ PDF/ june30_2003. pdf
External links
Asthma and Allergy Foundation of America (http://www.aafa.org) The National Institutes of Health (http://www.nih.gov) Shellfish Allergy (http://www.faiusa.org/?page=shellfish) at Food Allergy Initiative Fish Allergy (http://www.faiusa.org/?page=fish) at Food Allergy Initiative
Soy allergy
65
Soy allergy
Soy allergy is a type of food allergy. It is a hypersensitivity to dietary substances from soy causing an overreaction of the immune system which may lead to severe physical symptoms for millions of people.[1] The Asthma and Allergy Foundation of America estimates soy is among the nine most common food allergens for pediatric and adult food allergy patients.[2] It is usually treated with an exclusion diet and vigilant avoidance of foods that may be contaminated with soy ingredients. The most severe food allergy reaction is called anaphylaxis[3] and is a medical emergency requiring immediate attention and treatment with Epinephrine.
Soy allergy The following food additives may contain soy protein: chocolate hydrolyzed vegetable protein (HVP) flavoring (including natural and artificial) canned chicken broth vegetable broth, gum, protein, and starch bouillon cubes (beef, chicken, vegetable, etc.) lecithin caramel color vegetable vegetable oil methylcellulose vegetable fat vegetable oil mono- and di-glycerides
66
Dosage tolerance
Many people with soy allergy can not tolerate small or moderate amounts of soy protein: the typical dose needed to induce an allergic response is about 100 times lower than for many other food allergens, with 90% of sufferers being unable to tolerate doses up to 400mg.[6] As a result, not all of those allergic to soy need to avoid very minor sources of soy protein such as soy oil or soy lecithin.
References
[1] National Institutes of Health, NIAID Allergy Statistics 2005 http:/ / www. niaid. nih. gov/ factsheets/ allergystat. htm [2] Allergy Facts and Figures, Asthma and Allergy Foundation of America http:/ / www. aafa. org/ display. cfm?id=9& sub=20& cont=518 [3] National Report of the Expert Panel on Food Allergy Research, NIH-NIAID 2003 http:/ / www3. niaid. nih. gov/ about/ organization/ dait/ PDF/ june30_2003. pdf [4] "McDonald's Nutrition Information and Ingredients" (http:/ / www. mcdonalds. com/ app_controller. nutrition. categories. ingredients. index. html), August 26, 2006, retrieved September 7, 2006 [5] Burger King USA (http:/ / www. bk. com/ Nutrition/ PDFs/ ingredients. pdf) (11 page PDF file) "Burger King Nutrition and Ingredients" Burger King Brands Inc. USA, August, 2006, retrieved September 7, 2006 [6] Christopher T. Cordle (1 May 2004). "Soy Protein Allergy: Incidence and Relative Severity" (http:/ / jn. nutrition. org/ cgi/ content/ full/ 134/ 5/ 1213S). Journal of Nutrition 134 (5): 1213S1219S. PMID15113974. .
External links
Soy Allergy (http://www.aafa.org/display.cfm?id=9&sub=20&cont=522) information page. Asthma and Allergy Foundation of America Soy Allergy (http://www.faiusa.org/?page=soy) at Food Allergy Initiative Soy - One of the nine most common food allergens (http://www.hc-sc.gc.ca/fn-an/securit/allerg/fa-aa/ allergen_soy-soja-eng.php) Health Canada
67
D021184
[2]
Tree nut allergy is a common type of food allergy, affecting millions of people worldwide. It is a hypersensitivity to dietary substances from tree nuts causing an overreaction of the immune system, which may lead to severe physical symptoms[3]. Tree nuts include almonds, Brazil nuts, cashews, chestnuts, filberts/hazelnuts, macadamia nuts, coconut, pecans, pine nuts (pignolia nuts), pistachios, and walnuts. People with tree nut allergy are seldom allergic to just one type of nut, and are therefore usually advised to avoid all tree nuts, even though an individual may not be allergic to all varieties of tree nuts. Someone allergic to walnuts or pecans may not have an allergy to cashews or pistachios, even though close biological relatives often share related allergenic proteins. The severity of the allergy varies from person to person, and exposure can increase sensitization. For those with a milder form of the allergy, the raw nut protein usually causes a more severe reaction than the oil, and extra roasting or processing can reduce the allergic reaction. Those diagnosed with anaphylaxis will have a more immediate mast cell reaction and be required to avoid all exposure to any allergen-containing products or byproducts, regardless of processing, as they are prone to even greater sensitivity. An allergy test or food challenge may be performed at an allergy clinic to determine the exact allergens. New immunotherapy treatments are being developed for tree nut allergy. Tree nut allergy is distinct from peanut allergy, as peanuts are considered legumes, whereas a tree nut is a hard-shelled fruit of certain plants. This allergy tends to be life-long; recent studies have shown that only about 9% of children outgrow their tree nut allergy[3]. Hazelnut has been used as a model tree nut in the study of tree nut allergies.[4]
Tree nut allergy mortadella. Tree nut oils (especially shea nut) are also sometimes used in lotions and soaps. Asian and African restaurants, ice cream parlors, and bakeries are considered high-risk for people with tree nut allergy due to the common use of nuts and the possibility of cross contamination. Treatment usually involves an exclusion diet and vigilant avoidance of foods that may be contaminated with tree nuts, nut particles, or oils. The most severe nut allergy reaction is anaphylaxis,[5] an emergency situation requiring immediate attention and treatment with epinephrine.
68
References
[1] [2] [3] [4] http:/ / www. icd9data. com/ getICD9Code. ashx?icd9=995. 64 http:/ / www. nlm. nih. gov/ cgi/ mesh/ 2011/ MB_cgi?field=uid& term=D021184 National Institutes of Health, NIAID Allergy Statistics http:/ / www3. niaid. nih. gov/ topics/ foodAllergy/ understanding/ quickFacts. htm Birmingham NP, Parvataneni S, Hassan HM, et al. (2007). "An adjuvant-free mouse model of tree nut allergy using hazelnut as a model tree nut" (http:/ / content. karger. com/ produktedb/ produkte. asp?typ=fulltext& file=000103993). Int. Arch. Allergy Immunol. 144 (3): 20310. doi:10.1159/000103993. PMID17570928. . [5] National Report of the Expert Panel on Food Allergy Research, NIH-NIAID 2003 http:/ / www3. niaid. nih. gov/ about/ organization/ dait/ PDF/ june30_2003. pdf
External links
Tree nut allergy (http://www.faiusa.org/?page=treenuts) at Food Allergy Initiative "Are Nut Bans Promoting Hysteria?" (http://well.blogs.nytimes.com/2008/12/15/ are-nut-bans-promoting-hysteria/) by Tana Parker-Pope at The New York Times (15 Dec 2008)
Wheat allergy
69
Wheat allergy
Wheat allergy
Classification and external resources
Wheat allergy is a food allergy, but can also be a contact allergy resulting from occupational exposure. Like all allergies wheat allergy involves IgE and mast cell response. Typically the allergy is limited to the seed storage proteins of wheat, some reactions are restricted to wheat proteins, while others can react across many varieties of seeds and other plant tissues. Wheat allergy may be a misnomer since there are many allergenic components in wheat, for example serine protease inhibitors, glutelins and prolamins and different responses are often attributed to different proteins. Twenty-seven potential wheat allergens have been successfully identified.[2] The most severe response is exercise/aspirin induced anaphylaxis attributed to one omega gliadin that is a relative of the protein that causes celiac disease.[3] Other more common symptoms include nausea, urticaria, atopy.[4]
Types of allergens
There are four major classes of seed storage proteins: albumins, globulins, prolamins and glutelins. Within wheat, prolamins are called gliadins and glutelins are called glutenins. These two protein groups form the classic glutens. While gluten is a causative agent of Coeliac disease (CD), coeliac disease can be contrasted to gluten allergy by the involvement of different immune cells and antibody types (See Comparative pathophysiology of gluten sensitivities), and because the list of allergens extend beyond the classic gluten category of proteins.
Wheat allergy
70
Gluten allergy
Prolamin allergies Prolamins and the closely related glutelins, a recent study in Japan found that glutinins are a more frequent allergen, however gliadins are associated with the most severe disease. A proteomics based study found a -gliadin isoform gene.[3] Wheat dependent exercise induced anaphylaxis (WDEIA) is primarily mediated by -5 gliadin which is encoded by the Gli-1B gene derived from the Aegilops speltoides B genome within wheat. Glutelin allergies Glutenin (wheat glutelin) is a predominant allergen in wheat.[3] Nine subunits of LMW-glutinen have been linked in connection with wheat allergies.
Other allergies
Wheat pollen and grass allergies Respiratory allergies are an occupational disease that develop in food service workers. Previous studies detected 40 allergens from wheat; some cross-reacted with rye proteins and a few cross-reacted with grass pollens.[9] A later study showed that baker's allergy extend over a broad range of cereal grasses (wheat, durum wheat, triticale, cereal rye, barley, rye grass, oats, canary grass, rice, maize, sorghum and Johnson grass) though the greatest similarities were seen between wheat and rye,[10] and that these allergies show cross reactivity between seed proteins and pollen proteins,[11] including a prominent crossreactivity between the common environment rye pollen and wheat gluten.[12][13] Derivative allergies Proteins are made of a chain of dehydrated amino acids. When enzymes cut proteins into pieces they add water back to the site at which they cut, called enzymatic hydrolysis, for proteins it is called proteolysis. The initial products of this hydrolysis are polypeptides, and smaller products are called simply peptides; these are called wheat protein hydrolysates. These hydrolysates can create allergens out of wheat proteins that previously did not exist by the exposure of buried antigenic sites in the proteins. When proteins are cut into polypeptides, buried regions are exposed to the surface, and these buried regions may possibly be antigenic. Such hydrolyzed wheat protein is used as an additive in foods and cosmetics. The peptides are often 1 kD in size (9 amino acid residues in length) and may increase the allergic response.[14] These wheat polypeptides can cause immediate contact urticaria in susceptible people.[15]
Wheat allergy
71
Wheat allergy
72
Wheat allergies were also common with contact dermatitis. A primary cause was the donning agent used for latex gloves prior to the 1990s, however most gloves now use protein free starch as donning agents.
Neuropathies
Migraines. In the late 70s it was reported that people with migraines had reactions to food allergens, like ARA, the most common reaction was to wheat (78%), orange, eggs, tea, coffee, chocolate, milk, beef, corn, cane sugar, and yeast. When 10 foods causing the most reactions were removed migraines fell precipitously, hypertension declined.[30] Some specific instances are attributed to wheat.[31] Autism. Parents of children with autism often ascribe the children's gastrointestinal symptoms to allergies to wheat and other foods. The published data on this approach are sparse, with the only double-blind study reporting negative results.[32]
Diagnosis
Diagnoses of wheat allergy may deserve special consideration. Omega-5 gliadin, the most potent wheat allergen, cannot be detected in whole wheat preparations, it must be extracted and partially digested (similar to how it degrades in the intestine) to reach full activity. Other studies show that digestion of wheat proteins to about 10 amino acids can increase the allergic response 10 fold. Certain allergy test may not be suitable to detect all wheat allergies, resulting in cryptic allergies. Because many of the symptoms associated with wheat allergies, such as sacroiliitis, eczema and asthma, may be related or unrelated to a wheat allergy, medical deduction can be an effective way of determining the cause. Wheat proteins can take months to fully metabolize so removing these foods from one's diet
Wheat allergy could be difficult to do as a method of diagnosis. If symptoms are alleviated by immunosuppressant drugs, such as Prednisone, an allergy related cause is likely. If multiple symptoms associated with wheat allergies are present in the absence of immunosuppressants then a wheat allergy is probable.[18]
73
Treatment
Wheat allergies differ from gluten-diet exclusion in that some types of allergens do not create species crossreactive responses, an individual may be able to consume barley and rye safely, although more than likely they will be allergic to other wheat such as spelt and Kamut. Wheat is often a cryptic contaminant of many foods; more obvious items are bread crumbs, maltodextrin, bran, cereal extract, couscous, cracker meal, enriched flour, gluten, high-gluten flour, high-protein flour, seitan, semolina wheat, vital gluten, wheat bran, wheat germ, wheat gluten, wheat malt, wheat starch or whole wheat flour. Less obvious sources of wheat could be gelatinized starch, hydrolyzed vegetable protein, modified food starch, modified starch, natural flavoring, soy sauce, soy bean paste, hoisin sauce, starch, vegetable gum, specifically Beta-glucan, vegetable starch. People with wheat allergy who are gluten sensitive may also need to avoid related cereals, rye and barley, which have similar glutinous proteins.
Alternative cereals
Triticeae gluten-free oats (free of wheat, rye or barley) may be a useful source of cereal fiber. Some wheat allergies allow the use of rye bread as a substitute. Rice flour is a commonly used alternative for those allergic to wheat. Wheat-free millet flour, buckwheat, flax seed meal, corn meal, quinoa flour, chia seed flour, tapioca starch or flour, and others can be used a substitutes. Spelt and khorasan wheat are grains related to common wheat, but are usually a suitable substitute for people with wheat allergies or that are gluten intolerant. Spelt and khorasan wheat are not options for those with Coeliac disease.
References
[1] http:/ / www. nlm. nih. gov/ cgi/ mesh/ 2011/ MB_cgi?field=uid& term=D021182 [2] Sotkovsk P, Sklen J, Halada P, Cinov J, Setinov I, Kainarov A, Goli J, Pavlskov K, Honzov S, Tukov L.,"A new approach to the isolation and characterization of wheat flour allergens.", Clin Exp Allergy. 2011 Jul;41(7):1031-43 [3] Akagawa M, Handoyo T, Ishii T, Kumazawa S, Morita N, Suyama K (2007). "Proteomic analysis of wheat flour allergens". J. Agric. Food Chem. 55 (17): 686370. doi:10.1021/jf070843a. PMID17655322. [4] Perr HA (2006). "Novel foods to treat food allergy and gastrointestinal infection". Current allergy and asthma reports 6 (2): 1539. doi:10.1007/s11882-006-0054-z. PMID16566866. [5] Sutton R, Hill DJ, Baldo BA, Wrigley CW (1982). "Immunoglobulin E antibodies to ingested cereal flour components: studies with sera from subjects with asthma and eczema". Clin. Allergy 12 (1): 6374. doi:10.1111/j.1365-2222.1982.tb03127.x. PMID7067068. [6] Armentia A, Sanchez-Monge R, Gomez L, Barber D, Salcedo G (1993). "In vivo allergenic activities of eleven purified members of a major allergen family from wheat and barley flour". Clin. Exp. Allergy 23 (5): 4105. doi:10.1111/j.1365-2222.1993.tb00347.x. PMID8334538. [7] Pastorello EA, Farioli L, Conti A et al (2007). "Wheat IgE-mediated food allergy in European patients: alpha-amylase inhibitors, lipid transfer proteins and low-molecular-weight glutenins. Allergenic molecules recognized by double-blind, placebo-controlled food challenge". Int. Arch. Allergy Immunol. 144 (1): 1022. doi:10.1159/000102609. PMID17496422. [8] Walsh BJ, Wrigley CW, Musk AW, Baldo BA (1985). "A comparison of the binding of IgE in the sera of patients with bakers' asthma to soluble and insoluble wheat-grain proteins". J. Allergy Clin. Immunol. 76 (1): 238. doi:10.1016/0091-6749(85)90799-7. PMID3839248. [9] Blands J, Diamant B, Kalls P, Kalls-Deffner L, Lowenstein H (1976). "Flour allergy in bakers. I. Identification of allergenic fractions in flour and comparison of diagnostic methods". Int. Arch. Allergy Appl. Immunol. 52 (14): 392406. PMID65335. [10] Baldo BA, Krilis S, Wrigley CW (1980). "Hypersensitivity to inhaled flour allergens. Comparison between cereals". Allergy 35 (1): 4556. doi:10.1111/j.1398-9995.1980.tb01716.x. PMID6154431. [11] Valero Santiago A, Amat Par P, Sanosa Valls J, Sierra Martnez P, Malet Casajuana A, Garca Caldern PA (1988). "Hypersensitivity to wheat flour in bakers". Allergologia et immunopathologia 16 (5): 30914. PMID3228051. [12] Donovan GR, Baldo BA (1990). "Crossreactivity of IgE antibodies from sera of subjects allergic to both ryegrass pollen and wheat endosperm proteins: evidence for common allergenic determinants". Clin. Exp. Allergy 20 (5): 5019. doi:10.1111/j.1365-2222.1990.tb03142.x. PMID2253081. [13] Yazicioglu M, Oner N, Celtik C, Okutan O, Pala O (2004). "Sensitization to common allergens, especially pollens, among children with respiratory allergy in the Trakya region of Turkey". Asian Pac. J. Allergy Immunol. 22 (4): 18390. PMID15783130..
Wheat allergy
[14] Akiyama H, Sakata K, Yoshioka Y et al (2006). "Profile analysis and immunoglobulin E reactivity of wheat protein hydrolysates". Int. Arch. Allergy Immunol. 140 (1): 3642. doi:10.1159/000092000. PMID16534217. [15] Laurire M, Pecquet C, Bouchez-Mahiout I et al (2006). "Hydrolysed wheat proteins present in cosmetics can induce immediate hypersensitivities". Contact Derm. 54 (5): 2839. doi:10.1111/j.0105-1873.2006.00830.x. PMID16689814. [16] "Allergy Society of South Africa - Wheat Allergy" (http:/ / web. archive. org/ web/ 20080424072330/ http:/ / www. allergysa. org/ wheat. htm). Archived from the original (http:/ / www. allergysa. org/ wheat. htm) on 2008-04-24. . Retrieved 2008-10-20. [17] Mittag D, Niggemann B, Sander I, Reese I, Fiedler EM, Worm M, Vieths S, Reese G. (2004). "Immunoglobulin E-reactivity of wheat-allergic subjects (baker's asthma, food allergy, wheat-dependent, exercise-induced anaphylaxis) to wheat protein fractions with different solubility and digestibility". Mol Nutr Food Res. 48 (5): 380389. doi:10.1002/mnfr.200400016. PMID15672478. [18] Matsuo H, Morita E, Tatham AS, Morimoto K, Horikawa T, Osuna H, Ikezawa Z, Kaneko S, Kohno K, and Dekio S. (2004). "Identification of the IgE-binding epitope in omega-5 gliadin, a major allergen in wheat-dependent exercise-induced anaphylaxis". J Biol Chem. 279 (13): 1213512140. doi:10.1074/jbc.M311340200. PMID14699123. [19] Matsuo H, Morimoto K, Akaki T, Kaneko S, Kusatake K, Kuroda T, Niihara H, Hide M, and Morita E. (2005). "Exercise and aspirin increase levels of circulating gliadin peptides in patients with wheat-dependent exercise-induced anaphylaxis". Clin Exp Allergy. 35 (4): 461466. doi:10.1111/j.1365-2222.2005.02213.x. PMID15836754. [20] Denery-Papini S, Laurire M, Branlard G et al (2007). "Influence of the allelic variants encoded at the Gli-B1 locus, responsible for a major allergen of wheat, on IgE reactivity for patients suffering from food allergy to wheat". J. Agric. Food Chem. 55 (3): 799805. doi:10.1021/jf062749k. PMID17263477. [21] Morita E, Kunie K, Matsuo H (2007). "Food-dependent exercise-induced anaphylaxis". J. Dermatol. Sci. 47 (2): 10917. doi:10.1016/j.jdermsci.2007.03.004. PMID17507204. [22] Weichel M, Glaser AG, Ballmer-Weber BK, Schmid-Grendelmeier P, Crameri R (2006). "Wheat and maize thioredoxins: a novel cross-reactive cereal allergen family related to baker's asthma". J. Allergy Clin. Immunol. 117 (3): 67681. doi:10.1016/j.jaci.2005.11.040. PMID16522470. [23] Langeland T, Nyrud M (1982). "Contact urticaria to wheat bran bath: a case report". Acta Derm. Venereol. 62 (1): 823. PMID6175150. [24] Barnetson RS, Wright AL, Benton EC (1989). "IgE-mediated allergy in adults with severe atopic eczema". Clin. Exp. Allergy 19 (3): 3215. doi:10.1111/j.1365-2222.1989.tb02390.x. PMID2736432. [25] Zeiger RS, Heller S, Mellon MH et al (1989). "Effect of combined maternal and infant food-allergen avoidance on development of atopy in early infancy: a randomized study". J. Allergy Clin. Immunol. 84 (1): 7289. doi:10.1016/0091-6749(89)90181-4. PMID2754147. [26] Van Bever HP, Docx M, Stevens WJ (1989). "Food and food additives in severe atopic dermatitis". Allergy 44 (8): 58894. doi:10.1111/j.1398-9995.1989.tb04205.x. PMID2610332. [27] Hvatum M, Kanerud L, Hllgren R, Brandtzaeg P (2006). "The gutjoint axis: cross reactive food antibodies in rheumatoid arthritis". Gut 55 (9): 12407. doi:10.1136/gut.2005.076901. PMC1860040. PMID16484508. [28] Karatay S, Erdem T, Kiziltunc A et al (2006). "General or personal diet: the individualized model for diet challenges in patients with rheumatoid arthritis". Rheumatol. Int. 26 (6): 55660. doi:10.1007/s00296-005-0018-y. PMID16025333. [29] Dieterich W, Esslinger B, Trapp D, Hahn E, Huff T, Seilmeier W, Wieser H, and Schuppan D. (2006). "Cross linking to tissue transglutaminase and collagen favours gliadin toxicity in coeliac disease". Gut. 55 (4): 47884. doi:10.1136/gut.2005.069385. PMC1856150. PMID16188922. [30] Grant EC (1979). "Food allergies and migraine". Lancet 1 (8123): 9669. doi:10.1016/S0140-6736(79)91735-5. PMID87628. [31] Pascual J, Leno C (2005). "A woman with daily headaches". The journal of headache and pain : official journal of the Italian Society for the Study of Headaches 6 (2): 912. doi:10.1007/s10194-005-0158-1. PMID16362649. [32] Elder JH (2008). "The gluten-free, casein-free diet in autism: an overview with clinical implications". Nutr Clin Pract 23 (6): 5838. doi:10.1177/0884533608326061. PMID19033217.
74
Gluten sensitivity
75
Gluten sensitivity
Gluten sensitivity (also gluten intolerance) is a spectrum of disorders, including celiac disease and wheat allergy, in which gluten has an adverse effect on the body. It can be defined as a non-allergic and non-autoimmune condition in which the consumption of gluten can lead to symptoms similar to those observed in celiac disease or wheat allergy (other conditions which fall under the gluten-related disorders spectrum). Gluten sensitivity is thought to affect roughly 10% of the general population.[1] Symptoms of gluten sensitivity include bloating, abdominal discomfort, pain or diarrhea; or it may present with a variety of extraintestinal symptoms including headaches and migraines, lethargy and tiredness, attention-deficit disorder and hyperactivity, schizophrenia, muscular disturbances as well as bone and joint pain.[2][3][4][5] Until recently, the terms gluten sensitivity and celiac disease were used interchangeably in literature. However, emerging research is beginning to identify the differences that exist between celiac disease and gluten sensitivity. If the medical history of a patient, along with clinical tests, rule out celiac disease and wheat allergy, a diagnosis of gluten sensitivity can be considered. However, certain criteria need to be met before a diagnosis of gluten sensitivity can be confirmed (see diagnosis section). Treatment for all three conditions is a gluten-free diet; the difference being that with wheat allergy the interruption is temporary and drugs may be administered; in the case of celiac disease the diet is lifelong and even ingesting very small amounts of gluten-containing food could damage their health and, in the case of gluten sensitivity the withdrawal of gluten from the diet may only be temporary. Gluten is a protein composite found in foods processed from wheat and related species, including barley and rye. It gives elasticity to dough helping it to rise and to keep its shape. It is found in many staple foods in the Western diet. Gluten is composed of a gliadin fraction (alcohol soluble) and a glutenin fraction (only soluble in dilute acids or alkali).
Symptoms
Symptoms of gluten sensitivity may include bloating, abdominal discomfort, pain, or diarrhea; or it may present with a variety of extraintestinal symptoms including headaches and migraines, lethargy and tiredness, attention-deficit disorder and hyperactivity, muscular disturbances as well as bone and joint pain.[4][5][6]
Diagnosis
If the medical history of a patient, along with clinical tests, rule out celiac disease and wheat allergy, a diagnosis of gluten sensitivity can be considered. However, before a diagnosis of gluten sensitivity can be confirmed the following criteria need to be met: Wheat allergy excluded (anti IgE antibody negative) Celiac disease excluded (negative serological results of tTG/EMA/dAGA and IgA deficiency) Not HLA restricted- the absence of HLA DQ2/8 heterodimers makes it possible to practically rule out celiac disease, however, it is also important to note that the presence of HLA DQ 2 or DQ8 does not always mean celiac disease Intestinal biopsy shows no villous atrophy (Marsh III classification) but there may be minimal changes to the lining of the gut (Marsh 0-I classification) Possible presence of serum anti-gliadin antibodies (AGA) IgA and/or IgG investigated If the patient reports alleviation of symptoms on a gluten-free diet If the above criteria are met then the person can be classed as gluten sensitive and it can be treated with a gluten-free diet for a period of time. This should lead to symptom resolution.
Gluten sensitivity
76
Etiology
Gluten sensitivity can develop at any point in life, and symptomatic disease may appear years after disease develops. When enteropathy develops in early childhood symptomatic disease is more rapidly evident. A survey of geriatrics with celiac disease in Finland[12] revealed that the incidence of disease was much higher than the general population. Allergic disease may rise or fall with age; however, certain evidence points to the increased or daily use of non-steroidal anti-inflammatory factors (aspirin, ibuprofen) as an increased risk factor for urticaria or anaphylaxis, and the sensitizing dose may include low-dose aspirin therapy used in the treatment of heart disease. Idiopathic disease appears largely late onset. Gluten-sensitive enteropathy develops as a consequence of genetic and environmental factors. Other than the involvement of certain HLA-DQ isoforms (antigen presenting proteins in humans) and certain wheat proteins, there is no clarity in the involvement of other genes or other environmental factors (see risk modifiers). Strong genetic factors such as seen in GSE have not been seen in gluten allergy, and with idiopathic gluten-sensitivity the HLA-DQ associations are weak. Researchers reported extreme fatigue and pain in patients without celiac disease, with gliadin antibodies. They called this a non-celiac gluten intolerance for which there is no explanation as to the mechanisms involved.[13]
Gluten sensitivity
77
Illustration of the brush border membrane of small intestinal villi Wheat proteins interact with the immune system by means of DQ2-mediated programmed cell death (apoptosis) of the gut in sensitive individuals. New research is finding that the celiac gut may be predisposed to sensitivity in the absence of HLA genetic factors. How diet proteins reach the blood
The fate of digestible protein in the small intestine In the normal gut, proteins are digested to peptides by pepsin (stomach), trypsin and chymotrypsin (derived from the pancreas and activated in the gut). Peptides are further digested when they enter the villi, where brush border peptidase break proteins into amino acids. Over much of the small intestine only small solutes, like water, can cross the tight junctions, however some regions of the intestine peptides as large as 500 daltons (4 amino-acids residues in length can cross). The gluten sensitive gut
Gluten sensitivity
78
The fate of gluten in celiac disease or EIA There is a growing body of evidence that the gluten-sensitive intestine differs from the normal gut. Several gluten peptides can infiltrate the region behind the cells lining the small intestine. The "33mer" of -2 gliadin is a magnitude larger than the maximum size allowable by the barrier around the cell, the tight junctions. Omega-5 gliadin peptides have been found in the blood stream of people with exercise-induced anaphylaxis, aided by salicylates. And the innate "25mer" is capable of reaching mononuclear cells in celiac gut, but in normal gut is broken down by brush border peptidases. It may be a lower peptidase activity that explains the presence of these peptides behind the brush border membrane. Recently, it was found that an -9 gliadin peptide was capable of binding the "CXCR3" receptor, increasing zonulin production and weakening tight junctions, this may explain how, generally, larger peptides can enter the gluten-sensitive gut.
Gluten toxicity
Further information: Innate immunity of gluten An increasing number of studies on gliadin indicate gluten has a direct and modifying effect on the cells of the small intestine. Two different lines of research show that different gliadins can increase permeability of the epithelial cells (outermost cells of the villus) allowing food proteins to enter. One study examined the effect of -5 gliadin, the primary cause of Wheat Dependent exercise/aspirin induced anaphylaxis, and found increased permeability of intestinal cells caused by this gliadin and another wheat albumin.[17]
Illustration of 2 alpha gliadins showing 2 proteolytically resistant sites, Top shows 6 T-cells sites in 33mer, and bottom shows innate immune peptide and two CXCR3 binding sites
Another line of research shows gliadin binds a chemoattractant receptor and causes increases of a factor that destroys tight junctions.[18] These junctions prevent leakage around the cells that line the small intestine, resulting in the
Gluten sensitivity leaking of food proteins into the body.[19] These toxicities of gluten that are not part of the adaptive immune response may be the link between wheat and gluten sensitivity, and possibly type 1 diabetes.
79
Immunochemistry of glutens
Triticeae glutens are important factors in several inflammatory diseases. The immunochemistry can be subdivided into innate responses (direct stimulation of immune system), class II mediated presentation (HLA DQ), class I mediated stimulation of killer cells, and antibody recognition. The responses to gluten proteins and polypeptide regions differs according to the type of gluten sensitivity. The response is also dependent on the genetic makeup of the human leukocyte antigen genes. In enteropathy, there are at least 3 types of recognition, innate immunity (a form of cellular immunity priming), HLA-DQ and antibody recognition of gliadin and transglutaminase.[20] The three dominant sequences responsible for the antibody reaction have been identified.[21][22] With idiopathic disease only antibody recognition to gliadin has been resolved. In wheat allergy, there appears to be an innate components and the response pathways are mediated through IgE against gliadin and other wheat proteins.[23][24][25]
Gluten sensitivity progresses to celiac disease (Marsh grade 3 and 4). The dietary cause of GSE is not limited to wheat gluten; 'glutens' from all known edible cultivars of Triticeae can induce GSE in susceptible individuals (see: Gluten immunochemistry). There are a large number of medical conditions that result from GSE that can occur prior to the development of celiac disease and might be gluten responsive. While the level of villus atrophy in some cases of GSE may not reach clinical celiac disease recognition, the elevation of cellular immunity is capable of producing disorders more frequently found in celiac disease. Conditions secondary to GSE are important diagnostic criteria for gluten sensitivity when there may be no obvious intestinal abnormality.
80
2.5 1.7
Presentation of GSE is often the result of initial recognition of the secondary condition which in followup testing (ATA test, AGA test, HLA-DQ typing, and/or biopsy) recognizes the primary condition. The secondary conditions associated with GSE tend to make late onset celiac disease a systemic phenomena.
Gluten sensitivity
81
Other conditions
Antibodies to -gliadin have been significantly increased in non-celiacs individuals with oral ulceration.[32] Anti--gliadin antibodies are frequently found in celiac disease(CD), to a lesser degree subclinical CD, but are also found in a subset who do not have the disease. The 1991 reference comes from a period when testing for subclinical CD was undeveloped. Of people with pseudo-exfoliation syndrome, 25% showed increased levels of anti-gliadin IgA.[33] One fourth of people with Sjgren's syndrome had responses to gluten, of 5 that had positive response to gluten, only one could be confirmed as CD and another was potentially GSE, the remaining 3 appear to be gluten-sensitive. All were HLA-DQ2 and/or DQ8-positive.[34] Treatment to produce remission of Crohns disease(CrD) symptoms on elimination diet indicated the most important foods provoking symptoms were wheat and dairy.[35] A later paper showed little IgE mediated response except to the dairy,[36] while another paper showed no significant anti-food IgE association.[37] Crohn's disease (CrD) may have a link to wheat that is independent of gluten. CrD appears to be associated with high anti-yeast antibodies (ASCA yeast antigens that are found in bread and other cereal derived products) and affected individuals lack lectin binding proteins such that the mannins in yeast, the antibodies that bind them and aggravate inflammatory colitis. One concern of the above studies is the high prevalence of markers for gluten-sensitive enteropathy, one has to question how idiopathic these conditions are if close examination for GSE has not been undertaken.
82
Comparative pathophysiology
Comparison of different forms of gluten sensitivity Gluten-sensitive enteropathy Typical symptoms Primary tissue targets Atypical pathologies Secondary targets (common) Immunoglobin isotype Antibody recognition HLA associations Cellular immunity Innate responses Background & references steatorrhoea, malnutrition, diarrhea, lactose intolerance, food allergies epithelia of small intestine other autoimmune diseases, chronic constipation, neuropathies, cancer (lymphoid) blood (chemistry), bowel, nervous system, autoantigens IgA, IgG /,-gliadin (AGA), transglutaminase (ATA) DQ2.5, DQ8, DQ2.2/DQ7.5 T-cells, Eosinophils, Monocytes (-gliadin) immune, increased permeability Celiac disease, GSEA conditions Wheat allergy eczema, asthma (epi) dermis, bronchi, intestines arthritis, migraines, anaphylaxis (exercise or aspirin induced) connective tissue, CNS, vascular IgE, IgG, IgA albumins, globulins, prolamins (-gliadin)(AGA), glutelins (LMW)(AGA) unknown Mast cells, Eosinophils (-5 gliadin)- increased permeability Wheat allergy IgG, IgA /-gliadin Gluten-sensitive idiopathic neuropathy ataxia, peripheral neuropathies CNS, Peripheral nerves unknown
Notes on table. Features of idiopathic neuropathy assume that all GSE cohort has been removed, assuming there is a gluten-sensitive, but not GSE contingent. Anti-gliadin antibodies covers all immunoglobulin isotypes and all gliadin isoforms. T-cell, Killer cell, and other gluten recognitions are covered in Gluten immunochemistry.
Gluten sources
Politics of Gluten-Free and Oats
Current guidelinesAs a consequence, the current international standard for the "Gluten-free" designation, drafted in 1981 and agreed on in 1983[39] within the Codex Alimentarius (CA), states: For the purpose of this standard, gluten is defined as those proteins, commonly found in wheat, triticale, rye, barley or oats to which some persons are intolerant.[40] The American Dietetic Associations Nutrition Care Manual position on the use of oats in a medically necessitated gluten-free diet is: However, commercially available oats in the United States may be contaminated with small amounts of wheat, barley, or rye. For this reason, if you are newly diagnosed with celiac disease, you should not eat oats. Once your intestine heals, you may want to discuss the use of oats with your dietitian and physician.[41]
Gluten sensitivity indicating the need for a separate standard of purity for people with gluten sensitivity. New standards in developmentCodex Alimentarius is undergoing revision and a revised standard will be presented at the meeting of the Codex Alimentarius Commission at the end of June 2008.[42] The proposed standard limits the amount of contaminant in product that would qualify that product as gluten-free: Gluten-free foods are dietary foods a) consisting of or made only from one or more ingredients which do not contain wheat (i.e., all Triticum species, such as durum wheat, spelt, and kamut), rye, barley, oats1 or their crossbred varieties, and the gluten level does not exceed 20 mg/kg in total, based on the food as sold or distributed to the consumer, and/or b) consisting of one or more ingredients from wheat (i.e., all Triticum species, such as durum wheat, spelt, and kamut), rye, barley, oats1 or their crossbred varieties, which have been specially processed to remove gluten, and the gluten level does not exceed 20 mg/kg in total, based on the food as sold or distributed to the consumer.[43]
1
83
The Committee agreed to specify that the allowance of oats that are not contaminated with wheat, rye or barley in foods covered by the standard may be determined at national level."[43] In realizing the benefit of whole oats in a gluten free diet, the Canadian Celiac Association sought to assure oats and oat products fulfill the gluten-free standards set by the Canadian Food Inspection Agency and Health Canada: in consultation with Health Canada, Agriculture & Agri-Food Canada and the Canadian Food Inspection Agency, has established requirements for growing, processing, and purity testing and labelling of pure oats.[44] From the perspective of gluten sensitivity there is no single definition of gluten that concisely defines all potentially pathogenic glutens. With wheat allergies, there can be a wide spectrum of species that may trigger allergies with similar proteins, the omega-gliadin proteins have similar proteins found in oats at high frequency, but omega-gliadin allergy is not a predictor of oat allergy or intolerance.[45] A person can have an allergy to wheat, but not rye.[46] Glutelins have not been characterized over broad taxa. With idiopathic gluten sensitivity, the antibodies that correlate with disease are anti-gliadin antibodies. Whether these antibodies are pathogenic or are simply indicators of circulating gliadin is unknown. For gluten-sensitive enteropathy, gliadin and homologous proteins from rye and barley cause disease. T-cell epitopes implicated in disease have been found in glutinous protein genes in all species sequenced within the tribe Triticeae.[47] Also, since barley is distantly related to wheat, but carries pathogenic epitopes it can be assumed that all members of Triticeae should carry T-cell sites capable of sustaining disease (see also Genetics of Triticeae). While often not explicitly stated in some standards, pathogenic glutens found in wheat are also found in Spelt and Kamut (both types of wheat), Triticale (a trans-species Triticeae hybrid).
Gluten sensitivity Origin of controversy After World War II, wheat was suspected as the cause of celiac disease, and the gluten from wheat was identified as a cause soon after. At the time, duodenal biopsythe current "gold standard" of diagnosishad not yet been developed;[49] indirect measures of disease were used. In two studies, three children were fed 75 to 150grams of oats per day and developed symptoms. In three concurrent studies, 10 children and two adults were allowed to eat 28 to 60grams of oats and developed no symptoms.[50] Since wheat, barley and sometimes rye are common contaminants in oats,[41][51] until this was investigated, oats were considered to be toxic to celiacs. Further information: History of celiac disease Current findings While the problem of contamination has been known for several years, scientists' understanding of how oats and gluten are related continues to evolve. A study published in February 2011 uncovered differing levels of toxicity amongst different varieties of oat, indicating that cross-contamination is not the only reason why some oats provoke reactions in some people with a gluten intolerance.[48] A study published in June 2008 found that of 109 sources of oats screened, 85 had unacceptable levels of gluten from wheat, barley or rye.[52] Triticeae contaminated oats in the study came from many countries indicating that most sources of oats are unacceptable for GS based on contamination.
84
Gluten-free testing
As of February 2011, G12, the newest monoclonal antibody (moAb) available, is the only one proven to detect both cross-contamination in oats and also the inherent gluten / avenin that is only found in some varieties of oat.[48] Alternative methods of detection, while currently accepted by many gluten-free certification organizations, are not in fact able to detect this second form of gluten in oats. This may partially explain why some celiacs react to oats and others do not. A barley-sensitive ELISA called the R5 sandwich assay does not detect gluten in any of 25 pure oat varieties, but it does detect barley, wheat and rye.[52] Disease-sensitive farming practices, antibody testing and species specific genetic testing are capable of producing pure oats.[52] In the United States, 3 domestic GF-brands are available and one brand imported from Ireland 'reckons' to be 99.95% pure oats.[54][55] Two brands in the United States use the R5 antibody test and claim to be below 20 PPM in defined gluten.[54][56] However, the R5 antibody test has not been proven to be as sensitive as the G12 test. Further information: Antibody testing for gluten-free foods
Diets
Gluten-free oats in a gluten-free diet. Gluten-free oats can provide a valuable source of fiber, vitamin B, iron, zinc and complex carbohydrates.[57] Recent studies show that gluten-sensitive individuals on a gluten-free diet often get too much simple starch, too little fibre and vitamin B. Currently most guidelines do not include oats in a gluten-free diet. While this is likely to change, oats are not recommended within a year of diagnosis because of the oat-sensitive enteropathy (ASE) risk, the desire to establish a clinical baseline and complexity of the contamination issue.[58] Consuming oats when anti-gliadin antibodies or gliadin are present increases anti-avenin antibodies, and may promote ASE. Duodenal biopsy may be recommended after oat consumption is initiated. The DQ phenotype of all 3
Gluten sensitivity ASE individuals studied so far indicated DQ2 homozygotes are at risk for ASE. Preferably, newly diagnosed celiacs seek the help of a dietician. However, guidelines are also available for the introduction of pure, uncontaminated oats into the gluten-free diet.[58] Further information: Oat sensitivity
85
References
[1] Sapone A et al. (2011). "Divergence of gut permeability and mucosal immune gene expression in two gluten-associated conditions: celiac disease and gluten sensitivity.". BMC Medicine 9 (23). doi:10.1186/1741-7015-9-23. [2] Sapone A et al. Differential mucosal IL-17 expression in two gliadin-induced disorders: gluten sensitivity and the autoimmune enteropathy celiac disease. International Archives of Allergy and Immunology. 2010;152:75-80 [3] Ford RP. The gluten syndrome. A neurological disease. Medical Hypotheses. 2009; 73 (3):438-440 [4] Dickerson F et al. Markers of gluten sensitivity and celiac disease in recent onset psychosis and multi-episode schizophrenia. Biological Psychiatry. 2010;68(1):100-104 [5] Hadjivassiliou M et al. Myopathy associated with gluten sensitivity. Muscle Nerve. 2007;35:443-450 [6] Sapone A et al. Differential mucosal IL-17 expression in two gliadin-induced disorders: gluten sensitivity and the autoimmune enteropathy celiac disease. International Archives of Allergy and Immunology. 2010;152:75-80; Ford RP. The gluten syndrome. A neurological disease. Medical Hypotheses. 2009; 73 (3):438-440 [7] Verdu EF, Armstrong D, Murray JA. Between celiac disease and irritable bowel syndrome: The No Mans Land of Gluten Sensitivity. The American Journal of Gastroenterology. 2009;104(6):1587-1594 [8] Sapone A et al. (2010). Differential mucosal IL-17 expression in two gliadin-induced disorders: gluten sensitivity and the autoimmune enteropathy celiac disease. International Archives of Allergy & Immunology; 152: 75-80 [9] Bizzaro N et al. (2010) Cutting edge issues in celiac disease and in gluten intolerance. Clinical Reviews in Allergy & immunology. [10] Sapone A et al. (2010). Differential mucosal IL-17 expression in two gliadin-induced disorders: gluten sensitivity and the autoimmune enteropathy celiac disease. International Archives of Allergy & Immunology; 152: 75-80. [11] Hadjivassiliou M, Grnewald R, Sharrack B, et al. (2003). "Gluten ataxia in perspective: epidemiology, genetic susceptibility and clinical characteristics". Brain 126 (Pt 3): 68591. doi:10.1093/brain/awg050. PMID 12566288. [12] A. Vilpulla, P. Collin, M. Maki et al (2008) "Undetected coeliac disease in the elderly. A biopsy-proven population-based study." Digestive and Liver Disease 40 (2008) 809-813 [13] Biesiekierski, Jessica R et al (March 2011). "Gluten Causes Gastrointestinal Symptoms in Subjects Without Celiac Disease: A Double-Blind Randomized Placebo-Controlled Trial". Am J Gastroenterol 106 (3): 508514. doi:10.1038/ajg.2010.487. PMID21224837. [14] Bandani AR (2005). "Effect of plant a-amylase inhibitors on sunn pest, Eurygaster integriceps Puton (Hemiptera: Scutelleridae), alpha-amylase activity". Commun. Agric. Appl. Biol. Sci. 70 (4): 86973. PMID16628930. [15] Stepnkov R, Kofronov O, Tuckov L, Kozkov H, Cebra JJ, Tlaskalov- Hogenov H (January 2003). "Experimentally induced gluten enteropathy and protective effect of epidermal growth factor in artificially fed neonatal rats" (http:/ / meta. wkhealth. com/ pt/ pt-core/ template-journal/ lwwgateway/ media/ landingpage. htm?issn=0277-2116& volume=36& issue=1& spage=96). J. Pediatr. Gastroenterol. Nutr. 36 (1): 96104. doi:10.1097/00005176-200301000-00018. PMID12500003. . [16] Bernardo D, Garrote JA, Fernndez-Salazar L, Riestra S, Arranz E (2007). "Is gliadin really safe for noncoeliac individuals? Production of interleukin 15 in biopsy culture from noncoeliac individuals challenged with gliadin peptides". Gut 56 (6): 88990. doi:10.1136/gut.2006.118265. PMC1954879. PMID17519496. [17] Bodinier M, Legoux MA, Pineau F, et al. (May 2007). "Intestinal translocation capabilities of wheat allergens using the Caco-2 cell line". J. Agric. Food Chem. 55 (11): 457683. doi:10.1021/jf070187e. PMID17477542. [18] Thomas KE, Sapone A, Fasano A, Vogel SN (February 2006). "Gliadin stimulation of murine macrophage inflammatory gene expression and intestinal permeability are MyD88-dependent: role of the innate immune response in Celiac disease" (http:/ / www. jimmunol. org/ cgi/ pmidlookup?view=long& pmid=16456012). J. Immunol. 176 (4): 251221. PMID16456012. . [19] Lammers KM, Lu R, Brownley J, et al. (March 2008). "Gliadin Induces an Increase in Intestinal Permeability and Zonulin Release by Binding to the Chemokine Receptor CXCR3". Gastroenterology 135 (1): 194204.e3. doi:10.1053/j.gastro.2008.03.023. PMC2653457. PMID18485912. [20] van Heel DA, West J (July 2006). "Recent advances in coeliac disease". Gut 55 (7): 103746. doi:10.1136/gut.2005.075119. PMC1856316. PMID16766754. [21] http:/ / www. livescience. com/ health/ celiac-disease-gluten-peptides-100721. html [22] Tye-Din JA, Stewart JA, Dromey JA, Beissbarth T, van Heel DA, Tatham A, Henderson K, Mannering SI, Gianfrani C, Jewell DP, Hill AV, McCluskey J, Rossjohn J, Anderson RP (2010). "Comprehensive, quantitative mapping of T cell epitopes in gluten in celiac disease". Sci Transl Med 2 (41): 41ra51. doi:10.1126/scitranslmed.3001012. PMID20650871. [23] Bittner C, Grassau B, Frenzel K, Baur X (March 2008). "Identification of wheat gliadins as an allergen family related to baker's asthma". J. Allergy Clin. Immunol. 121 (3): 7449. doi:10.1016/j.jaci.2007.09.051. PMID18036646. [24] Matsuo H, Dahlstrm J, Tanaka A, et al. (February 2008). "Sensitivity and specificity of recombinant omega-5 gliadin-specific IgE measurement for the diagnosis of wheat-dependent exercise-induced anaphylaxis". Allergy 63 (2): 2336.
Gluten sensitivity
doi:10.1111/j.1398-9995.2007.01504.x. PMID18186814. [25] Akagawa M, Handoyo T, Ishii T, Kumazawa S, Morita N, Suyama K (August 2007). "Proteomic analysis of wheat flour allergens". J. Agric. Food Chem. 55 (17): 686370. doi:10.1021/jf070843a. PMID17655322. [26] Hopper AD, Cross SS, Hurlstone DP, et al. (April 2007). "Pre-endoscopy serological testing for celiac disease: evaluation of a clinical decision tool". BMJ 334 (7596): 729. doi:10.1136/bmj.39133.668681.BE. PMC1847864. PMID17383983. [27] Hopper AD, Cross SS, Sanders DS (March 2008). "Patchy villous atrophy in adult patients with suspected gluten-sensitive enteropathy: is a multiple duodenal biopsy strategy appropriate?". Endoscopy 40 (3): 21924. doi:10.1055/s-2007-995361. PMID18058655. [28] Kaukinen K, Peraho M, Collin P, et al. (May 2005). "Small-bowel mucosal transglutaminase 2-specific IgA deposits in celiac disease without villous atrophy: a prospective and randomized clinical study". Scand. J. Gastroenterol. 40 (5): 56472. doi:10.1080/00365520510023422. PMID16036509. [29] Kaukinen K, Turjanmaa K, Mki M, et al. (September 2000). "Intolerance to cereals is not specific for coeliac disease". Scand. J. Gastroenterol. 35 (9): 9426. doi:10.1080/003655200750022995. PMID11063153. [30] Hadjivassiliou M, Sanders DS, Woodroofe N et al. (2008). Gluten ataxia. The Cerebellum; 494-498 [31] Anderson LA, McMillan SA, Watson RG, et al. (2007). "Malignancy and mortality in a population-based cohort of patients with coeliac disease or "gluten sensitivity"". World J. Gastroenterol. 13 (1): 14651. PMID17206762. [32] O'Farrelly C, O'Mahony C, Graeme-Cook F, Feighery C, McCartan BE, Weir DG (1991). "Gliadin antibodies identify gluten-sensitive oral ulceration in the absence of villous atrophy". J. Oral Pathol. Med. 20 (10): 4768. doi:10.1111/j.1600-0714.1991.tb00407.x. PMID1753350. [33] Ringvold A, Overgaard RG (1995). "Increased IgA antibodies to gluten and gliadin in serum of persons with ocular pseudo-exfoliation". Acta ophthalmologica Scandinavica 73 (2): 1712. doi:10.1111/j.1600-0420.1995.tb00662.x. PMID7656149. [34] Lidn M, Kristjnsson G, Valtsdttir S, Hllgren R (2007). "Gluten sensitivity in patients with primary Sjgren's syndrome". Scand. J. Gastroenterol. 42 (8): 9627. doi:10.1080/00365520701195345. PMID17613926. [35] Workman EM, Alun Jones V, Wilson AJ, Hunter JO (1984). "Diet in the management of Crohn's disease". Human nutrition. Applied nutrition 38 (6): 46973. PMID6526690. [36] Frieri M, Claus M, Boris M, Zitt M, Scalise D, Harris N (1990). "Preliminary investigation on humoral and cellular immune responses to selected food proteins in patients with Crohn's disease". Annals of allergy 64 (4): 34551. PMID2321808. [37] Huber A, Genser D, Spitzauer S, Scheiner O, Jensen-Jarolim E (1998). "IgE/anti-IgE immune complexes in sera from patients with Crohn's disease do not contain food-specific IgE". Int. Arch. Allergy Immunol. 115 (1): 6772. doi:10.1159/000023832. PMID9430498. [38] Pfeil T, Schwabl U, Ulmer WT, Knig W (1990). "Western blot analysis of water-soluble wheat flour (Triticum vulgaris) allergens". Int. Arch. Allergy Appl. Immunol. 91 (3): 22431. doi:10.1159/000235121. PMID1693911. [39] p.47, JOINT FAO/WHO FOOD STANDARDS PROGRAMME CODEX ALIMENTARIUS COMMISSION 15th Session Rome, 415 July 1983 REPORT OF THE 13TH SESSION OF THE CODEX COMMITTEE ON FOODS FOR SPECIAL DIETARY USES (http:/ / www. codexalimentarius. net/ download/ report/ 241/ al83_26e. pdf) Bonn-Bad Godesberg, 2024 September 1982 [40] "Codex standard for "GLUTEN-FREE FOODS", CODEX STAN 118-19811 (http:/ / www. codexalimentarius. net/ download/ standards/ 291/ CXS_118e. pdf). Codex alimentaris, Food and Agricultural Organization of the United Nations [41] American Dietetic Association. Nutrition Care Manual: Celiac Disease. Available at: http:/ / www. nutritioncaremanual. org. Accessed December 15, 2004. [42] "CODEX ALIMENTARIUS COMMISSION - Thirty first Session - Geneva, Switzerland, 30 June - 5 July 2008". From Title page. Committee on Nutrition and Foods for Special Dietary Uses. JOINT FAO/WHO FOOD STANDARDS PROGRAMME CODEX ALIMENTARIUS COMMISSION. Thirty-first Session Geneva, Switzerland, 30 June 4 July 2008, Codex Alimentarius Commission REPORT OF THE 29th SESSION OF THE CODEX COMMITTEE ON NUTRITION AND FOODS FOR SPECIAL DIETARY USES (http:/ / www. codexalimentarius. net/ download/ report/ 687/ al08_26e. pdf) [43] "Draft Revised Standard for Foods for Special Dietary Use for Persons intolerant to Gluten (at Step 8)". page 50-51. Committee on Nutrition and Foods for Special Dietary Uses. JOINT FAO/WHO FOOD STANDARDS PROGRAMME CODEX ALIMENTARIUS COMMISSION. Thirty-first Session Geneva, Switzerland, 30 June 4 July 2008, Codex Alimentarius Commission REPORT OF THE 29th SESSION OF THE CODEX COMMITTEE ON NUTRITION AND FOODS FOR SPECIAL DIETARY USES (http:/ / www. codexalimentarius. net/ download/ report/ 687/ al08_26e. pdf) [44] Rashid M, Butzner D, Burrows V, et al. (October 2007). "Consumption of pure oats by individuals with celiac disease: A position statement by the Canadian Celiac Association". Can. J. Gastroenterol. 21 (10): 64951. PMC2658132. PMID17948135. [45] Baldo BA, Krilis S, Wrigley CW (1980). "Hypersensitivity to inhaled flour allergens. Comparison between cereals". Allergy 35 (1): 4556. doi:10.1111/j.1398-9995.1980.tb01716.x. PMID6154431. [46] Karatay S, Erdem T, Kiziltunc A, et al. (2006). "General or personal diet: the individualized model for diet challenges in patients with rheumatoid arthritis". Rheumatol. Int. 26 (6): 55660. doi:10.1007/s00296-005-0018-y. PMID16025333. [47] Kupper C (2005). "Dietary guidelines and implementation for celiac disease". Gastroenterology 128 (4 Suppl 1): S1217. doi:10.1053/j.gastro.2005.02.024. PMID15825119. [48] Comino, Isabel; Ana Real, Laura de Lorenzo, Hugh Cornell, Miguel ngel Lpez-Casado, Francisco Barro, Pedro Lorite, Ma Isabel Torres, ngel Cebolla, Carolina Sousa (12). "Diversity in oat potential immunogenicity: basis for the selection of oat varieties with no toxicity in coeliac disease" (http:/ / gut. bmj. com/ content/ early/ 2011/ 02/ 11/ gut. 2010. 225268. abstract). Gut 60 (First Online): 91522. doi:10.1136/gut.2010.225268. PMC3112367. PMID21317420. . Retrieved 12 March 2011.
86
Gluten sensitivity
[49] SMITH RB, SPRINZ H, CROSBY WH, SULLIVAN BH (September 1958). "Peroral small bowel mucosal biopsy" (http:/ / linkinghub. elsevier. com/ retrieve/ pii/ 0002-9343(58)90077-9). Am. J. Med. 25 (3): 3914. doi:10.1016/0002-9343(58)90077-9. PMID13571252. . [50] Garsed K, Scott BB (February 2007). "Can oats be taken in a gluten-free diet? A systematic review". Scand. J. Gastroenterol. 42 (2): 1718. doi:10.1080/00365520600863944. PMID17327936. [51] Thompson T (November 2004). "Gluten contamination of commercial oat products in the United States". N. Engl. J. Med. 351 (19): 20212. doi:10.1056/NEJM200411043511924. PMID15525734. [52] Hernando A, Mujico JR, Mena MC, Lombarda M, Mndez E (June 2008). "Measurement of wheat gluten and barley hordeins in contaminated oats from Europe, the United States and Canada by Sandwich R5 ELISA". Eur J Gastroenterol Hepatol 20 (6): 54554. doi:10.1097/MEG.0b013e3282f46597. PMID18467914. [53] Catassi C et al (2007) "A prospective, double-blind, placebo-controlled trial to establish a safe gluten threshold for patients with coeliac disease." American Journal of Clinical Nutrition, Vol 85, No 1, 160-166 [54] Cleaning/Inspection Process Gluten Free Oats (http:/ / www. glutenfreeoats. com/ cleaning. aspx) [55] "Are McCann's Oat products gluten free?". URL: FAQ - Frequently asked questions (http:/ / www. mccanns. ie/ faq. html) [56] GLUTEN FREE ROLLED OATS Bob's Red Mill Natural Foods (http:/ / www. bobsredmill. com/ catalog/ index. php?action=showdetails& product_ID=680) [57] Strsrud S, Hulthn LR, Lenner RA (July 2003). "Beneficial effects of oats in the gluten-free diet of adults with special reference to nutrient status, symptoms and subjective experiences". Br. J. Nutr. 90 (1): 1017. doi:10.1079/BJN2003872. PMID12844381. [58] Rashid, Mohsin (2007-06-08). "Guidelines for Consumption of Pure and Uncontaminated Oats by Individuals with Celiac Disease" (http:/ / www. celiac. ca/ Articles/ PABoatsguidelines2007June. html). Professional Advisory Board of Canadian Celiac Association. . Retrieved 2008-08-14.
87
88
Other Allergies
Allergic contact dermatitis
Allergic contact dermatitis
Classification and external resources ICD-10 ICD-9 MeSH L23 692 [1] [2] [3]
D017449
Allergic contact dermatitis (ACD) is a form of contact dermatitis that is the manifestation of an allergic response caused by contact with a substance; the other type being irritant contact dermatitis (ICD). Although less common than ICD, ACD is accepted to be the most prevalent form of immunotoxicity found in humans.[4] By its allergic nature, this form of contact dermatitis is a hypersensitive reaction that is atypical within the population. The mechanisms by which these reactions occur are complex, with many levels of fine control. Their immunology centres around the interaction of immunoregulatory cytokines and discrete subpopulations of T lymphocytes.
Pathophysiology
ACD arises as a result of two essential stages: an induction phase, which primes and sensitizes the immune system for an allergic response, and an elicitation phase, in which this response is triggered (Kimble et al. 2002). As such, ACD is termed a Type IV delayed hypersensitivity reaction involving a cell-mediated allergic response. Contact allergens are essentially soluble haptens (low in molecular weight) and, as such, have the physico-chemical properties that allow them to cross the stratum corneum of the skin. They can only cause their response as part of a complete antigen, involving their association with epidermal proteins forming hapten-protein conjugates. This, in turn, requires them to be protein-reactive. The conjugate formed is then recognized as a foreign body by the Langerhans cells (LCs) (and in some cases other Dendritic cells (DCs)), which then internalize the protein; transport it via the lymphatic system to the regional lymph nodes; and present the antigen to T-lymphocytes. This process is controlled by cytokines and chemokines - with tumor necrosis factor alpha (TNF-) and certain members of the interleukin family (1, 13 and 18) - and their action serves either to promote or to inhibit the mobilization and migration of these LCs. (Kimble et al. 2002) As the LCs are transported to the lymph nodes, they become differentiated and transform into DCs, which are immunostimulatory in nature. Once within the lymph glands, the differentiated DCs present the allergenic epitope associated with the allergen to T lymphocytes. These T cells then divide and differentiate, clonally multiplying so that if the allergen is experienced again by the individual, these T cells will respond more quickly and more aggressively. White et al. have suggested that there appears to be a threshold to the mechanisms of allergic sensitisation by ACD-associated allergens (1986).[5] This is thought to be linked to the level at which the toxin induces the up-regulation of the required mandatory cytokines and chemokines. It has also been proposed that the vehicle in which the allergen reaches the skin could take some responsibility in the sensitisation of the epidermis by both
Allergic contact dermatitis assisting the percutaneous penetration and causing some form of trauma and mobilization of cytokines itself.
89
Allergens
Common allergens implicated include the following: Nickel (nickel sulfate hexahydrate) - metal frequently encountered in jewelry and clasps or buttons on clothing Gold (gold sodium thiosulfate) - precious metal often found in jewelry and dental materials Balsam of Peru (Myroxylon pereirae) - a fragrance used in perfumes and skin lotions, derived from tree resin (see also Tolu balsam). It may also be a component of artificial vanilla and/or cinnamon flavorings. Chromium - used in the tanning of leather. Also a component of uncured cement/mortar, facial cosmetics and some bar soaps. Oily coating from plants of the Toxicodendron genus: poison ivy, poison oak, and poison sumac. Thimerosal - a mercury compound used in local antiseptics and in vaccines Neomycin - a topical antibiotic common in first aid creams and ointments, cosmetics, deodorant, soap and pet food. Found by itself, or in Polysporin or Triple Antibiotic Fragrance mix - a group of the eight most common fragrance allergens found in foods, cosmetic products, insecticides, antiseptics, soaps, perfumes and dental products [6] Formaldehyde - a preservative with multiple uses, e.g., in paper products, paints, medications, household cleaners, cosmetic products and fabric finishes. Often released into products by the use of formaldehyde releasers such as imidazolidinyl urea, diazolidinyl urea, Quaternium-15, DMDM Hydantoin and 2-bromo-2-nitropropane-1,3-diol. Cobalt chloride - metal found in medical products; hair dye; antiperspirant; metal-plated objects such as snaps, buttons or tools; and in cobalt blue pigment Bacitracin - a topical antibiotic found by itself, or as Polysporin or Triple Antibiotic Quaternium-15 - preservative in cosmetic products (self-tanners, shampoo, nail polish, sunscreen) and in industrial products (polishes, paints and waxes).[7] Colophony (Rosin) - Rosin, sap or sawdust typically from spruce or fir trees Topical steroid - see steroid allergy Photographic developers, especially those containing metol Topical anesthetics such as pramoxine or diphenhydramine, after prolonged use Methylchloroisothiazolinone/Methylisothiazolinone is a preservative used in wash-off products such as shampoos/conditioners.
Symptoms
The symptoms of allergic contact dermatitis are very similar to the ones caused by irritant contact dermatitis, which makes the first even harder to diagnose. The first sign of allergic contact dermatitis is the presence of the rash or skin lesion at the site of exposure.[8] Depending on the type of allergen causing it, the rash can ooze, drain or crust and it can become raw, scaled or thickened. Also, it is possible that the skin lesion does not take the form of a rash but it may include papules, blisters, vesicles or even a simple red area. The main difference between the rash caused by allergic contact dermatitis and the one caused by irritant contact dermatitis is that the first one tends to be confined to the area where the trigger touched the skin, whereas in the second case, the rash is more likely to be more widespread on the skin.[9] Another characteristic of the allergic contact dermatitis rash is that it usually appears after a day or two after exposure to the allergen, unlike irritant contact dermatitis that appears immediately after the contact with the trigger. Other symptoms may include itching, skin redness or inflammation, localized swelling and the area may become more tender or warmer. If left untreated, the skin may darken and become leathery and cracked.[10] Pain can also be present.
Allergic contact dermatitis The symptoms of allergic contact may persist for as long as one month before resolving completely. Once an individual has developed a skin reaction to a certain substance it is most likely that he will have it for the rest of the life, and the symptoms will reappear when in contact with the allergen.
90
Treatment
The main treatment to cure allergic contact dermatitis consists of avoiding the allergen. Persons who develop the rash and the other symptoms from a certain trigger are most likely to have it for the rest of their lives and detecting and avoiding the allergen is mandatory in treating the condition and resolving its symptoms. The first step in treating the condition is applying a damp cloth shortly after the skin problem first shows to make sure that all of the irritant has been removed from the area.[11] In some cases, the best treatment is to do nothing to the area.[8] In mild to moderate cases, patients may use skin creams containing corticosteroids to reduce the inflammation. These creams should be used carefully and according to the instructions they come with because when overused over longer periods of time they can cause serious skin conditions. Also, calamine lotion and cool oatmeal baths may relieve itching.[12]. Over the counter diphenhydramine by mouth is helpful for night time itching. Usually, severe cases are treated with systemic corticosteroids which may be tapered gradually, with various dosing schedules ranging from a total of 12 - 20 days to prevent the recurrence of the rash as well as a topical corticosteroid.[8] Tacrolimus ointment or pimecrolimus cream can also be used additionally to the corticosteroid creams or instead of these. Oral antihistamines such as diphenhydramine or hydroxyzine may also be used in more severe cases to relieve the intense itching. Topical antihistamines are not advised as there might be a second skin reactions from the lotion itself. The other symptoms caused by allergic contact dermatitis are generally eased with wet dressings and drying lotions to stop the itching. In most cases however, medication or actual treatment is not required as long as the trigger has been identified and avoided. The discomfort caused by the symptoms may be relieved by wearing smooth-textured clothing to avoid more skin irritation or by avoiding soaps with perfumes and dyes. Commonly, the symptoms may resolve without treatment in 2 to 4 weeks but specific medication may hasten the healing as long as the trigger is avoided. Also, the condition might become chronic if the allergen is not detected and therefore it is not avoided.
Diagnosis
Diagnosing allergic contact dermatitis is primarily based on physical exam and medical history. In some cases doctors can establish an accurate diagnosis based on the symptoms that the patient experiences and on the rash's appearance. In the case of a single episode of allergic contact dermatitis, this is all that is necessary. Chronic and/or intermittent rashes which are not readily explained by history and physical exam often will benefit from further testing. A patch test (contact delayed hypersensitivity allergy test)[13] is a commonly used examination to determine the exact cause of an allergic contact dermatitis. According to the American Academy of Allergy, Asthma, and Immunology, "patch testing is the gold standard for contact allergen identification".[8] The patch test consists in applying small quantities of potential allergens to small patches and which are then placed on the skin.[14] After two days, they are removed and if a skin reaction occurred to one of the substances applied, a raised bump will be noticeable underneath the patch. The tests are again read at 72 or 96 hours after application. Patch testing is used for patients who have chronic, recurring contact dermatitis.[8] Other tests that may be used to diagnose contact dermatitis and rule out other potential causes of the symptoms include a skin biopsy and culture of the skin lesion.
91
References
[1] [2] [3] [4] http:/ / apps. who. int/ classifications/ icd10/ browse/ 2010/ en#/ L23 http:/ / www. icd9data. com/ getICD9Code. ashx?icd9=692 http:/ / www. nlm. nih. gov/ cgi/ mesh/ 2011/ MB_cgi?field=uid& term=D017449 Kimber I, Basketter DA, Gerberick GF, Dearman RJ (2002). "Allergic contact dermatitis" (http:/ / linkinghub. elsevier. com/ retrieve/ pii/ S1567-5769(01)00173-4). Int. Immunopharmacol. 2 (23): 20111. doi:10.1016/S1567-5769(01)00173-4. PMID11811925. . [5] White SI, Friedmann PS, Moss C, Simpson JM (1986). "The effect of altering area of application and dose per unit area on sensitization by DNCB". Br. J. Dermatol. 115 (6): 6638. doi:10.1111/j.1365-2133.1986.tb06646.x. PMID3801307. [6] Allergy to fragrance mix at DermNetNZ, http:/ / dermnetnz. org/ dermatitis/ fragrance-allergy. html [7] Mayo Clinic study, http:/ / www. mayoclinic. org/ news2006-rst/ 3268. html [8] "Contact dermatitis" (http:/ / www. nlm. nih. gov/ medlineplus/ ency/ article/ 000869. htm). . Retrieved 2010-06-16. [9] "Contact Dermatitis Symptoms" (http:/ / www. emedicinehealth. com/ contact_dermatitis/ page3_em. htm#Contact Dermatitis Symptoms). . Retrieved 2010-06-16. [10] "Allergic Contact Dermatitis" (http:/ / www. aocd. org/ skin/ dermatologic_diseases/ allergic_contact_d. html). . Retrieved 2010-06-16. [11] "Allergic Dermatitis Symptoms and Treatment" (http:/ / www. allergicdermatitis. org/ ). . Retrieved 2010-06-16. [12] "Self-Care at Home" (http:/ / www. emedicinehealth. com/ contact_dermatitis/ page7_em. htm#Self-Care at Home). . Retrieved 2010-06-16. [13] "Contact dermatitis" (http:/ / www. mayoclinic. com/ health/ contact-dermatitis/ DS00985/ DSECTION=tests-and-diagnosis). . Retrieved 2010-06-16. [14] "Tests and diagnosis" (http:/ / www. mayoclinic. com/ health/ contact-dermatitis/ DS00985/ DSECTION=tests-and-diagnosis). . Retrieved 2010-06-16.
Further reading
A list of common allergens is shown in Table III in: Kucenic MJ, Belsito DV (2002). "Occupational allergic contact dermatitis is more prevalent than irritant contact dermatitis: a 5-year study" (http://linkinghub.elsevier. com/retrieve/pii/S0190962202083366). J. Am. Acad. Dermatol. 46 (5): 6959. doi:10.1067/mjd.2002.118561. PMID12004309.
Drug allergy
92
Drug allergy
Drug allergy
Classification and external resources ICD-10 ICD-9 T88.7 995.27 [1]
A drug allergy is an allergy to a drug, most commonly a medication. Medical attention should be sought immediately if an allergic reaction is suspected. An allergic reaction will not occur on the first exposure to a substance. The first exposure allows the body to create antibodies and memory lymphocyte cells for the antigen. However, drugs often contain many different substances, including dyes, which could cause allergic reactions. This can cause an allergic reaction on the first administration of a drug. For example, a person who developed an allergy to a red dye will be allergic to any new drug which contains that red dye. A drug allergy is different from an intolerance. A drug intolerance, which is often a milder, non-immune-mediated reaction, does not depend on prior exposure. Most people who believe they are allergic to aspirin are actually suffering from a drug intolerance.
Risk factors
A drug allergy is more likely to develop with large doses and extended exposure.
References
[1] http:/ / www. icd9data. com/ getICD9Code. ashx?icd9=995. 27 [2] "eMedicine" (http:/ / www. emedicinehealth. com/ drug_allergy/ page2_em. htm). . Retrieved 2007-06-08.
Latex allergy
93
Latex allergy
Latex allergy
Classification and external resources
D020315
Latex allergy is a medical term encompassing a range of allergic reactions to natural rubber latex.
Types
Latex is known to cause 2 of the 4 (or 5) types of hypersensitivity.
Type I
The most serious and rare form, type I is an immediate and potentially life-threatening reaction, not unlike the severe reaction some people have to bee stings. Such reactions account for a significant proportion of perioperative anaphylactic reaction, especially in children with myelomeningocele.[3] [4] Testing for type I natural rubber latex allergy is through blood testing, such as RAST (radioallergosorbent test) identifies what types of IgE proteins trigger allergic reactions. While the standard for allergen testing is the skin prick test, there is no approved skin testing reagent for latex in the United States, though some other countries do have approved skin testing reagents. Type I natural rubber latex allergy is caused from IgE (immune) mediated reactions to proteins found in the Hevea brasiliensis tree, a type of rubber tree. Some people who are allergic to latex are also allergic to clothes, shoes, and other things that contain natural rubber latexfor example elastic bands, rubber gloves, condoms, pacifiers and baby-bottle nipples, balloons, cars, and clothing containing natural rubber based elastic. A Type I reaction can be triggered by exposure to airborne particles resulting from the inflation of balloons even if the person is not present while the balloons are being inflated.
Latex allergy
94
Latex allergy
95
Alternatives
Synthetic elastic such as elastane or neoprene do not contain the proteins from the Hevea brasiliensis tree that trigger type I reactions. Products made from guayule natural rubber emulsions also do not contain the proteins from the Hevea rubber tree,[6] and have only trace amounts of other proteins, indicating a very low potential for causing sensitization to this material. Chemical treatment to reduce the amount of antigenic proteins in Hevea latex has yielded alternative materials, such as Vytex, which reduce exposure to latex allergens while otherwise retaining the properties of natural rubber. Some patients' sensitivity is so extreme that replacement of Latex products with non-latex products may still result in a reaction if the products are manufactured in the same facility as the Latex-containing products.
Latex allergens
Hevein-like protein domains[13] are a possible cause for allergen cross-reactivity between latex and banana[14] or fruits in general (latex-fruit syndrome).[15] Natural rubber latex contains several conformational epitopes located on several enzymes like Hev b 1[16], Hev b 2[17], Hev b 4[18], Hev b 5[19] and Hev b 6.02.[20][21] FITkit is a latex allergen testing method for quantification of the major natural rubber latex (NRL) specific allergens: Hev b 1, Hev b 3, Hev b 5 and Hev b 6.02.[22]
References
[1] http:/ / www. icd9data. com/ getICD9Code. ashx?icd9=V15. 07 [2] http:/ / www. nlm. nih. gov/ cgi/ mesh/ 2011/ MB_cgi?field=uid& term=D020315 [3] Rendeli C, Nucera E, Ausili E, Tabacco F, Roncallo C, Pollastrini E, Scorzoni M, Schiavino D, Caldarelli M, Pietrini D, Patriarca G. (Jan 2006). "Latex sensitisation and allergy in children with myelomeningocele.". Childs Nerv Syst 22 (1): 2832. doi:10.1007/s00381-004-1110-4. PMID15703967. [4] Banta JV, Bonanni C, Prebluda J. (Jun 1993). "Latex anaphylaxis during spinal surgery in children with myelomeningocele". Dev Med Child Neurol 235 (6): 5438. PMID8504897. [5] "Latex Allergy" (http:/ / www. aafp. org/ afp/ 980101ap/ reddy. html). . Retrieved 2009-08-08. [6] "Plant Biologists And Immunochemists Develop Hypoallergenic Alternative To Latex" (http:/ / www. sciencedaily. com/ videos/ 2008/ 1206-protect_yourself_from_latex_allergies. htm). ScienceDaily. December 1, 2008. . Retrieved 2010-02-13. [7] "NIOSH Alert:Preventing Allergic Reactions to Natural Rubber Latex in the Workplace" (http:/ / www. cdc. gov/ niosh/ latexalt. html). United States National Institute for Occupational Safety and Health. . Retrieved 2008-01-20. [8] Latex Allergy (http:/ / www. latexallergy. ndo. co. uk/ ) [9] WJZ 13 (CBS) (2008-01-15). "Hopkins ceases use of latex gloves during surgery" (http:/ / wjz. com/ local/ johns. hopkins. hospital. 2. 629922. html). Baltimore. . Retrieved 2009-07-30. [10] Grzybowski M, Ownby DR, Rivers EP, Ander D, Nowak RM (October 2002). "The prevalence of latex-specific IgE in patients presenting to an urban emergency department". Ann Emerg Med 40 (4): 4119. doi:10.1016/S0196-0644(02)00063-X. PMID12239498. [11] Brehler R, Theissen U, Mohr C, Luger T (April 1997). ""Latex-fruit syndrome": frequency of cross-reacting IgE antibodies". Allergy 52 (4): 40410. doi:10.1111/j.1398-9995.1997.tb01019.x. PMID9188921. [12] Allergy Facts and Figures, Asthma and Allergy Foundation of America http:/ / www. aafa. org/ display. cfm?id=9& sub=30 [13] Daz-Perales, A; Snchez-Monge, R; Blanco, C; Lombardero, M; Carillo, T; Salcedo, G (2002). "What is the role of the hevein-like domain of fruit class I chitinases in their allergenic capacity?". Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 32 (3): 44854. doi:10.1046/j.1365-2222.2002.01306.x. PMID11940077. [14] Mikkola JH, Alenius H, Kalkkinen N, Turjanmaa K, Palosuo T, Reunala T (December 1998). "Hevein-like protein domains as a possible cause for allergen cross-reactivity between latex and banana". J. Allergy Clin. Immunol. 102 (6 Pt 1): 100512. doi:10.1016/S0091-6749(98)70339-2. PMID9847442. [15] Wagner, S; Breiteneder, H (2002). "The latex-fruit syndrome". Biochemical Society transactions 30 (Pt 6): 93540. PMID12440950. [16] Chen, Zhiping; Cremer, Reinhold; Posch, Anton; Raulf-Heimsoth, Monika; Rihs, Hans-Peter; Baur, Xaver (1997). "On the allergenicity of Hev b 1 among health care workers and patients with spina bifida allergic to natural rubber latex". Journal of Allergy and Clinical Immunology 100 (5): 68493. doi:10.1016/S0091-6749(97)70174-X. PMID9389300.
Latex allergy
[17] Barre, Annick; Culerrier, Raphal; Granier, Claude; Selman, Laetitia; Peumans, Willy J.; Van Damme, Els J.M.; Bienvenu, Franoise; Bienvenu, Jacques et al (2009). "Mapping of IgE-binding epitopes on the major latex allergen Hev b 2 and the cross-reacting 1,3-glucanase fruit allergens as a molecular basis for the latex-fruit syndrome". Molecular Immunology 46 (89): 1595604. doi:10.1016/j.molimm.2008.12.007. PMID19185347. [18] Kolarich, Daniel; Altmann, Friedrich; Sunderasan, Elumalai (2006). "Structural analysis of the glycoprotein allergen Hev b 4 from natural rubber latex by mass spectrometry". Biochimica et Biophysica Acta (BBA) - General Subjects 1760 (4): 715. doi:10.1016/j.bbagen.2005.11.012. [19] Beezhold, Donald H.; Hickey, Vicky L.; Slater, Jay E.; Sussman, Gordon L. (1999). "Human IgE-binding epitopes of the latex allergen Hev b 5". Journal of Allergy and Clinical Immunology 103 (6): 116672. doi:10.1016/S0091-6749(99)70194-6. PMID10359901. [20] Reyes-Lpez, CA; Hernndez-Santoyo, A; Pedraza-Escalona, M; Mendoza, G; Hernndez-Arana, A; Rodrguez-Romero, A (2004). "Insights into a conformational epitope of Hev b 6.02 (hevein)". Biochemical and biophysical research communications 314 (1): 12330. PMID14715255. [21] Pedraza-Escalona, Martha; Becerril-Lujn, Baltazar; Agundis, Concepcin; Domnguez-Ramrez, Lenin; Pereyra, Ali; Riao-Umbarila, Lidia; Rodrguez-Romero, Adela (2009). "Analysis of B-cell epitopes from the allergen Hev b 6.02 revealed by using blocking antibodies". Molecular Immunology 46 (4): 66876. doi:10.1016/j.molimm.2008.08.282. PMID18930549. [22] Koh D, Ng V, Leow YH, Goh CL. (2005). "A study of natural rubber latex allergens in gloves used by healthcare workers in Singapore". Br. J. Dermatol. 153 (5): 95459. doi:10.1111/j.1365-2133.2005.06820.x. PMID16225605.
96
External links
The American Latex Allergy Association (http://www.latexallergyresources.org/) UK Latex Allergy Support Group (http://www.lasg.org.uk/) NIOSH Latex Allergy Alert (http://www.cdc.gov/niosh/latexalt.html) from the U.S. Centers for Disease Control and Prevention Asthma and Allergy Foundation of America (http://aafa.org/display.cfm?id=9&sub=21/)
97
References
[1] http:/ / www. insectstings. co. uk/ immunotherapy. shtml [2] Golden DBK. Epidemiology of allergy to insect venoms and stings. Allergy Proc 1989;10:103-7
Golden DBK. Epidemiology of allergy to insect venoms and stings. Allergy Proc 1989;10:103-7
Cat allergy
Cat allergy in humans is an allergic reaction to one or more of the five known allergens produced by cats. The most common of these are the glycoprotein Fel d 1, secreted by the cat's sebaceous glands and Fel d 4, which is expressed in saliva. An allergic reaction is a histamine reaction that is usually characterized by coughing, wheezing, chest tightening, itching, nasal congestion, rash, watering eyes, sneezing, chapped lips, and similar symptoms.
Cat allergens
Five cat allergens have been described in medical literature. The two major allergens are Fel d 1 (a secretoglobin) and Fel d 4 (a lipocalin). The minor allergens include Fel d 2 (an albumin), Fel d 3 (a cystatin), and cat IgA.[1] Fel d 4 is the product of the cat major urinary protein gene. It is primarily expressed in the submandibular salivary gland and is deposited onto dander as the cat grooms itself. A study found that 63% of cat allergic people have antibodies against Fel d 4.[2]
Symptoms
Symptoms of an allergic reaction to cats include: swollen, red, itchy, watery eyes; nasal congestion, itchy nose, sneezing, chronic sore throat or itchy throat, coughing, wheezing, asthma, hay fever[3], hives or rash on the face or chest, or itchy skin. If a cat has scratched, licked, or bitten someone who is allergic to cats, redness will occur.[4] Symptoms are often confused with a common cold.[5]
Lower exposure
Allergens are airborne and survive for months or even years by themselves, hence removing anything that can trap and hold the allergens (carpet, rugs, pillows) and cleaning regularly and thoroughly with HEPA filters and Air purifier systems reduces risk. Frequent hand washing, especially after handling the cat, and washing hands prior to touching eyes, nose, or mouth, and limiting the cat to the outdoors or barring the animal from certain rooms, such as the bedroom or other rooms where much time is spent, may also reduce allergic reactions.
Cat allergy
98
Medications
Cat allergies can often be controlled with over the counter or prescription medications. Antihistamines and decongestants may provide allergy relief.[6]
Allergy shots
Some allergy sufferers find relief in immunotherapy, a periodic injection therapy designed to stimulate the body's natural immune responses to the cat allergens.[7][8]
Cat Bathing
Regularly bathing the cat may remove significant amounts of allergens from the fur.[10] Furthermore, regularly brushing the cat will reduce the amount of loose fur (and its attached saliva) in the air. Feeding the cat a high quality diet with plenty of Omega-3 fatty acids will help keep the coat healthy and minimize dander.[11]
Hypoallergenic cats
A hypoallergenic cat is a cat which is less likely to provoke an allergic reaction in humans; Although the topic is controversial, with many studies showing statistically significant results,[12] owner's experience and recent clinical studies suggest that Siberian cats, Russian Blue cats, Devon Rex and Cornish Rex cats, Abyssinian cats, and several other breeds, especially females are likely to have low levels of Fel d 1, the main allergenic protein.[13] In 2006, the Allerca company announced the successful breeding of a line of hypoallergenic cats. However, no peer-reviewed studies have been done to confirm their claims and many scientists and consumers are skeptical of the company's assertions.[14] The company has announced that on January 1, 2010 they will cease their breeding activities.[15] Another company, Felix Pets, also claims to be developing a breed of hypoallergenic cat.[16]
References
[1] Addoyin J, et. al. "Cat IgA, representative of new carbohydrate cross-reactive allergens" (http:/ / download. journals. elsevierhealth. com/ pdfs/ journals/ 0091-6749/ PIIS0091674906030284. pdf) The Journal of Allergy and Clinical Immunology, 2007-3. Retrieved on 2009-8-1. [2] Smith W, Butler AJ, Hazell LA, Chapman MD, Poms A, Nickels DG et al (2004). "Fel d 4, a cat lipocalin allergen". Clin Exp Allergy 34 (11): 17328. doi:10.1111/j.1365-2222.2004.02090.x. PMID15544598. [3] "Allergy to pets and animals" (http:/ / www. allergyclinic. co. uk/ animals. htm). allergyclinic.co.uk. . Retrieved 9 November 2011. [4] "WebMD - Cat Allergies" (http:/ / www. webmd. com/ allergies/ cat-allergies). WebMD, LLC.. . Retrieved 9 November 2011. [5] "Human Allergies to Cats" (http:/ / www. peteducation. com/ article. cfm?c=0+ 1278& aid=144). Foster & Smith, Inc.. . Retrieved 9 November 2011. [6] Cat Allergies, WebMD, http:/ / www. webmd. com/ allergies/ cat-allergies [7] Clinical efficacy of specific immunotherapy to cat dander: a double-blind placebo-controlled trial http:/ / www. jacionline. org/ medline/ record/ ivp_09547894_27_860. Accessed 08 Jan 2011.
Cat allergy
[8] Immunotherapy with cat- and dog-dander extracts. V. Effects of 3 years of treatment. http:/ / www. jacionline. org/ medline/ record/ ivp_00916749_87_955. Accessed 08 Jan 2011. [9] Larch, M.; Akdis, C.; Valenta, R. (2006). "Immunological mechanisms of allergen-specific immunotherapy.". Nature reviews. Immunology 6 (10): 761771. doi:10.1038/nri1934. PMID16998509. [10] Evaluation of different techniques for washing cats: Quantitation of allergen removed from the cat and the effect on airborne Fel d 1 http:/ / www. jacionline. org/ article/ S0091-6749(97)70242-2/ fulltext. Retrieved 10 Jan 2011. [11] Human Allergies to Cats. http:/ / www. peteducation. com/ article. cfm?c=0+ 1278& aid=144 [12] Hypoallergenic Cats - Do They Exist? http:/ / www. cat-world. com. au/ hypoallergenic-cats-do-they-exist Accessed 10 Jan 2011. [13] http:/ / www. siberianresearch. com/ index. php?option=com_content& view=article& id=125:siberian-allergen-levels& catid=45:allergens& Itemid=75 [14] Felis Enigmaticus (http:/ / www. the-scientist. com/ 2007/ 1/ 1/ 32/ 1/ ) [15] "Lifestyle Pets" (http:/ / www. webcitation. org/ query?url=http:/ / www. allerca. com/ html/ aboutallerca. html& date=2009-11-01). Allerca. Archived from the original (http:/ / www. allerca. com/ html/ aboutallerca. html) on 2009-11-01. . Retrieved 2009-11-01. [16] Pepling, Racheal. (9 June 2006). "Hypoallergenic" Cats For Sale, U.S. Firm Announces. (http:/ / news. nationalgeographic. com/ news/ 2006/ 06/ 060609-allergies-cats_2. html) National Geographic News. Accessed 13 March 2010. [17] Sex difference in Fel d 1 allergen production. http:/ / www. jacionline. org/ article/ S0091-6749(96)70238-5/ fulltext . Accessed 11 Jan 2011. [18] preliminary results (http:/ / www. prevention. com/ article/ 0,5778,s1-1-51-288-756-1,00. html), cited in Prevention (magazine) [19] full study (http:/ / jama. ama-assn. org/ cgi/ content/ extract/ 284/ 24/ 3115-a), cited in the Journal of the American Medical Association [20] Hussain S, Bassett C, Kaplan S, Schneider A, Silverman B. (2000). "Correlation between the color of cat hair and severity of allergic symptoms in patients with allergic rhinitis" (http:/ / download. journals. elsevierhealth. com/ pdfs/ journals/ 0091-6749/ PIIS0091674900904433. pdf). Journal of Allergy and Clinical Immunology. 105(1 Part 2):S5. [21] cited by Allergy New Zealand (http:/ / www. allergy. org. nz/ newsMedia/ news/ snippets/ cats. php) [22] This citation will be automatically completed in the next few minutes. You can jump the queue or expand by hand (http:/ / en. wikipedia. org/ wiki/ Template:cite_doi/ _10. 1067. 2fmai. 2001. 118788?preload=Template:Cite_doi/ preload& editintro=Template:Cite_doi/ editintro& action=edit)
99
External links
Allergen-free cats a breed apart? (http://www.newscientist.com/article.ns?id=dn9313& feedId=online-news_rss20) - article from New Scientist. Cat Choo (http://www.accessexcellence.org/WN/SUA02/cat-choo.html) - News on immunisation Coping with Allergies (http://www.allergyfiles.com/cat-allergies-how-to-cope-18) - Pet Allergy Information
Perfume allergy
100
Perfume allergy
The most common allergic reactions to perfume or fragrance added to products is contact allergy,[1][2] although other symptoms may occur, including allergic conjunctivitis.[3] As with all allergies, it is important to note the difference between hypersensitivity and true allergy. Many claiming to be allergic to perfumes are not allergic but hypersensitive towards perfumes. True allergy is an immunological overreaction which is specific at a molecular level to a certain substance. A perfume contains thousands of different substances. It is not likely that anyone has true allergy towards all perfumes, unless it is towards a common ingredient. Hypersensitivity is usually a feeling of obnoxiousness towards solvents involving sore feeling and itching in nose, mouth, and throat and hypersecretion of snot and saliva. Immunological mechanisms may or may not be involved, but is not detectable by current methods. The nose and sense of smell is evolutionary very important to all living beings. How smell interacts with other cerebral function in higher animals is not fully understood. For certain, complex psychosomatic mechanisms not fully understood is involved in perfume hypersensitivity. Household products such as soaps and detergents, perfume products, cosmetics, and other consumer goods are estimated to use 2500 different fragrance ingredients. Of those, approximately 100 different substances are known to elicit allergic responses in at least some individuals. It is estimated that 1.7-4.1% of the general population shows a contact allergic response to a mix of common perfume ingredients. [4] Although products can be labeled "fragrance-free", many still contain lesser-known fragrance chemicals that consumers may not recognize.[5]
Fragrance allergens
cinnamic aldehyde[6][7]
References
[1] [2] [3] [4] http:/ / etd. ohiolink. edu/ send-pdf. cgi/ SAIYASOMBATI%20PENPAN. pdf?ucin1061561348 https:/ / depts. washington. edu/ exposure/ article_faqs. html http:/ / www. mckinley. illinois. edu/ handouts/ allergies. htm "Fragrance Contact Allergy: A Clinical Review" (http:/ / www. ingentaconnect. com/ content/ adis/ derm/ 2003/ 00000004/ 00000011/ art00006). American Journal of Clinical Dermatology. . Retrieved 11 Feb 2012. "Fragrance ingredients are also one of the most frequent causes of contact allergic reactions. The diagnosis is made by patch testing with a mixture of fragrance ingredients, the fragrance mix. This gives a positive patch-test reaction in about 10% of tested patients with eczema, and the most recent estimates show that 1.74.1% of the general population are sensitized to ingredients of the fragrance mix." [5] . PMID11753900. [6] http:/ / www. emeraldmaterials. com/ epm/ kalama/ micms_doc_admin. display?p_customer=FISKALAMA& p_name=PRODBULL-CINNAMICALDEHYDE. PDF [7] http:/ / etd. ohiolink. edu/ send-pdf. cgi/ SAIYASOMBATI%20PENPAN. pdf?ucin1061561348
Further reading
Elberling J, Linneberg A, Dirksen A, Johansen JD, Frlund L, Madsen F, et al. Mucosal symptoms elicited by fragrance products in a population-based sample in relation to atopy and bronchial hyper-reactivity. Clin Exp Allergy 2005 Kumar P, Caradonna-Graham VM, Gupta S, Cai X, Rao PN, Thompson J. Inhalation challenge effects of perfume scent strips in patients with asthma. Ann Allergy Asthma Immunol 1995
Perfume allergy
101
External links
Allergy to Perfume in the Air (http://www.users.globalnet.co.uk/~aair/perfume_corr.htm) Fragranced Products Information Network (http://www.fpinva.org)
102
Testing
Skin allergy test
Skin allergy testing is a method for medical diagnosis of allergies that attempts to provoke a small, controlled, allergic response.
Process
A microscopic amount of an allergen is introduced to a patient's skin by various means: Prick test or scratch test: pricking the skin with a needle or pin containing a small amount of the allergen. Patch test: applying a patch to the skin, where the patch contains the allergen If an immuno-response is seen in the form of a rash, urticaria (hives), or (worse) anaphylaxis it can be concluded that the patient has a hypersensitivity (or allergy) to that allergen. Further testing can be done to identify the particular allergen. The "scratch test" as it's called, is still very commonly used as an allergen test. A similar test involving injecting the allergen is also used, but is not quite as common due to increased likelihood of infection and general ineffectiveness by comparison. There are other methods available to test for allergy. Some allergies are identified in a few minutes but others may take several days. In all cases where the test is positive, the skin will Skin testing on back become raised, red and appear itchy. The results are recorded- larger wheals indicating that the subject is more sensitive to that particular allergen. A negative test does not mean that the subject is not allergic; simply that either the right concentration was not used or the body failed to elicit a response.
Skin testing on arm
103
Prick test
In the prick (scratch) test, a few drops of the purified allergen are gently pricked on to the skin surface, usually the forearm. This test is usually done in order to identify allergies to pet dander, dust, pollen, foods or dust mites. Intradermal injections are done by injecting a small amount of allergen just beneath the skin surface. The test is done to assess allergies to drugs like penicillin or bee venom. To ensure that the skin is reacting in the way it is supposed to, all skin allergy tests are also performed with proven allergens like histamine or glycerin. The majority of people do react to histamine and do not react to glycerin. If the skin does not react appropriately to these allergens then it most likely will not react to the other allergens. These results are interpreted as falsely negative.[1]
Patch test
The patch test simply uses a large patch which has different allergens on it. The patch is applied onto the skin, usually on the back. The allergens on the patch include latex, medications, preservatives, hair dyes, fragrances, resins and various metals. When a patch is applied the subject should avoid bathing or exercise for at least 48 hours.
Preparation
There are no major preparations required for skin testing. At the first consult, the subject's medical history is obtained and physical examination is performed. All consumers should bring a list of their medications because some may interfere with the testing. Other medications may increase the chance of a severe allergic reaction. Medications that commonly interfere with skin testing include the following: Histamine antagonists like Allegra, Claritin, Benadryl, Zyrtec Antidepressants like Amitriptyline, Doxepin Antacid like Tagamet or Zantac Consumers who undergo skin testing should know that anaphylaxis can occur anytime. So if any of the following symptoms are experienced, a physician consultation is recommended immediately: Low grade Fever Lightheadedness or dizziness Wheezing or Shortness of breath Extensive skin rash Swelling of face, lips or mouth Difficulty swallowing or speaking
104
Contraindications
Even though skin testing may sound like a benign procedure it does have some risks which include swollen red bumps (hives) may occur after the test. The hivesusually disappear in a few hours after the test. In rare cases they can persist for a day or two. These hives may be itchy and are best treated by applying an over the counter hydrocortisone cream.[3] In very rare cases one may develop a full blown allergic reaction. Physicians who perform skin test always have equipment and medications available in case an anaphylaxis reaction occurs. This is the main reason why consumers should not get skin testing performed at corner stores or by people who have no medical training.[4] Skin testing can be done on individuals of all ages. However, there are times when a skin test should not be done. Individuals who take medications for depression, gastric acidity or antihistamines should not undergo this test. In such cases, stopping the medications for a skin test may not be worthwhile as one may develop symptoms from the untreated medical disorders. Individuals who have severe, generalized skin disease or an acute skin infection should not undergo skin testing. One needs uninvolved skin for testing. There are some individuals who are highly sensitive to even the smallest amount of allergen and in such scenarios, allergic testing is not recommended. Whenever the chances of an anaphylactic shock are high, the test is best avoided.[5] Besides skin tests, there are blood tests which measure a specific antibody in the blood. The IgE antibody plays a vital role in allergies but its levels in blood do not always correlate with the allergic reaction.[6] There are many alternative health care practitioners who perform a variety of provocation neutralization tests, but the vast majority of these tests have no validity and have never been proven to work scientifically.
Notes
[1] American Academy of Allergy Asthma & Immunology: What is Allergy Testing? (http:/ / www. aaaai. org/ patients/ publicedmat/ tips/ whatisallergytesting. stm), Retrieved on 2010-01-20. [2] MeSH Skin Test End-Point Titration (http:/ / www. nlm. nih. gov/ cgi/ mesh/ 2011/ MB_cgi?mode=& term=Skin+ Test+ End-Point+ Titration) [3] Skin Testing and Allergy Injection Treatment for Allergies and Asthma - The University of Arizona Health Sciences Center (http:/ / allergy. peds. arizona. edu/ southwest/ skintesting. html), Retrieved on 2010-01-20. [4] Allergy Testing - August 15,2002 - American Family Physician (http:/ / www. aafp. org/ afp/ 2002/ 0815/ p621. html), Retrieved on 2010-01-20. [5] Skin test for Allergy (http:/ / www. medicinenet. com/ skin_test_for_allergy/ article. htm), Retrieved on 2010-01-20. [6] Skin Testing Basic Information (http:/ / www. skintesting. net/ ), Retrieved on 2010-01-20.
Patch test
105
Patch test
Patch test (medicine)
Intervention
A patch test is a method used to determine if a specific substance causes allergic inflammation of the skin. Any individual with eczema suspected of having allergic contact dermatitis and/or atopic dermatitis needs patch testing. Patch testing helps identify which substances may be causing a reaction in a patient. It is intended to produce a local allergic reaction on a small area of your back where the diluted chemicals were planted. The chemicals included in the patch test kit are the offenders in approximately 85-90 percent of contact allergic eczema and include chemicals present in metals (e.g. nickel), rubber, leather, hair dyes, formaldehyde, lanolin, fragrance, preservative and other additives.
Mechanism
A patch test relies on the principle of a type IV hypersensitivity reaction. The first step in becoming allergic is sensitization. When the skin is exposed to an allergen, the antigen presenting cells (APCs) - also known as Langerhans cell or Dermal Dendritic Cell - eat up substance (phagocytoze) and break it into smaller pieces. This is where a substance is recognized by immune cells in the skin. They then put parts of the substance onto their surface (technically holds the part of the molecule on the surface in the major histocompatibility complex type two (MHC-II). Once this is done the APC moves down the lymphatic system to a lymph node where it presents this part of the substance (what we now call an antigen) to a particular immune cell called a CD4+ T-cell or T-helper cell. The T-cell, if it recognizes the substance as dangerous, expands in number and sends out more of itself to the skin, at the site of antigen exposure. When the skin is again exposed to the antigen, the memory t-cells in the skin recognize the antigen and produce cytokines (chemical signals) which cause more T-cells to migrate from blood vessels. This starts a complex immune cascade leading to skin inflammation, itching and the typical rash of contact dermatitis. In general, it takes 2 to 4 days for a response in patch testing to develop. The patch test is really just induction of a contact dermatitis in a small area. Interestingly, the size of the molecule necessary to be picked up and recognized is ten times the size of the largest molecule that can pass through the skin. Therefore, it is likely that an antigen (like nickel) when it has passed through the skin, combines with something else before it is recognized.
Patch test
106
Setting up a service
Setting up a patch testing service is a time consuming process (see below) and takes up three clinic spaces a week for each patient. It is useful to know how many patients are likely to be seen and how useful the testing will be to pick up positive results. Studies have shown that the optimum number of patients to be tested is 1 in 700 of a population.[2] So in a population of 70,000, 100 patients should be tested annually to detect contact allergy. Coupled with this, differences exist between the rates of positive reactions to the patients tested in different centers. Effectively, the greater the proportion of the population tested for contact allergy, the lower the proportion of positive outcomes identified.[3] When setting up a service, it is important to know what impact it will have on the population. The British Association of Dermatology has set guidelines for patch testing within the UK which state that a patch test service needs: A named lead dermatologist for the unit who has received training for at least 6 months at a recognized contact dermatitis investigation unit or who can demonstrate comparable experience. That the contact dermatitis investigation unit conforms to best practice guidelines. The unit and the staff should Have a dedicated investigation clinic which should include an area for storage (refrigerator) and preparation of allergens. Record investigation results on an electronic database with a minimum data set: site of onset of dermatitis and duration; gender, occupational, atopy, hand dermatitis, leg dermatitis, face dermatitis and age index; details of occupation and leisure activities; patch test results including type (allergic/irritant) and severity of reaction; relevance of positive tests, occupational or otherwise; and final diagnosis. Participate in regular audit of data and benchmarks results with nationally pooled data. This is evolving and will be reviewed periodically. The lead dermatologist demonstrates regular attendance at CME-approved update meetings on contact dermatitis (at least every 2 years). The unit should have up-to-date reference textbooks on contact dermatitis including occupational dermatitis and relevant journals.[4]
Process
Prior to testing, avoid taking oral prednisone or other immunosuppressive medications for at least a week prior to testing. Steroid inhalers are OK to use. Avoid sunlight/sunburn for at least a week on the back as this may suppress positive reactions. Antihistamines such as diphenhydramine (Benadryl) or cetirizine (Zyrtec) are permissible prior to and during testing. Application of the patch tests will take about half an hour, though many times the overall appointment time will be longer as your provider will take an extensive history. Tiny quantities of 25 to ~150 materials (allergens) in individual square plastic or round aluminium chambers are applied to the upper back. They are kept in place with special hypoallergenic adhesive tape. The patches stay in place undisturbed for at least 48 hours. Getting the back wet during patch testing should be avoided (no shower). Vigorous exercise or stretching may disrupt the tests. At the second appointment, usually 48 hours later, the patches will be removed. Sometimes further patches are applied. The back is marked with an indelible black felt tip pen or other suitable marker to identify the test sites and a preliminary reading is done. These marks must be visible at the third appointment, usually 2448 hours later (7296 hours after application). The back should be checked and if necessary re-marked on several occasions between the 2nd and 3rd appointments. In some cases, a reading at 7 days may be requested, especially if a special metal series is tested.
Patch test
107
108
Extreme reaction (+++) Irritant reactions include miliaria (sweat rash), follicular pustules and burn-like reactions. Uncertain reactions refer to a pink area under the test chamber. Weak positives are slightly elevated pink or red plaques, usually with mild vesiculation. Strong positives are papulovesicles and extreme reactions have spreading redness, severe itching and blisters or ulcers. Relevance is determined by exposure to the positive allergen(s) and is rated as definite, probable, possible, past or unknown. For an allergen to have definite relevance, the product the patient is exposed to must be tested and also be positive in addition to the test allergen. Probable would be used to describe a positive allergen ingredient which is in a product the patient uses (i.e. quaternium-15 listed in a moisturizing cream used on the sites of dermatitis). The interpretation of the results requires considerable experience and training. A positive patch test(s), might not explain the present skin problem since the test only indicates that the individual became allergic during the encounters with that chemical(s) at some point in their life. Relevance, therefore, has to be established by determining the casual relationship between the positive test(s) and the eczema. The confirmation of relevance will occur after the patient has avoided exposure to the chemical(s) and after they have noticed that the improvement or clearance of your dermatitis is directly related to this avoidance. This outcome usually occurs within four to six weeks after stopping the exposure to the chemical(s). If all patch tests are negative, the eczema is probably not due to an allergic reaction to a contactant. It is possible, however, that you were not tested to other chemical(s) that can produce allergic reactions on the rare occasions. If the suspicion is high in spite of negative patch testing, further investigation might be required. This can be discussed during the final evaluation of the patch test procedure.
Patch test
109
Common allergens
The most frequent allergen that was recorded in many research studies all around the world is Nickel. Nickel allergy is more prevalent in young women and it is especially associated with ear piercing or any nickel-containing watch, belt, zipper or jewelry. Other common allergens are surveyed in North America by the North American Contact Dermatitis Group (NACDG)[5]. The latest update of top allergens from 2005-2006 were: Nickel sulfate (19.0%), Myroxylon pereirae (balsam of Peru, 11.9%), fragrance mix I (11.5%), quaternium-15 (10.3%), neomycin (10.0%), bacitracin (9.2%), formaldehyde (9.0%), cobalt chloride (8.4%), methyldibromoglutaronitrile/phenoxyethanol (5.8%), p-phenylenediamine (5.0%), potassium dichromate (4.8%), carba mix (3.9%), thiuram mix (3.9%), diazolidinyl urea (3.7%), and 2-bromo-2-nitropropane-1,3-diol (3.4%)
Food allergy
There is often an assumption that certain foods can cause or worsen skin complaints like eczema. However, there is very little evidence that cutting out foods such as milk and eggs actually improves eczema. Dermatologists may refer patients with suspected food allergies for patch testing. Sometimes this is justified as certain food additives and flavorings can cause dermatitis around the mouth, around the anus and vagina as food allergens pass out of the body or cause a widespread rash on the skin. While this is controversial, allergens such as nickel, Balsam of Peru, parabens, sodium benzoate or cinnamic aldehyde may worsen or cause skin rashes. However, the foods that cause urticaria (hives) or anaphylaxis (such as peanuts) cause a type I hypersensitivity reaction whereby the part of the food molecule is directly recognized by cells close to the skin called mast cells. Mast cells have antibodies on their surface called immunoglobulin E (IgE). These act as receptors and if they recognize the allergen, they release their contents, causing an immediate allergic reaction. Type I reactions like anaphylaxis are immediate and do not take 2 to 4 days to appear. In a recent study of patients with chronic hives who were patch tested, those who were found allergic and avoided all contact with their allergen, including dietary intake, stopped having hives. Those who started eating their allergen again had recurrence of their hives.[6] Often, patch testing for food allergies is not necessary, but in selected individuals it may be helpful.
References
[1] http:/ / www. nlm. nih. gov/ cgi/ mesh/ 2011/ MB_cgi?field=uid& term=D010328 [2] Bhushan M. Beck, MH. An audit to identify the optimum referral rate to a contact dermatitis investigation unit. British Journal of Dermatology, 1999 141(3) P570-572 [3] Statham B, Mughal A, Bodger O. The relationship between the proportion of the population tested annually and the rate of patients with positive patch test reactions. Contact Dermatitis. 2011 64(1) P54-57 [4] J. Bourke, I. Coulson and J. English Guidelines for the management of contact dermatitis: British Journal of Dermatology 2009 160 P946-954. [5] Zug KA, Warshaw EM, Fowler JF Jr, Maibach HI, Belsito DL, Pratt MD, Sasseville D, Storrs FJ, Taylor JS, Mathias CG, Deleo VA, Rietschel RL, Marks J. Patch-test results of the North American Contact Dermatitis Group 2005-2006. Dermatitis. 2009 May-Jun;20(3):149-60. [6] Guerra L, Rogkakou A, Massacane P, Gamalero C, Compalati E, Zanella C, Scordamaglia A, Canonica WG, Passalacqua G. Role of contact sensitization in chronic urticaria. J Am Acad Dermatol 2007; 56:88-90.
Patch test
110
External links
MeSH Patch tests (http://www.nlm.nih.gov/cgi/mesh/2011/MB_cgi?mode=&term=patch+tests) DermNet NZ: Patch tests (contact allergy testing) (http://dermnetnz.org/procedures/patch-tests.html) Netdoctor: Patch testing for skin allergies (http://www.netdoctor.co.uk/health_advice/examinations/ patchtesting.htm) American Contact Dermatitis Society (http://www.contactderm.org)
RAST test
111
RAST test
RAST test
Diagnostics MeSH D011852 [1]
A RAST test (short for radioallergosorbent test) is a blood test used to determine to what substances a person is allergic. This is different from a skin allergy test, which determines allergy by the reaction of a person's skin to different substances. Because there are other tests that help with confirmation, results are best interpreted by a doctor.
History
The market-leading RAST methodology was invented and marketed in 1974 by Pharmacia Diagnostics AB, Uppsala, Sweden, and the acronym RAST is actually a brand name. In 1989, Pharmacia Diagnostics AB replaced it with a superior test named the ImmunoCAP Specific IgE blood test, which literature may also describe as: CAP RAST, CAP FEIA (fluorenzymeimmunoassay), and Pharmacia CAP. A review of applicable quality assessment programs shows that this new test has replaced the original RAST in approximately 80% of the world's commercial clinical laboratories, where specific IgE testing is performed. The newest version, the ImmunoCAP Specific IgE 0-100, is the only specific IgE assay to receive FDA approval to quantitatively report to its detection limit of 0.1kU/l. This clearance is based on the CLSI/NCCLS-17A Limits of Detection and Limits of Quantitation, October 2004 guideline. The guidelines for diagnosis and management of food allergy issues by the National Institute of Health state that: "sIgE levels were originally measured using the radioallergosorbent test (RAST), but this test has been replaced by more sensitive fluorescence enzyme-labeled assays and the term RAST should be abandoned"[2]
Indication
The two most commonly used methods of confirming allergen sensitization are skin testing and allergy blood testing. Both methods are recommended by the NIH guidelines and have similar diagnostic value in terms of sensitivity and specificity.[3][4] Advantages of the allergy blood test range from: excellent reproducibility across the full measuring range of the calibration curve, it has very high specificity as it binds to allergen specific IgE, and extremely sensitive too, when compared with skin prick testing. In general, this method of blood testing (in-vitro, out of body) vs skin-prick testing (in-vivo, in body) has a major advantage: it is not always necessary to remove the patient from an anthihistamine medication regimen, and if the skin conditions (such as eczema) are so widespread that allergy skin testing cannot be done. Allergy blood tests, such as ImmunoCAP, are performed without procedure variations, and the results are of excellent standardization[5]. Adults and children of any age can take an allergy blood test. For babies and very young children, a single needle stick for allergy blood testing is often more gentle than several skin tests. In the NIH food guidelines issued in December 2010 it was stated that The predictive values associated with clinical evidence of allergy for ImmunoCAP cannot be applied to to other test methods.[6] With over 4000 scientific articles using ImmunoCAP and showing its clinical value, ImmunoCAP is perceived as Gold standard for in vitro IgE testing[7][8]
RAST test
112
Method
The RAST test is a radioimmunoassay test to detect specific IgE antibodies to suspected or known allergens. IgE is the antibody associated with Type I allergic response: for example, if a person exhibits a high level of IgE directed against pollen, the test may indicate the person is allergic to pollen (or pollen-like) proteins. A person who has outgrown an allergy may still have a positive IgE years after exposure. The suspected allergen is bound to an insoluble material and the patient's serum is added. If the serum contains antibodies to the allergen, those antibodies will bind to the allergen. Radiolabeled anti-human IgE antibody is added where it binds to those IgE antibodies already bound to the insoluble material. The unbound anti-human IgE antibodies are washed away. The amount of radioactivity is proportional to the serum IgE for the allergen.[9] RAST are often used to test for allergies when: a physician advises against the discontinuation of medications that can interfere with test results or cause medical complications; a patient suffers from severe skin conditions such as widespread eczema or psoriasis; or a patient has such a high sensitivity level to suspected allergens that any administration of those allergens might result in potentially serious side effects.
Scale
The RAST test is scored on a scale from 0 to 6:
RAST rating IgE level (KU/L) 0 1 2 3 4 5 6 < 0.35 0.35 - 0.69 0.70 - 3.49 3.50 - 17.49 17.50 - 49.99 50.0 - 100.00 > 100.00 comment ABSENT OR UNDETECTABLE ALLERGEN SPECIFIC IgE LOW LEVEL OF ALLERGEN SPECIFIC IgE MODERATE LEVEL OF ALLERGEN SPECIFIC IgE HIGH LEVEL OF ALLERGEN SPECIFIC IgE VERY HIGH LEVEL OF ALLERGEN SPECIFIC IgE VERY HIGH LEVEL OF ALLERGEN SPECIFIC IgE EXTREMELY HIGH LEVEL OF ALLERGEN SPECIFIC IgE
References
[1] http:/ / www. nlm. nih. gov/ cgi/ mesh/ 2011/ MB_cgi?field=uid& term=D011852 [2] NIH Guidelines for the Diagnosis and Management of Food Allergy in the United States. Report of the NIAID- Sponsored Expert Panel, 2010, NIH Publication no. 11-7700. [3] NIH Guidelines for the Diagnosis and Management of Food Allergy in the United States. Report of the NIAID- Sponsored Expert Panel, 2010, NIH Publication no. 11-7700. [4] Cox, L. Overview of Serological-Specific IgE Antibody Testing in Children. Pediatric Allergy and Immunology. 2011. [5] Hamilton R et al. Proficiency Survey-Based Evaluation of Clinical Total and Allergen-Specific IgE Assay Performance. Arch Pathol Lab Med. 2010; 134: 975982 [6] Boyce J et al. Guidelines for the Diagnosis and Management of Food Allergy in the United States: Report of [7] Wood R et al. Accuracy of IgE antibody laboratory results. Ann Allergy Asthma Immunol. 2007; 99: 3441. [8] Wang J, et al. J Allergy Clin Immunol. 2008;121(5):1219-1224 [9] WebMD > Medical Dictionary > radioallergosorbent test (RAST) (http:/ / dictionary. webmd. com/ terms/ radioallergosorbent-test(rast)) Citing: Stedmans Medical Dictionary 28th Edition. Copyright 2006
RAST test
113
External links
A discussion by world renowned experts on the relative value of RAST testing from the American Academy of Allergy, Asthma and Immunology (AAAAI), the largest professional medical specialty organization representing allergists, clinical immunologists, allied health professionals, and other physicians with a special interest in allergy http://www.aaaai.org/aadmc/ate/category.asp?cat=1137 ImmunoCAP articles, disease management data, product info from the manufacturer that markets this product: http://isitallergy.com/ http://www.phadia.us/ Short FAQ's: How a RAST test is performed, results, when ordered: http://www.healthatoz.com/healthatoz/Atoz/dc/tp/tprast.jsp http://www.labtestsonline.org/understanding/analytes/allergy/test.html A glossary of allergy testing information regarding RAST http://www.acaai.org/public/background/testing.htm MeSH Radioallergosorbent+Test (http://www.nlm.nih.gov/cgi/mesh/2011/MB_cgi?mode=& term=Radioallergosorbent+Test)
114
History
The concept of the elimination diet was first proposed by Dr. Albert Rowe in 1926 and expounded upon in his book, Elimination Diets and the Patient's Allergies, published in 1941.[8] In 1978 Australian researchers published details of an 'exclusion diet' to exclude specific food chemicals from the diet of patients. This provided a basis for challenge with these additives and natural chemicals. Using this approach, the role played by dietary chemical factors in the pathogenesis of chronic idiopathic urticaria (CIU) was first established and set the stage for futute DBPCT trials of such substances in food intolerance studies.[9][10]
Elimination diet
115
Definitions
'Food hypersensitivity' is an umbrella term which includes food allergy and food intolerance. [11] [12] [13] Food allergy is defined as an immunological hypersensitivity which occurs most commonly to food proteins such as egg, milk, seafood, shellfish, tree nuts, soya, wheat and peanuts. Its biological response mechanism is characterized by an increased production of IgE (immunoglobulin E) antibodies.[14] A food intolerance on the other hand does not activate the individual's immune response system. A food intolerance differs from a food allergy or chemical sensitivity because it generally requires a normal serving size to produce symptoms similar to an IgE immunologic response. While food intolerances may be mistaken for a food allergy, they are thought to originate in the gastrointestinal system. Food intolerances are usually caused by the individuals inability to digest or absorb foods or food components in the intestinal tract.[14] One common example of food intolerance is lactose intolerance. Metabolic food reactions are due to an inborn or acquired errors of metabolism of nutrients such as in diabetes melitus, lactase deficiency, phenylketonuria and favism. Toxic food reactions are caused by the direct action of a food or additive without immune involvement.[15] Pharmacological reactions are generally to low molecular weight chemicals which occur either as natural compounds such as salicylates, amines, or to artificially added substances such as preservatives, coloring, emulsifiers and taste enhancers including glutamate (MSG).[16] These chemicals are capable of causing drug-like (biochemical) side effects in susceptible individuals. Toxins may either be present naturally in food or released by bacteria or from contamination of food products.[17][18] Psychological reactions involve manifestation of clinical symptoms caused not by the food but by emotions associated with the food. The symptoms do not occur when the food is given in an unrecognizable form.[19] Although an individual may have an adverse reaction to a food, this is not considered a food intolerance. Elimination diets are useful to assist in the diagnosis of food allergy and pharmacological food intolerance. Metabolic, toxic and psychological reactions should be diagnosed by other means.[2][20][21]
Diagnosis
Food allergy is principally diagnosed by careful history and examination. When reactions occur immediately after certain food ingestion then diagnosis is straight forward and can be documented by using carefully performed tests such as the skin prick test (SPT) and the radioallergosorbent test RAST to detect specific IgE antibodies to specific food proteins and aero-allergens. However false positive results occur when using the SPT when diagnosis of a particular food allergen is hard to determine. This can be confirmed by exclusion of the suspected food or allergen from the patient's diet. It is then followed by an appropriately timed challenge under careful medical supervision. If there is no change of symptoms after 2 to 4 weeks of avoidance of the protein then food allergy is unlikely to be the cause and other causes such as food intolerance should be investigated.[21][22][23] This method of exclusion-challenge testing is the premise by which the Elimination Diet is built upon, as explained in the sections below. Vega testing, a bioelectric test, is a controversial method that attempt to measure allergies or food or environmental intolerances. Currently this test has not been shown to be an effective measure of an allergy or intolerance.[24][25] Food intolerance due to pharmacological reaction is more common than food allergy and has been estimated to occur in 10% of the population. Unlike a food allergy, a food intolerance can occur in non-atopic individuals. Food intolerances are more difficult to diagnose since individual food chemicals are widespread and can occur across a range of foods. Elimination of these foods one at a time would be unhelpful in diagnosing the sensitiveity. Natural chemicals such as benzoates and salicylates found in food are identical to artificial additives in food processing and can provoke the same response. Since a specific component is not readily known and the reactions are often delayed
Elimination diet up to 48 hours after ingestion, it can be difficult to identify suspect foods. In addition, chemicals often exhibit dose-response relationships and so the food may not trigger the same response each time. There is currently no skin or blood test available to identify the offending chemical(s), and consequently, elimination diets aimed at identifying food intolerances need to be carefully designed. All patients with suspected food intolerance should consult a physician first to eliminate other possible causes.[2][20]
116
Elimination diet
The elimination diet must be comprehensive and should contain only those foods unlikely to provoke a reaction in a patient. They also need to be able to provide complete nutrition and energy for the weeks it will be conducted. Professional nutritional advice from a dietitian or nutritionist is strongly recommended. Thorough education about the elimination diet is essential to ensure patients and the parents of children with suspected food intolerance understand the importance of complete adherence to the diet, as inadvertent consumption of an offending chemical can prevent resolution of symptoms and render challenge results useless. While on the elimination diet, records are kept of all foods eaten, medications taken, and symptoms that the patient may be experiencing. Patients are advised that withdrawal symptoms can occur in the first weeks on the elimination diet and some patients may experience symptoms that are worse initially before settling down. While on the diet some patients become sensitive to fumes and odours, which may also cause symptoms. They are advised to avoid such exposures as this can complicate the elimination and challenge procedures. Petroleum products, paints, cleaning agents, perfumes, smoke and pressure pack sprays are particular chemicals to avoid when participating in an elimination diet. Once the procedure is complete this sensitivity becomes less of a problem. Clinical improvement usually occurs over a 2 to 4 week period; if there is no change after a strict adherence to the elimination diet and precipitating factors, then food intolerance is unlikely to be the cause. A normal diet can then be resumed by gradually introducing suspected and eliminated foods or chemical group of foods one at a time. Gradually increasing the amount up to high doses over 3 to 7 days to see if exacerbated reactions are provoked before permanently reintroducing that food to the diet. A strict elimination diet is not usually recommended during pregnancy, although a reduction in suspected foods that reduce symptoms can be helpful.[2] Reasons for undertaking an elimination diet may vary from patient to patient, as some types of elimination diets are not out of medical necessity but completely by choice. Some of the most common elimination diets include Veganism, where an individual removes all animal products from the diet, including meat, dairy, fish, eggs, and even honey. Many will refuse to use any item that has been produced by an animal, like leather or fur clothing. Vegetarianism, which tends to be a less extreme version of veganism, with options ranging from an ovo-lacto vegetarian, a person who will consume no meat, but will consume dairy products and eggs, a Pescetarian that consumes no meat products except fish and shellfish, or even a flexitarian who will consume a mostly vegan diet, but eats meat and other animal products on occasion. Gluten-free, a diet where all grains that contain gluten are eliminated from the diet, including wheat, kamut, spelt, barley, rye, and potentially oats, though there is some controversy on this grain. This is the only medically accepted treatment for patients who have Celiac disease and has some inconclusive studies linked to decreasing symptoms of autism.
Challenge testing
Challenge testing is not carried out until all symptoms have cleared or improved significantly for five days after a minimum period of two weeks on the elimination diet. The restrictions of the elimination diet is maintained throughout the challenge period. Open food challenges on wheat and milk can be carried out first, then followed by challenge periods with natural food chemicals, then with food additives. Challenges can take the form of purified food chemicals or with foods grouped according to food chemical. Purified food chemicals are used in double blind
Elimination diet placebo controlled testing, and food challenges involve foods containing only one suspect food chemical eaten several times a day over 3 to 7 days. If a reaction occurs patients must wait until all symptoms subside completely and then wait a further 3 days (to overcome a refractory period) before recommencing challenges. Patients with a history of asthma, laryngeal oedema or anaphylaxis may be hospitalised as inpatients or attended in specialist clinics where resuscitation facilities are available for the testing. If any results are doubtful the testing is repeated, only when all tests are completed is a treatment diet determined for the patient. The diet restricts only those compounds to which the patient has reacted and over time liberalisation is attempted. In some patients food allergy and food intolerance can coexist, with symptoms such as asthma, eczema and rhinitis. In such cases the elimination diet for food intolerance is used for dietary investigation. Any foods identified by SPT or RAST as suspect should not be included in the elimination diet.[2][7][20][21][22][23][26][27][28][29][30]
117
Tax Credit
Some countries offer a tax credit available to a patient if they are on a specific elimination diet. More commonly a tax credit will be issued to an individual suffering from Celiac Disease who is required to maintain a gluten free diet for life. Countries involved in this type of medical tax credit include Canada[31] and the U.S.[32]
References
[1] "Allergies: Elimination Diet and Food Challenge Test" (http:/ / www. webmd. com/ allergies/ allergies-elimination-diet). WebMD. . Retrieved 2009-04-01. [2] Clarke L, McQueen J, Samild A, Swain AR (1996). "Dietitians Association of Australia review paper. The dietary management of food allergy and food intolerance in children and adults" (http:/ / www. fedupwithfoodadditives. info/ information/ Clarke et al 1996. pdf) (PDF). Aust J Nutr Dietetics 53 (3): 8998. ISSN1032-1322. OCLC20142084. . [3] Is migraine food allergy? A double-blind controlled trial of oligoantigenic diet treatment. PMID6137694. [4] Minford, A M; MacDonald, A; Littlewood, J M (October 1982). "Food intolerance and food allergy in children: a review of 68 cases". Arch Dis Child 57 (10): 7427. doi:10.1136/adc.57.10.742. PMC1627921. PMID7138062. [5] Laitinen K, Isolauri E (2007). "Allergic infants: growth and implications while on exclusion diets" (http:/ / content. karger. com/ produktedb/ produkte. asp?doi=10. 1159/ 0000106367& typ=pdf). Nestle Nutr Workshop Ser Pediatr Program 60: 15767; discussion 1679. doi:10.1159/0000106367. PMID17664903. . [6] Barbi E, Berti I, Longo G (2008). "Food allergy: from the of loss of tolerance induced by exclusion diets to specific oral tolerance induction" (http:/ / www. bentham-direct. org/ pages/ content. php?IAD/ 2008/ 00000002/ 00000003/ 0007IAD. SGM). Recent Pat Inflamm Allergy Drug Discov 2 (3): 2124. doi:10.2174/187221308786241875. PMID19076011. . [7] Allen DH, Van Nunen S, Loblay R, Clarke L, Swain A (1984). "Adverse reactions to foods". Med J Aust 141 (5 Suppl): S3742. PMID6482784. [8] Rowe, A. Elimination Diets and the Patient's Allergies. 2nd Edition. Lea & Febiger, Philadelphia, PA: 1944 [9] Gibson AR, Clancy RL (March 1978). "An Australian exclusion diet". Med. J. Aust. 1 (5): 2902. PMID661687. [10] Gibson A, Clancy R (November 1980). "Management of chronic idiopathic urticaria by the identification and exclusion of dietary factors". Clin. Allergy 10 (6): 699704. doi:10.1111/j.1365-2222.1980.tb02154.x. PMID7460264. [11] Gerth van Wijk R, van Cauwenberge PB, Johansson SG (August 2003). "[Revised terminology for allergies and related conditions]" (in Dutch; Flemish). Ned Tijdschr Tandheelkd 110 (8): 32831. PMID12953386. [12] Johansson SG, Bieber T, Dahl R, et al. (May 2004). "Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003" (http:/ / linkinghub. elsevier. com/ retrieve/ pii/ S0091674904009303). J. Allergy Clin. Immunol. 113 (5): 8326. doi:10.1016/j.jaci.2003.12.591. PMID15131563. . [13] Johansson SG, Hourihane JO, Bousquet J, et al. (September 2001). "A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force" (http:/ / www3. interscience. wiley. com/ resolve/ openurl?genre=article& sid=nlm:pubmed& issn=0105-4538& date=2001& volume=56& issue=9& spage=813). Allergy 56 (9): 81324. doi:10.1034/j.1398-9995.2001.t01-1-00001.x. PMID11551246. . [14] "Food Allergies and Intolerances" (http:/ / www. hc-sc. gc. ca/ fn-an/ securit/ allerg/ index-eng. php). Health Canada. . Retrieved 2010-12-01. [15] "UNL Food: Food Allergies: General information on food allergies and sensitivities" (http:/ / food. unl. edu/ web/ allergy/ allergy-sensitivity#metabolic). University of Nebraska-Lincoln. . Retrieved 2010-12-01. [16] Asero R, Bottazzi G (2007). "Chronic rhinitis with nasal polyposis associated with sodium glutamate intolerance" (http:/ / content. karger. com/ produktedb/ produkte. asp?typ=fulltext& file=000103229). Int. Arch. Allergy Immunol. 144 (2): 15961. doi:10.1159/000103229.
Elimination diet
PMID17536215. . [17] "Marine Toxins" (http:/ / www. cdc. gov/ ncidod/ dbmd/ diseaseinfo/ marinetoxins_g. htm). Centers for Disease Control and Prevention. . Retrieved 2010-12-01. [18] "Protecting Against Foodborne Illnesses" (http:/ / www. nsf. org/ consumer/ food_safety/ fsafety_illness. asp). NSF: The Public Health and Safety Company. . Retrieved 2010-12-01. [19] "Food allergy or food intolerance" (http:/ / www. umm. edu/ careguides/ 000013. htm). University of Maryland: Medical Center. . Retrieved 2010-12-01. [20] Ortolani C, Pastorello EA (2006). "Food allergies and food intolerances". Best practice & research. Clinical gastroenterology 20 (3): 46783. doi:10.1016/j.bpg.2005.11.010. PMID16782524. [21] Pastar Z, Lipozenci J (2006). "Adverse reactions to food and clinical expressions of food allergy". Skinmed 5 (3): 11925; quiz 1267. doi:10.1111/j.1540-9740.2006.04913.x. PMID16687980. [22] Schnyder B, Pichler WJ (1999). "[Food intolerance and food allergy]" (in German). Schweizerische medizinische Wochenschrift 129 (24): 92833. PMID10413828. [23] Kitts D, Yuan Y, Joneja J, et al. (1997). "Adverse reactions to food constituents: allergy, intolerance, and autoimmunity". Can. J. Physiol. Pharmacol. 75 (4): 24154. doi:10.1139/cjpp-75-4-241. PMID9196849. [24] "Vegatest High Tech Pseudoscience" (http:/ / www. theness. com/ neurologicablog/ ?p=2177). Neurologica. . Retrieved 2010-12-01. [25] "Vega Machine" (http:/ / en. wikipedia. org/ wiki/ Vega_machine). Wikipedia. . Retrieved 2010-12-01. [26] Sullivan PB (1999). "Food allergy and food intolerance in childhood". Indian journal of pediatrics 66 (1 Suppl): S3745. PMID11132467. [27] Vanderhoof JA (1998). "Food hypersensitivity in children". Current opinion in clinical nutrition and metabolic care 1 (5): 41922. doi:10.1097/00075197-199809000-00009. PMID10565387. [28] Liu Z, Li N, Neu J (2005). "Tight junctions, leaky intestines, and pediatric diseases". Acta Paediatr 94 (4): 38693. doi:10.1111/j.1651-2227.2005.tb01904.x. PMID16092447. [29] MacDermott RP (2007). "Treatment of irritable bowel syndrome in outpatients with inflammatory bowel disease using a food and beverage intolerance, food and beverage avoidance diet". Inflamm Bowel Dis 13 (1): 916. doi:10.1002/ibd.20048. PMID17206644. [30] Carroccio A, Di Prima L, Iacono G, et al. (2006). "Multiple food hypersensitivity as a cause of refractory chronic constipation in adults". Scand J Gastroenterol 41 (4): 498504. doi:10.1080/00365520500367400. PMID16635922. [31] "Celiac disease - Medical expenses" (http:/ / www. cra-arc. gc. ca/ tx/ ndvdls/ tpcs/ clc-eng. html). Canada Revenue Agency. . Retrieved 2010-12-02. [32] "Medical and Dental expenses (Including the Health Coverage Tax Credit) Publication 502" (http:/ / www. irs. gov/ pub/ irs-pdf/ p502. pdf). Internal Revenue Service. . Retrieved 2010-12-02.
118
Feingold diet
119
Feingold diet
The Feingold diet is a food elimination program developed by Ben F. Feingold, MD to treat hyperactivity. It eliminates a number of artificial colors and artificial flavors, aspartame, three petroleum-based preservatives, and (at least initially) certain salicylates. There has been much debate about the efficacy of this program. The mainstream medical establishment dismissed it as an "outmoded approach" lacking evidence and efficacy,[1] however some medical practitioners, as well as many people living with ADHD and parents of children with ADHD, claim that it is effective in the management of ADHD as well as a number of other behavioral, physical and neurological conditions including salicylate sensitivity. The debate has continued for more than 30 years, involving not only consumers and physicians, but scientists, politicians, and the pharmaceutical and food industries.
History
Dr. Feingold was a pediatrician and allergist, and was considered a pioneer in the fields of allergy and immunology.[6] He served as Chief of Pediatrics, Cedars of Lebanon Hospital, Los Angeles, CA; later he established a number of allergy centers for Kaiser Permanente of Northern California, and served as Chief of Allergy at the Kaiser Permanente Medical Center in San Francisco.
Feingold diet The first clear case for Dr. Feingold was an adult patient referred to him for treatment of her severe hives in 1965.[9] Typical treatments had not worked for her. Dr. Feingold placed her on a low-salicylate diet with no synthetic coloring or flavoring. Soon her hives were gone, and the patient was happy. Ten days later, however, her psychiatrist called Dr. Feingold to ask, "What did you do to my patient?" She had been receiving treatment for a personality disorder for years, but in less than two weeks on the diet, her behavior had noticeably improved. Both doctors were puzzled. Dr. Feingold asked his staff to watch for other patients who did not respond to standard treatments. He suggested the diet regimen to them, and sometimes it worked. As more reports of behavioral improvement came in, he began to use the diet for people - especially children - with behavioral problems as well as allergy, and eventually found the diet often worked for children with behavioral problems even without allergy symptoms. He named the diet the K-P Diet for Kaiser-Permanente (and he liked the pun of "K-P" as Kitchen Police).[10] Later, as this diet became more well-known for helping hyperactive and learning disabled children, the media dubbed it the "Feingold diet."
120
Initial controversy
In late 1972, Dr. Feingold was invited to present his findings at the annual conference of the American Medical Association in June 1973, which he did.[15][16] Before that time, he had been treating children and adults with allergy symptoms as well as behavioral symptoms, but by 1972 he had arranged for a group of 25 children with a primary complaint of behavioral problems to be managed by the K-P diet. Dramatic improvement in behavior was repeated in this group as well. Dr. Feingold was again invited to participate in the June 1974 AMA conference, where he reported on 169 children in five separate samples that had experienced a success rate of 30 to 50 percent, depending on the age of the child and the sample. (Note, this was also before the diet eliminated preservatives.) This led to the first controlled double-blind crossover study, at the University of Pittsburgh, which was funded by the National Institute of Education. It was directed by Dr. C. Keith Connors, with Dr. Feingold as consultant, and the favorable results were published in the August 1976 issue of Pediatrics, the official publication of the American Academy of Pediatrics.[17] Meanwhile, in 1974, the food industry became involved via its industry-supported organization called the "Nutrition Foundation of New York."[16] This is an organization whose members included Dow Chemical, Coca Cola, and several companies who make, use, and distribute the food additives removed from the K-P diet.[18] In December, 1974, the Nutrition Foundation issued a "proposal for the study of dietary relationship to hyperkenesis" which
Feingold diet promised, in its final paragraph, that "no publicity will be given to the findings until the committee has approved the report for release." A two-week long conference, by invitation only, was arranged in January, 1975, in Glen Cove, Long Island. There, they created what they called the National Advisory Committee, which was not government-related in any way. One week later - and certainly long before any of the planned studies had been done, let alone published - this committee widely published its preliminary report concluding that "no controlled studies have demonstrated that hyperkinesis is related to the ingestion of food additives."[16] This conclusion is still quoted today, more than 30 years later.[19][20] Adding to the confusion is the assumption that the National Advisory Committee is a governmental agency rather than an arm of industry. Over the next few years, the Nutrition Foundation funded and designed several small studies, each concluding that the diet produced little effect.[21][22] Although the studies were conducted at universities, which would normally have lent them credibility, Congressman Ben Rosenthal of New York complained, "Despite the compelling need for experts who can examine the food industry with a critical eye, nutrition and food science communities have fallen under the $200 billion industry's influence. At our more prominent universities, eminent nutritionists have traded their independence for food companies' favors."[16] A review of the early studies published by M.A. Lipton in 1983[23] concluded that possibly 2% of children respond adversely to food additives, and that "even the 2% are questionable." Dr. Lipton further asserted that there "is no need for high-priority research or for changes in public policy regarding the use and labeling of foods containing additives." It should be noted that Dr. Lipton chaired the National Advisory Committee set up by the food industry's Nutrition Foundation discussed above.[16] However, when toxicologist Bernard Weiss[24] and autism expert Bernard Rimland[22] analyzed these same studies, they found that they actually did support the positive effects of the Feingold diet. Meanwhile, the media had begun calling the K-P Diet the "Feingold Diet," but because of the confusion with weight-loss diets, and because more than just food is involved in the management of ADHD suggested by the Feingold Association, the "Feingold Diet" was renamed the "Feingold Program."
121
Research findings
Many studies show that 70% or more of hyperactive children respond positively to the removal of synthetic additives, especially when salicylates or allergens are removed.[25][26] There is controversy, however, over what happens when researchers take children whose behavior has improved on a diet that eliminates several thousand additives, and then challenge them with one or a few additives, usually synthetic colors. Especially in the early studies, if such a challenge did not produce a change in behavior, researchers often concluded that the diet had not directly caused the initial improvement in behavior. Rather, the assumption was that the improvement had been due to a placebo effect. There are other possible reasons for the failure of a challenge to evoke a response, however. For example, the amount of additive used as a challenge might have been too small to cause an effect.[22] Rowe & Rowe in 1994 found a dose-related effect; the higher the amount of coloring he used for his double-blind challenge, the stronger (and longer) the reaction of the children.[25] The following chart lists the amount of coloring used in various studies along with the rate of response:
Feingold diet
122
Amount of Food Dye Challenge Used in Study 4mg in cookies w/1mg each
0% of 8 children 1 child was dropped from study when behavior deteriorated on challenge 0% of 12 children
Levy 1978
[27]
5mg in cookies w/1mg each testing done day AFTER challenge 17mg 35.26mg 26mg 26mg
[28]
5% of 19 children 9% of 22 children (not ADHD) 11% of 26 children 19% of 16 children showed visual tracking problem; Behavior of all the children was worse after eating food dye, but not significantly so 100% of 8 children were impaired by food dye
[29] [30]
Williams 1978
26mg, using younger children This is a higher dose in a younger child 50mg 50mg 100mg or 5 g other provoking food 100 & 150mg 125mg 150mg
25% of 8 children 64.7% of 34 children 81% of 16 children 85% of 20 children 89.5% of 19 children 79% of 34 children
[26] [33]
[34]
[35]
Considering that in 1976 an FDA scientist estimated that children may be consuming up to 315mg food dye per day,[36] all the above studies appear to be overly conservative in their choice of challenge amounts. In addition, the effect of an additive might only be seen in synergy with other additives or foods,[5] or the additive used for the challenge may simply not be among those causing the original effect.[36]
Early studies
As with many new developments, the first reports of improvement of behavior via diet were anecdotal. This was followed by clinical trials and eventually by larger, double-blind placebo-controlled studies. In 1976, a double-blind crossover diet trial found that both parents and teachers saw fewer hyperkinetic symptoms on the K-P diet as compared to the pretreatment baseline.[37] A 1978 double-blind crossover study using cookies with 13mg food dye each combined with either medication or placebo found, "The results of this study offer data that a diet free of artificial flavors and colors results in a reduction of symptoms in some hyperactive children."[38] In 1980, forty children were put on a diet free of artificial food dyes and other additives for five days. They then performed the usual double-blind placebo-controlled test but used 100mg or 150mg of the food dye mix. They found that the food dyes impaired the performance of the 20 hyperactive children on paired-associate learning tests. The dyes did not hurt the performance of the 20 non-hyperactive children. The study states: "Our data suggest that a large dose of food dye blend decreases attention span in hyperactive children as reflected by performance on the learning test."[39] Seven small studies adding up to a total of 190 children were published starting in the late 1970s. Some of them were elaborate double-blind diet studies using a Feingold-type diet. In some of these studies, the children were taken off their medication, while in others, they continued on stimulant medications including artificial colorants, in spite of the interference that this would create with the diet.
Feingold diet One of the studies in 1978,[40] for example, used 36 children between 6 and 12, and 10 children between 3 and 5. The teachers of the school-aged children did not record any improvement, but 63% of the mothers reported improved behavior, as well as 100% of the mothers of the preschoolers; however, since the improvement was reported by the parents of the children rather than teachers, and locomotor activity tests were unaffected, it was reported that there was "no diet effect." In 1980 the Nutrition Foundation set up a review team to review studies related to the Feingold diet.[41] They published a report that stated that there was no response at all to the diet. In 1983, the review team's co-chairman and a colleague reviewed a variety of studies and concluded that no more than 2% of children respond adversely to dye additives.[23] An influential comparative diet study was conducted in 1987 by Gross et al.[42] This was a study of 39 children, of whom 18 were hyperactive, and the balance had other learning disorders. Of those 18, all but one were on behavior-modifying medications during the entire study. The researchers provided a Feingold-type diet for a single week that was, by their own description, unpalatable. They particularly noted that the children missed mustard and ketchup; however, mustard is not eliminated by the Feingold diet, and no reason was given for its exclusion. This diet week was followed by an additive-rich diet the next week. Although the study reported that the camp director and all teachers felt that the children were noisier and more active during the second, additive-rich week, they discounted these observations in favor of filmed 4-minute sequences made during meals. These films were intended to measure reaction to additives in the meals in spite of the fact that any such reaction would not be expected to occur for some time after eating. During the course of the study, three children were dropped: one who was not on stimulant medication, whose behavior became worse during the second week; one who refused to behave altogether; and one whose dose of Cylert became "inadequate" and whose behavior worsened when additives were allowed during the second week. They concluded that the "Feingold diet has no beneficial effect on most children with learning disorders" and moreover that the diet was "distasteful to the typical American child."
123
Later studies
A number of studies conducted since 1980 using diets similar to the Feingold Program report greater than 70% of children responding positively to the diets. Others that eliminated synthetic colors and flavors, but included salicylates still reported greater than 50% positive response.[25][26][32][33] [35][43][44][45][46] In the biggest such study ever performed, published in 1986, the performance of over a million children in 803 New York City public schools was studied for seven years. The children's average standardized test scores rose 8.1% when levels of sucrose (normal table sugar) were restricted to 11 percent along with the removal of two synthetic food colors; when the remaining food colors and all artificial flavors were removed the next academic year, performance rose another 3.8%; when no further changes were made the following academic year, test performance also remained stable; finally, when the petroleum-based preservatives BHT and BHA were removed from the menu in the next academic year, performance improved another 3.7% for an overall improvement of 15.7% in mean national percentile rankings (from 39.2% to 54.9%).[47] Although it appears that improvement increases as the diet approaches the guidelines of the Feingold Program, the researchers suggest that by removing sugar and additives thereby removing empty calories and processed foods - malnutrition is reduced. It is not clear what portion of the effects can be contributed to limiting sugar intake or the foods containing BHT and BHA (the related preservative TBHQ did not exist at that time) and what portion can be attributed to the removal of the artificial colorants themselves. A most important and often overlooked detail in this study is that all the children did not improve equally. There was a dramatic decline in learning disabled and repeat-failure children. In 1979, 12.4% of the million children were performing two or more grades below their proper level. By the end of the study in 1983, the percent of children two or more grades below proper level had dropped to 4.9%. Moreover, before the dietary changes, the more school food
Feingold diet that was consumed, the worse the children did academically. After the changes, however, the more school food the children ate, the better they did academically.[48] In 1997, an association between brain electrical activity and intake of provoking foods was shown in children with food-induced ADHD. (Picture [49]) [50] Another study showed that an oligoantigenic diet can work as well as Ritalin for conduct-disordered children.[51] Other research demonstrated the positive effect of treating young criminals with dietary intervention and correction of mineral imbalances,[52][53] and that toddlers show both significant reductions in hyperactive behaviour when additives are removed from their diet, as well as increased hyperactivity when exposed to a very small (20mg) amount of food coloring and a benzoate preservative. This effect was observed by parents whether or not the child was hyperactive or atopic.[54] A 2007 British study at the University of Southampton[55] has pointed to food additives as a health hazard for all children, whether they have ADHD or not. The study concluded that artificial colors or a sodium benzoate preservative (or both) in the diet result in increased hyperactivity in 3-year-old and 8/9-year-old children in the general population. In response to this study and a massive media and grass-roots campaign, the major supermarket chains in the UK have removed additives from their house brands. Several American-based candy companies have done the same with the candies they sell in the UK. In response to that study, which had been financed by Britains Food Standards Agency and published online by the British medical journal The Lancet, the American Academy of Pediatrics concluded that a low-additive diet is a valid intervention for children with ADHD. It released the following statement in the February 2008 issue of its publication, AAP Grand Rounds: Although quite complicated, this was a carefully conducted study in which the investigators went to great lengths to eliminate bias and to rigorously measure outcomes. The results are hard to follow and somewhat inconsistent. For many of the assessments there were small but statistically significant differences of measured behaviors in children who consumed the food additives compared with those who did not. In each case increased hyperactive behaviors were associated with consuming the additives. For those comparisons in which no statistically significant differences were found, there was a trend for more hyperactive behaviors associated with the food additive drink in virtually every assessment. Thus, the overall findings of the study are clear and require that even we skeptics, who have long doubted parental claims of the effects of various foods on the behavior of their children, admit we might have been wrong. Anne Swain, of the Allergy Unit at Royal Prince Alfred Hospital in Sydney Australia, measured amounts (but not type) of salicylate in 333 foods in 1985,[56] and has done other research based on the Feingold Diet.[57]
124
Feingold diet & Restaurant Guide as well as other help. Like any change in diet, the Feingold Program does require that patients make changes in the food that they eat. However, these changes do not usually require significant changes in the types or cost of food a family may choose or the way a family chooses to prepare them. Such choices can be more difficult when little is known about the exact ingredients used in a product, such as at a restaurant or when purchasing food from a vending machine. This requires that a family identify restaurants or products that are not likely to create a problem. Questionable choices can also be avoided by bringing appropriate food when necessary, such as bringing a lunch to school. Parents are encouraged to keep treats available at home and school, so that the children never need feel deprived or left out.[] Nutritionally, the Feingold Program is little different from a normal diet. While some fruits and a few vegetables are eliminated in the first weeks of the Program, they are replaced by others. Often, some or all of these items can be returned to the diet, once the level of tolerance is determined. Studies have found that children on the Feingold Program actually ate better than those eating a "usual" diet, and were more likely to achieve the Recommended Dietary Allowance (RDA) of various nutrients.[58][59]
125
Feingold diet
126
References
[1] Turka, L.A. and Caplan, A. (2011 July 1). "What is the evidence for our standards of care?". Journal of Clinical Investigation 121: 2530-2530. doi:10.1172/JCI59185. [2] Dale Blumenthal. "U.S. Food & Drug Administration, Red No. 3 and Other Colorful Controversies" (http:/ / web. archive. org/ web/ 20080223165547/ http:/ / www. fda. gov/ bbs/ topics/ CONSUMER/ CON00063. html). Archived from the original (http:/ / www. fda. gov/ bbs/ topics/ CONSUMER/ CON00063. html) on 2008-02-23. . Retrieved 2008-03-15. "Approved color additives were divided into two groups: those requiring FDA's certification (synthetic dyes made mostly from coal tar and petroleum derivatives) and those exempt from FDA's certification (substances derived from vegetable, animal or mineral products)." [3] "Food Additives" (http:/ / www. imadrugpat. org/ foodadditives. htm). . Retrieved 2008-03-15. "E319 Tert-ButylHydroQuinone (TBHQ) Petroleum based... E320 Butylated hydroxy-anisole (BHA) Petroleum derivative ... E321 Butylated hydroxy-toluene (BHT) Petroleum derivate." [4] "Threshold of toxicological concern (TTC) in food safety assessment." (http:/ / www. feingold. org/ Research/ dye. html#Kroes2002). . [5] Lau, K. and McLean, W.G. and Williams, D.P. and Howard, C.V. (March 2006). "Synergistic interactions between commonly used food additives in a developmental neurotoxicity test". Toxocological Sciences 90 (1): 178187. doi:10.1093/toxsci/kfj073. PMID16352620. [6] Allan Magaziner, Linda Bonvie, Anthony Zolezzi (2003). Chemical-Free Kids: How to Safeguard Your Child's Diet and Environment (pp.62). Kensington Books. ISBN0-7582-0369-1. [7] "National Health Museum" (http:/ / www. accessexcellence. org/ HHQ/ qow/ qow05/ qow051031. html). . Retrieved 2008-03-31. [8] Lockey, SD (1959 SeptemberOctober). "Allergic reactions due to F D and C Yellow No. 5, tartrazine, an aniline dye used as a coloring and identifying agent in various steroids" (http:/ / www. feingold. org/ Research/ lockey1959. html). Annals of Allergy 17: 71921. PMID14417794. . [9] Feingold, B.F. (1985). Why Your Child is Hyperactive (pp.1-2). Random House. ISBN0-394-73426-2. [10] Feingold, B.F. (1985). Why Your Child is Hyperactive (p.37). Random House. ISBN0-394-73426-2. [11] Feingold, Ben F. (November 1976). "Hyperkinesis and learning disabilities linked to the ingestion of artificial food colors and flavors" (http:/ / www. feingold. org/ Research/ PDFstudies/ Feingold76. pdf) (PDF). Journal of Learning Disabilities 9 (9): 551559. doi:10.1177/002221947600900902. . [12] Feingold, Ben F. (May 1975). "Hyperkinesis and learning disabilities linked to artificial food colors and flavors" (http:/ / www. feingold. org/ Research/ PDFstudies/ Feingold75. pdf) (PDF). American Journal of Nursing (Lippincott Williams &) 75 (5): 79703. doi:10.2307/3423460. JSTOR3423460. PMID1039267. . [13] Brenner, A. (July 1977). "A study of the efficacy of the Feingold diet on hyperkinetic children" (http:/ / www. feingold. org/ Research/ PDFstudies/ Brenner77. pdf) (PDF). Clinical Pediatrics 16 (7): 652656. doi:10.1177/000992287701600715. PMID862303. . [14] Feingold, Ben F. (1979). "Dietary management of juvenile delinquency" (http:/ / www. feingold. org/ Research/ PDFstudies/ Feingold-delinq79. pdf) (PDF). International Journal of Offender Therapy and Comparative Criminology. 23 (1): 7384. doi:10.1177/0306624X7902300108. .
Feingold diet
[15] Feingold, Ben F. (1982). "The Role of Diet in Behavior" (http:/ / www. feingold. org/ Research/ PDFstudies/ Feingold82. pdf) (PDF). Ecology of Disease 2 (2/3): 153165. PMID6090095. . [16] Feingold, Ben F. (June 8, 1977). "A View of the Press From the Other Side" (http:/ / www. feingold. org/ Research/ PDFstudies/ Feingold-view. pdf) (PDF). Newspaper Food Editors & Writers Association. . [17] Conners CK, Goyette CH, Southwick DA, Lees JM, Andrulonis PA. (August 1976). "Food additives and hyperkinesis: a controlled double-blind experiment". Pediatrics 58 (2): 15466. PMID781610. [18] Feingold Association website: Who is the Nutrition Foundation? (http:/ / www. feingold. org/ nut. html) [19] Quackwatch website page (http:/ / www. quackwatch. org/ 01QuackeryRelatedTopics/ feingold. html) [20] Elisabeth Schafer, Iowa State University Professor, quoted in National Network for Child Care website (http:/ / www. nncc. org/ Nutrition/ hyper. html) [21] Weiss, Bernard (March 1982). "Food Additives and Environmental Chemicals as Sources of Childhood Behavior Disorders" (http:/ / www. feingold. org/ Research/ weiss. html). Journal of the American Academy of Child Psychiatry. 21 (2): 14452. doi:10.1016/S0002-7138(09)60913-4. PMID7069080. . [22] Rimland, Bernard (1983 JuneJuly). "The Feingold Diet: An Assessment of the Reviews by Mattes, by Kavale and Forness and Others" (http:/ / www. feingold. org/ Research/ rimland. html). Journal of Learning Disabilities. 16 (6): 3313. doi:10.1177/002221948301600605. PMID6886554. . [23] Lipton MA, Mayo JP (August 1983). "Diet and hyperkinesis--an update". J Am Diet Assoc 83 (2): 1324. PMID6875141. [24] Weiss, Bernard (1982). "Food additives and environmental chemicals as sources of childhood behavior disorders" (http:/ / www. feingold. org/ Research/ adhd. html#Weiss82). J Am Acad Child Psychiatry. 21 (2): 144152. doi:10.1016/S0002-7138(09)60913-4. PMID7069080. . [25] Rowe KS, Rowe KJ (1994). "Synthetic food coloring and behavior: A dose response effect in a double-blind, placebo-controlled, repeated-measures study". Journal of Pediatrics 125: 691698. doi:10.1016/S0022-3476(06)80164-2. PMID7965420. [26] Boris M., Mandel F.S. (1994). "Foods and additives are common causes of the attention deficit hyperactive disorder in children". Annals of Allergy 72 (5): 462468. PMID8179235. [27] Levy F, Dumbrell S, Hobbes G, Ryan M, Wilton N, Woodhill JM (January 1978). "Hyperkinesis and diet: a double-blind crossover trial with a tartrazine challenge". Medical Journal of Australia 1 (2): 614. PMID349320. [28] Wilson N, Scott A. (May 1989). "A double-blind assessment of additive intolerance in children using a 12-day challenge period at home". Clinical & Experimental Allergy 19 (3): 267272. doi:10.1111/j.1365-2222.1989.tb02382.x. PMID2736427. [29] Weiss, B. and Williams, J.H. and Margen, S. and Abrams, B. and Caan, B. and Citron, L.J. and Cox, C. and McKibben, J. and Ogar, D. and Schultz, S (March 1980). "Behavioral responses to artificial food colors". Science 207 (4438): 14871489. doi:10.1126/science.7361103. PMID7361103. [30] Williams, J.I. and Cram, D.M. and Tausig, F.T. and Webster, E. (June 1978). "Relative effects of drugs and diet on hyperactive behaviors: an experimental study". Pediatrics 61 (6): 811817. PMID353680. [31] Goyette, G.H. and Connors, C.K. and Petti, T.A. and Curtis, L.E. (April 1978). "Effects of artificial colors on hyperkinetic children: a double-blind challenge study" (http:/ / www. feingold. org/ Research/ adhd. html#Goyette). Psychopharmacol Bull 14 (2): 3940. PMID652927. . [32] Rowe KS (1988). "Synthetic food colourings and "hyperactivity': A double-blind crossover study". Australian Pediatrics 24 (2): 143147. PMID3395307. [33] Swanson, J. and Kinsbourne, M. (March 1980). "Food Dyes Impair Performance of Hyperactive Children on a Laboratory Learning Test". Science 207 (4438): 14851487. doi:10.1126/science.7361102. PMID7361102. [34] Pollock, I. and Warner, J.O. (January 1990). "Effect of artificial food colours on childhood behaviour". Arch Dis Child 65 (1): 7477. doi:10.1136/adc.65.1.74. PMC1792406. PMID2301986. [35] Egger, J. and Carter, C.M. and Soothill, J.F. and Wilson, J. (January 1989). "Oligoantigenic diet treatment of children with epilepsy and migraine". Journal of Pediatrics 114 (1): 5158. doi:10.1016/S0022-3476(89)80600-6. PMID2909707. [36] Center for Science in the Public Interest, Quarter-Century Review, pg.11 (http:/ / www. cspinet. org/ new/ adhd_resch_bk02. pdf) [37] Conners CK, Goyette CH, Southwick DA, Lees JM, Andrulonis PA. (August 1976). "Food additives and hyperkinesis: a controlled double-blind experiment". Pediatrics 58 (2): 15466. PMID781610. [38] Williams JI, Cram DM, Tausig FT, Webster E. (June 1978). "Relative effects of drugs and diet on hyperactive behaviors: an experimental study". Pediatrics 61 (6): 8117. PMID353680. [39] Swanson JM, Kinsbourne M. (March 1980). "Food dyes impair performance of hyperactive children on a laboratory learning test". Science 207 (4438): 14857. doi:10.1126/science.7361102. PMID7361102. [40] Harley, J.P. and Ray, R.S. and Tomasi, L. and Eichman, P.L. and Matthews, C.G. and Chun, R. and Cleeland, C.S. and Traisman, E. (June 1978). "Hyperkinesis and food additives: testing the Feingold hypothesis". Pediatrics 61 (6): 818828. PMID353681. [41] Wender EH, Lipton MA. The National Advisory Committee Report on Hyperkinesis and Food Additives -- Final Report to the Nutrition Foundation. Washington D.C: The Nutrition Foundation, 1980. [42] Gross, M.D. and Tofanelli, R.A. and Butzirus, S.M. and Snodgrass, E.W. (January 1987). "The effect of diets rich in and free from additives on the behavior of children with hyperkinetic and learning disorders" (http:/ / www. feingold. org/ Research/ PDFstudies/ Gross87. pdf) (PDF). Journal of the American Academy of Child and Adolescent Psychiatry 26 (1): 5355. doi:10.1097/00004583-198701000-00011. PMID3584001. .
127
Feingold diet
[43] Egger J, Carter CM, Graham PJ, Gumley D, Soothill JF (1985). "Controlled trial of oligoantigenic treatment in the hyperkinetic syndrome". Lancet 1 (8428): 5405. doi:10.1016/S0140-6736(85)91206-1. PMID2857900. [44] Kaplan BJ, McNicol J, Conte RA, Moghadam HK (1989). "Dietary replacement in preschool-aged hyperactive boys". Pediatrics 83 (1): 717. PMID2909977. [45] Egger J, Carter CH, Soothill JF, Wilson J. (1992). "Effect of diet treatment on enuresis in children with migraine or hyperkinetic behavior". Clinical Pediatrics. 31 (5): 3027. doi:10.1177/000992289203100508. PMID1582098. [46] Carter CM, Urbanowicz M, Hemsley R, Mantilla L, Strobel S, Graham PJ, Taylor E. (1993). "Effects of a few food diet in attention deficit disorder". Archives of Disease in Childhood. 69 (5): 5648.. doi:10.1136/adc.69.5.564. PMC1029619. PMID8257176. [47] Schoenthaler SJ, Doraz WE, Wakefield JA. (1986). "The Impact of a Low Food Additive and Sucrose Diet on Academic Performance in 803 New York City Public Schools" (http:/ / www. feingold. org/ Research/ research_school. html). International Journal of Biosocial Research 8 (2): 185195. . [48] Schoenthaler SJ, Doraz WE, Wakefield J. (1986). "The Testing of Various Hypothesis as Explanations for the Gains in National Standardized Academic Test Scores in the 1978-1983 New York City Nutrition Policy Modification Project". The International Journal of Biosocial Research. 8 (2): 196203.. [49] http:/ / www. feingold. org/ Research/ uhlig-pic. html [50] Uhlig T, Merkenschlager A, Brandmaier R, Egger J. (1997). "Topographic mapping of brain electrical activity in children with food-induced attention deficit hyperkinetic disorder". European Journal of Pediatrics. 156 (7): 55761. doi:10.1007/s004310050662. PMID9243241. [51] Schmidt MH, Mocks P, Lay B, Eisert HG, Fojkar R, Fritz-Sigmund D, Marcus A, Musaeus B. (1997). "Does oligoantigenic diet influence hyperactive/conduct-disordered children--a controlled trial". European Child & Adolescent Psychiatry. 6 (2): 8895. PMID9257090. [52] Peter C, Bennett W, Brostoff J. (1997). "The Health of Criminals Related to Behaviour, Food, Allergy and Nutrition: A Controlled Study of 100 Persistent Young Offenders" (http:/ / www. feingold. org/ Research/ PDFstudies/ Peter97. pdf) (PDF). Journal of Nutritional & Environmental Medicine. 7 (4): 359366. doi:10.1080/13590849762493. . [53] Peter C, Bennett W, McEwen, LM, McEwen HC, ROSE, EL. (1997). "The Shipley project: Treating food allergy to prevent criminal behavior in community settings" (http:/ / www. feingold. org/ Research/ PDFstudies/ Peter98. pdf) (PDF). Journal of Nutritional & Environmental Medicine. 8 (1): 778. . [54] Bateman B, Warner JO, Hutchinson E, Dean T, Rowlandson P, Gant C, Grundy J, Fitzgerald C, Stevenson J. (2004). "The effects of a double blind, placebo controlled, artificial food colourings and benzoate preservative challenge on hyperactivity in a general population sample of preschool children". Archives of Disease in Childhood. 89 (6): 50611. doi:10.1136/adc.2003.031435. PMC1719942. PMID15155391. [55] McCann D, Barrett A, Cooper A, et al. (November 2007). "Food additives and hyperactive behaviour in 3-year-old and 8/9-year-old children in the community: a randomised, double-blinded, placebo-controlled trial". Lancet 370 (9598): 15607. doi:10.1016/S0140-6736(07)61306-3. PMID17825405. [56] Swain AR, Dutton SP, Truswell AS (August 1985). "Salicylates in foods.". Journal of the American Dietetic Association. 85 (8): 95060.. PMID4019987. [57] "Food Intolerance Network" (http:/ / www. fedupwithfoodadditives. info/ information/ Swain et al 1985. pdf) (PDF). . Retrieved 2008-03-31. [58] Dumbrell, S. and Woodhill, J.M. and Mackie, L. and Leelarthaepin, B. (December 1978). "Is the Australian version of the Feingold diet safe?". The Medical Journal of Australia 2 (12): 569570. PMID364258. [59] Harper, P.H. and Goyette, C.H. and Conners, C.K. (November 1978). "Nutrient intakes of children on the hyperkinesis diet". Journal of the American Dietetic Association 73 (5): 515519. PMID701681. [60] The Feingold Association of the United States (2006). "Feingold Program - Symptoms" (http:/ / web. archive. org/ web/ 20061002063332/ http:/ / www. feingold. org/ symptom-pg. html). The Feingold Association website. The Feingold Association of the United States. Archived from the original (http:/ / www. feingold. org/ symptom-pg. html) on 2006-10-02. . Retrieved 2006-08-21. [61] Schab DW, Trinh NH. (December 2004). "Do artificial food colors promote hyperactivity in children with hyperactive syndromes? A meta-analysis of double-blind placebo-controlled trials". Journal of Developmental and Behavioral Pediatrics 25 (6): 42334. doi:10.1097/00004703-200412000-00007. PMID15613992. [62] Jimnez-Aranda GS, Flores-Sandoval G, Gmez-Vera J, Orea-Solano M. (Nov-Dec 1996). "Prevalence of chronic urticaria following the ingestion of food additives in a third tier hospital". Revista Alergia Mexico 43 (6): 1526. PMID9053127. [63] Egger J, Carter CH, Soothill JF, Wilson J. (May 1992). "Effect of diet treatment on enuresis in children with migraine or hyperkinetic behavior". Clinical Pediatrics 31 (5): 3027. doi:10.1177/000992289203100508. PMID1582098. [64] Schmidt MH, Mcks P, Lay B, Eisert HG, Fojkar R, Fritz-Sigmund D, Marcus A, Musaeus B. (June 1997). "Does oligoantigenic diet influence hyperactive/conduct-disordered children--a controlled trial.". European Child & Adolescent Psychiatry 6 (2): 8895. PMID9257090. [65] Novembre E, Dini L, Bernardini R, Resti M, Vierucci A. (Jan-Feb 1992). "Unusual reactions to food additives". Medical and Surgical Pediatrics 14 (1): 3942. PMID1579515. [66] Wasowka-Krlikowska K, Dynowski J, Godzisz J. (December 1998). "The way of nutrition and frequency of otitis media in hospitalized infants and 3-year-old children". Polski Merkuriusz Lekarski 5 (30): 3334. PMID10101517. [67] Moneret-Vautrin DA. (May 2003). "Allergic and pseudo-allergic reactions to foods in chronic urticaria". Annales de dermatologie et de vnrologie 130 Spec No 1: 1S3542. PMID12843808.
128
Feingold diet
[68] Feingold BF. (1979). "Dietary management of nystagmus". Journal of Neural Transmission 45 (2): 10715. doi:10.1007/BF01250086. PMID469522. [69] Inomata N, Osuna H, Fujita H, Ogawa T, Ikezawa Z. (June 2006). "Multiple chemical sensitivities following intolerance to azo dye in sweets in a 5-year-old girl". Allergology International 55 (2): 2035. doi:10.2332/allergolint.55.203. PMID17075259. [70] Spector SL, Wangaard CH, Farr RS. (December 1979). "Aspirin and concomitant idiosyncrasies in adult asthmatic patients". Journal of Allergy & Clinical Imunology 64 (6 Pt 1): 5006. doi:10.1016/0091-6749(79)90059-9. PMID512268. [71] Egger J, Carter CM, Soothill JF, Wilson J. (January 1989). "Oligoantigenic diet treatment of children with epilepsy and migraine". The Journal of Pediatrics 114 (1): 518. doi:10.1016/S0022-3476(89)80600-6. PMID2909707. [72] Feingold, B.F. (1985). Why Your Child is Hyperactive. Random House. ISBN0-394-73426-2. [73] Feingold, B.F. (1979). The Feingold Cookbook for Hyperactive Children. Random House. ISBN0-394-73664-8. [74] The Feingold Association of the United States (2006). "The Feingold Program" (http:/ / www. feingold. org/ materials-pg. html). The Feingold Association website. The Feingold Association of the United States. . Retrieved 2006-04-29. [75] Hersey, Jane; Robert C. Lawlor (2006). Why Can't My Child Behave? (http:/ / www. feingold. org/ book. html) (4th printing ed.). Williamsburg, VA: Pear Tree Press. ISBN0-9651105-0-8. .
129
External links
The Feingold Association website (http://www.feingold.org/) NIH Consensus Statement on ADHD (http://www.ajcn.org/content/37/1/161.full.pdf) 1982 Treatment alternatives for Attention-Deficit/Hyperactivity Disorder. (http://www.feingold.org/Research/ arnold.html) L.E. Arnold, Journal of Attention Disorders, Vol. 3, No. 1, April 1999, pp. 30-48 American Academy of Pediatrics Guideline for Diagnosis and Evaluation of the Child With ADHD (http://www. pediatrics.org/cgi/content/abstract/105/5/1158) 2000 Psychopharmacological and Other Treatments in Preschool Children with ADHD: Current Evidence and Practice (http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2935821/pdf/cap.2008.022.pdf/) J.K. Ghuman et al, J of Child & Adolescent Psychopharmacology, Vol.18, No.5, 2008
Allergen immunotherapy
130
Allergen immunotherapy
Allergen immunotherapy
Intervention ICD-10-PCS Z51.6 [1] ICD-9-CM MeSH 99.12 D003888 [2]
Allergen immunotherapy (also termed hyposensitization therapy, immunologic desensitization, hyposensibilization, or allergen-specific immunotherapy) is a form of immunotherapy for allergic disorders in which the patient is vaccinated with increasingly larger doses of an allergen (substances to which they are allergic) with the aim of inducing immunologic tolerance. Allergen specific immunotherapy is the only treatment strategy which treats the underlying cause of the allergic disorder. It is a highly cost-effective treatment strategy which results in an improved quality of life and a reduction in allergic- and allergen-related asthma, as well as a reduction in days off school/work.[3] Immunotherapy has been shown to produce long-term remission of allergic symptoms,[4] reduce severity of associated asthma, as well as reduce the chances of new sensitisations to allergens developing. This is achieved via immunotherapy modulating the immune system response to allergens.[5] Allergen immunotherapy can either reduce the need for medication, severity of symptoms or eliminate hypersensitivity altogether. Therapy can be administered under the tongue (sublingually) or by injections under the skin (subcutaneous). Allergen-specific immunotherapy is the only known treatment option that is known to modify the allergy disease process (with a possible chance of curing the disease), whereas other therapies merely suppress the symptoms.[6] Subcutaneous injection immunotherapy has been shown to be a highly efficient treatment for allergic disease, but due to a rare serious side effect of anaphylaxis, its use is restricted to specialist centers. As a result there has been growing interest in the sublingual immunotherapy which can be safely administered at home.[7]
Background
Allergic rhinitis (an allergic inflammation of the nasal airways) is an extremely common disorder. For example in the UK 1 in 5 people have allergic rhinitis with approximately 50 percent of those with allergic rhinitis being allergic to grass pollen. Over half of people receiving symptom based treatments report that they benefit poorly or only partially from symptomatic based treatments. For these patients immunodesensitisation therapy can be recommended. Subcutaneous injection based immunotherapy is one effective route but is complicated by rare but serious side effects. As a result of these rare but serious side effects the sublingual route for allergen vaccination immunotherapy is gaining increasing popularity among allergy specialists due to its lack of serious side effects.[8] Immunotherapy administered through cutaneous injections or sublingually has substantial empirical support. Numerous research articles and several meta-analytic studies support its clinical effectiveness. Immunotherapy can lead to a substantial decline in allergen symptomatology leading to a significant improvement in quality of life for allergy sufferers. Repeated courses of immuno-desensitisation leads to further reduction in allergy disease severity. Immunotherapy is superior to antihistamines and topical steroids in reducing severity of allergy symptoms and has been found to be a cost effective treatment strategy. Immunotherapy results in less time taken off work compared to those who rely solely on symptomatic relieving medications.[9][10] In the case of grass allergy immunotherapy the pollen from the grass species used has strong cross reactivity between the various grass species thus meaning that treatment leads to desensitisation to all grass species.[5]
Allergen immunotherapy Sublingual specific immunotherapy has the benefit of allowing treatment to be carried out in the home environment and has been found to be a cost effective treatment strategy for allergic disorders.[11][12] Sublingual immunotherapy cost effectiveness is significantly increased due to the reduced number of medical visits compared to those receiving subcutaneous injection based immunotherapy. For example, those receiving subcutaneous injections make almost seven times more visits than those receiving home based sublingual immunotherapy, as those receiving subcutaneous injections require frequent visits to doctors to receive their regular injections. Furthermore the sublingual route appears to be as effective as the subcutaneous route in trials of grass allergy.[5]
131
Allergen immunotherapy
132
Procedures
For benefits to be felt from either sublingual or injection based allergen specific immunotherapy it needs to be started 2 4 months before the start of the allergen season in the case of seasonal allergies. The earlier it is started the better the level of allergy protection.[26] Subcutaneous immunotherapy (SCIT) Immunotherapy via the subcutaneous route involves the use of small hypodermic syringes which are used to inject commercial allergen extracts. Injections are normally given into the loose tissue over the back of the upper arm, half way between the shoulder and elbow. Injections are given under the skin ("subcutaneous"). This is the least painful place to inject allergen, as there are few nerve endings in the skin. When given correctly, the injections should be only slightly uncomfortable. They are not normally painful and are usually well tolerated by adults and teenagers. Some doctors may advise you to take an antihistamine a few hours before each injection to reduce the likelihood of local discomfort and other side-effects. Allergy injections are started at very low doses. The dose is gradually increased on a regular (and usually weekly) basis, until a "maintenance" dose is reached. This usually means four to six months of weekly injections to reach the maintenance dose. Once the maintenance dose is reached, the injections are administered less often (every two to four weeks), still on a regular basis. Maintenance injections are normally given once per month for a few years. Generally, the longer the treatment and the higher the dose, the greater the therapeutic benefit.
Allergen immunotherapy After successful completion of immunotherapy, long-term protection can be expected for a period of 35 years or more. Therapy can be repeated should symptoms begin to return or if the individual becomes exposed to new allergens that were not included in the previous treatment regimen. Because allergy vaccine injections have a strong evidence base for clinical effectiveness, this form of treatment is covered by the vast majority of insurance companies in the United States. Intralymphatic immunotherapy (ILIT) Intralymphatic delivery of immunotherapy is another modality which is effective in the treatment of allergic disorders.[27] Intralymphatic immunotherapy (ILIT) administers allergens directly into a subcutaneous lymph node;[28] A paper in 2009 found that studies on both animals and humans demonstrated that a direct injection into lymph nodes enhanced the immune responses to protein, peptide, and naked DNA vaccines and that this increased response meant that the overall allergen dosage and therapy duration could be reduced.[29] A study on mice found that intralymphatic immunisation induced a more than 10-fold higher IgG2a response with 100-fold lower allergen doses than subcutaneous immunisation; and that only intralymphatic immunisation stimulated the production of the Th1-dependent subclass IgG2a, which is associated with improved protection against allergen-induced anaphylaxis.[30] ILIT is well tolerated and patients found it to be "practically painless" and easy to perform. Patient compliance with ILIT was improved as compared with SCIT.[29] Sublingual immunotherapy (SLIT) In some countries, particularly in Europe, there is a strong tradition of undertaking immunotherapy using oral vaccines or sublingual drops. While there has been some interesting research in this area in recent years, the effectiveness of this form of treatment is difficult to compare with standard injected immunotherapy. Double-blind, placebo-controlled studies in Europe using high-dose sublingual immunotherapy have shown benefit.[31] Some practitioners in the United States, particularly ENT physicians, offer sublingual immunotherapy as another immunotherapy option. Sublingual immunotherapy is a safe and effective alternative to injection based immunotherapy and can be administered in the home environment. Modest benefits have been demonstrated within the first season of therapy.[32] Treatment needs to be continued for at least 3 years to achieve maximum effectiveness in immune desensitisation to the allergen.[33] In the case of sublingual immunotherapy there is no need to do a titrated graduated updose and therapy is generally started at the usual clinical dose.[5] Transcutaneous immunotherapy (TCIT) / Epicutaneous immunotherapy (ELIT) This emerging therapy administers allergen by a skin patch. Though relatively new, clinical trials show that TCIT, EPIT is safe and comparably effective to conventional immunotherapy.[28]
133
Allergen immunotherapy
134
A relatively large but normative localized reaction to an allergy injection on the upper arm of a patient. This reaction would not cause concern, but larger reactions may require a readjustment of the treatment regimen.
About 74% of systemic reactions to SCIT are mild reactions such as cutaneous or upper respiratory symptoms; about 23% are moderate reactions such as asthma with reduced lung function, and about 3% are severe, where life-threatening airway compromising or hypo-tension occurs.[38] Based on the highest reported symptoms of a systemic reaction, such as generalized itching, upper airway itchiness, coughs, or a shortness of breath should be reported immediately so they can be monitored or managed.[34] These are usually managed through the use of epinephrine. If such reactions occur, the allergy specialist will adjust the dosage to a safe level. The risk of a systemic reaction is reduced if the patient avoids exercising or overheating for a few hours before and after the procedure. Some heart and blood pressure medications such as beta-blockers are contraindicated as well. The physician should be consulted if the patient notices a worsening of allergy symptoms or if he or she is suffering from a cold or has been undergoing a different kind of vaccination procedure. Immunotherapy does not increase the risk of contracting a cold. Sublingual immuno-therapy (SLIT) The side effects of sublingual desensitisation therapy are generally mild and limited to local reactions. Common side effects include oral pruritus, edema mouth, ear pruritus, throat irritation, sneezing, mild itching and swelling of the mouth. Side effects which are less common or rare include headache, oral paraesthesia, eye pruritus, conjunctivitis, cough, asthma, pharyngitis, rhinorrhoea, nasal congestion, rhinitis, throat tightness, pruritus and fatigue. In most cases these side effects diminished minutes or hours after immunotherapy and disappeared 1 7 days after commencement of therapy. As a precautionary measure against rare but serious side effects e.g. asthma attacks it is recommended that the first sublingual tablet containing the specific allergen for immunotherapy is administrated whilst under the observation of a medical doctor and observed for 30 minutes for any signs of serious side effects.[5][39] Sublingual immunotherapy is contraindicated in patients who have systemic diseases of the immune system, inflammatory conditions of the oral cavity with associated severe symptoms e.g. oral lichen planus with ulcers or severe oral mycosis or individuals with severe and uncontrolled asthma. Immunotherapy tablets are also
Allergen immunotherapy contraindicated in individuals who are allergic to any of the addition constituents of the tablet.[5]
135
Insurance Issues
Immunotherapy is one of the least-covered areas under most insurance plans. In the USA, sublingual immunotherapy is considered an "off-use" practice and is not approved by the FDA and therefore not covered by almost all insurers. Most insurers only cover immunotherapy if it is considered "medically necessary." The criteria for necessity generally require a history of allergic asthma, stinging insect allergy, and or severe reactivity. In the UK, injection immunotherapy is only covered for severe allergies and never for multiple allergies. For many government programs, including Healthy San Francisco, immunotherapy is not covered under any circumstances, including severe chronic asthma. Quality-of-life allergic rhinitis such as seasonal allergies, pet dander allergies often remain uncovered and undiagnosed.
References
[1] http:/ / apps. who. int/ classifications/ icd10/ browse/ 2010/ en#/ Z51. 6 [2] http:/ / www. nlm. nih. gov/ cgi/ mesh/ 2011/ MB_cgi?field=uid& term=D003888 [3] Nasser S, Vestenbaek U, Beriot-Mathiot A, Poulsen PB (December 2008). "Cost-effectiveness of specific immunotherapy with Grazax in allergic rhinitis co-existing with asthma" (http:/ / www3. interscience. wiley. com/ resolve/ openurl?genre=article& sid=nlm:pubmed& issn=0105-4538& date=2008& volume=63& issue=12& spage=1624). Allergy 63 (12): 16249. doi:10.1111/j.1398-9995.2008.01743.x. PMID19032235. . [4] Frew AJ (Feb 2010). "Allergen immunotherapy". Journal of Allergy Clinical Immunology 125 (2 Suppl 2): S30613. doi:10.1016/j.jaci.2009.10.064. PMID20176266. [5] Caldern M, Brandt T (December 2008). "Treatment of grass pollen allergy: focus on a standardized grass allergen extract Grazax". Ther Clin Risk Manag 4 (6): 125560. PMC2643106. PMID19337432. [6] Durham SR, Yang WH, Pedersen MR, Johansen N, Rak S (April 2006). "Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis" (http:/ / linkinghub. elsevier. com/ retrieve/ pii/ S0091-6749(06)00291-0). J. Allergy Clin. Immunol. 117 (4): 8029. doi:10.1016/j.jaci.2005.12.1358. PMID16630937. . [7] Kay AB (December 2007). "An extract of Timothy-grass pollen used as sublingual immunotherapy for summer hay fever" (http:/ / journals. prous. com/ journals/ servlet/ xmlxsl/ pk_journals. xml_summaryn_pr?p_JournalId=4& p_RefId=1162079). Drugs Today 43 (12): 8418. doi:10.1358/dot.2007.43.12.1162079. PMID18174969. . [8] Bmj, Group (February 2008). "Grazax for hay fever?" (http:/ / dtb. bmj. com/ cgi/ pmidlookup?view=long& pmid=18256175). Drug Ther Bull 46 (2): 910. doi:10.1136/dtb.2008.01.0001. PMID18256175. . [9] Rak S, Yang WH, Pedersen MR, Durham SR (March 2007). "Once-daily sublingual allergen-specific immunotherapy improves quality of life in patients with grass pollen-induced allergic rhinoconjunctivitis: a double-blind, randomised study". Qual Life Res 16 (2): 191201. doi:10.1007/s11136-006-9110-3. PMID17033900. [10] Bachert C, Vestenbaek U, Christensen J, Griffiths UK, Poulsen PB (May 2007). "Cost-effectiveness of grass allergen tablet (GRAZAX) for the prevention of seasonal grass pollen induced rhinoconjunctivitis - a Northern European perspective" (http:/ / www3. interscience. wiley. com/ resolve/ openurl?genre=article& sid=nlm:pubmed& issn=0954-7894& date=2007& volume=37& issue=5& spage=772). Clin. Exp. Allergy 37 (5): 7729. doi:10.1111/j.1365-2222.2007.02706.x. PMID17456225. . [11] Canonica GW, Poulsen PB, Vestenbaek U (September 2007). "Cost-effectiveness of GRAZAX for prevention of grass pollen induced rhinoconjunctivitis in Southern Europe" (http:/ / linkinghub. elsevier. com/ retrieve/ pii/ S0954-6111(07)00190-4). Respir Med 101 (9): 188594. doi:10.1016/j.rmed.2007.05.003. PMID17611095. . [12] Poulsen PB, Pedersen KM, Christensen J, Vestenbaek U (January 2008). "[Economic evaluation of a tablet-based vaccination against hay fever in Denmark]" (in Danish). Ugeskr. Laeg. 170 (3): 13842. PMID18208729. [13] World Allergy Organization | Allergic Diseases Resource Center (http:/ / www. worldallergy. org/ professional/ allergic_diseases_center/ ige/ ) [14] Ibaez MD, Kaiser F, Knecht R et al (September 2007). "Safety of specific sublingual immunotherapy with SQ standardized grass allergen tablets in children" (http:/ / www3. interscience. wiley. com/ resolve/ openurl?genre=article& sid=nlm:pubmed& issn=0905-6157& date=2007& volume=18& issue=6& spage=516). Pediatr Allergy Immunol 18 (6): 51622. doi:10.1111/j.1399-3038.2007.00556.x. PMID17680910. . [15] Durham SR, Riis B (August 2007). "Grass allergen tablet immunotherapy relieves individual seasonal eye and nasal symptoms, including nasal blockage" (http:/ / www3. interscience. wiley. com/ resolve/ openurl?genre=article& sid=nlm:pubmed& issn=0105-4538& date=2007& volume=62& issue=8& spage=954). Allergy 62 (8): 9547. doi:10.1111/j.1398-9995.2007.01402.x. PMID17620075. . [16] Introduction: Allergic Reactions: Merck Manual Home Edition (http:/ / www. merck. com/ mmhe/ sec16/ ch185/ ch185a. html?qt=immunotherapy& alt=sh#N38898)
Allergen immunotherapy
[17] Dahl R, Stender A, Rak S (February 2006). "Specific immunotherapy with SQ standardized grass allergen tablets in asthmatics with rhinoconjunctivitis" (http:/ / www3. interscience. wiley. com/ resolve/ openurl?genre=article& sid=nlm:pubmed& issn=0105-4538& date=2006& volume=61& issue=2& spage=185). Allergy 61 (2): 18590. doi:10.1111/j.1398-9995.2005.00949.x. PMID16409194. . [18] Dahl R, Kapp A, Colombo G et al (February 2008). "Sublingual grass allergen tablet immunotherapy provides sustained clinical benefit with progressive immunologic changes over 2 years" (http:/ / linkinghub. elsevier. com/ retrieve/ pii/ S0091-6749(07)02166-5). J. Allergy Clin. Immunol. 121 (2): 512518.e2. doi:10.1016/j.jaci.2007.10.039. PMID18155284. . [19] Bufe A, Eberle P, Franke-Beckmann E et al (January 2009). "Safety and efficacy in children of an SQ-standardized grass allergen tablet for sublingual immunotherapy" (http:/ / linkinghub. elsevier. com/ retrieve/ pii/ S0091-6749(08)01921-0). J. Allergy Clin. Immunol. 123 (1): 167173.e7. doi:10.1016/j.jaci.2008.10.044. PMID19130937. . [20] Hirata H, Arima M, Yukawa T (2000). "Effect of rush immunotherapy (RIT) on cytokine production in hymenoptera allergy". Dokkyo J Med Sci 27 (1): 2740. [21] Del Prete G, Maggi E, Parronchi P et al (June 1988). "IL-4 is an essential factor for the IgE synthesis induced in vitro by human T cell clones and their supernatants" (http:/ / www. jimmunol. org/ cgi/ pmidlookup?view=long& pmid=2967330). J. Immunol. 140 (12): 41938. PMID2967330. . [22] Punnonen J, Aversa G, Cocks BG et al (April 1993). "Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells". Proc. Natl. Acad. Sci. U.S.A. 90 (8): 37304. doi:10.1073/pnas.90.8.3730. PMC46375. PMID8097323. [23] Akdis CA, Blesken T, Akdis M, Wthrich B, Blaser K (July 1998). "Role of interleukin 10 in specific immunotherapy". J. Clin. Invest. 102 (1): 98106. doi:10.1172/JCI2250. PMC509070. PMID9649562. [24] Konno S, Golden DB, Schroeder J, Hamilton RG, Lichtenstein LM, Huang SK (May 2005). "Increased expression of osteopontin is associated with long-term bee venom immunotherapy" (http:/ / linkinghub. elsevier. com/ retrieve/ pii/ S0091674905002265). J. Allergy Clin. Immunol. 115 (5): 10637. doi:10.1016/j.jaci.2005.01.055. PMID15867867. . [25] Pereira-Santos MC, Baptista AP, Melo A et al (February 2008). "Expansion of circulating Foxp3+D25bright CD4+ T cells during specific venom immunotherapy" (http:/ / www3. interscience. wiley. com/ resolve/ openurl?genre=article& sid=nlm:pubmed& issn=0954-7894& date=2008& volume=38& issue=2& spage=291). Clin. Exp. Allergy 38 (2): 2917. doi:10.1111/j.1365-2222.2007.02887.x. PMID18070166. . [26] Calderon MA, Birk AO, Andersen JS, Durham SR (August 2007). "Prolonged preseasonal treatment phase with Grazax sublingual immunotherapy increases clinical efficacy" (http:/ / www3. interscience. wiley. com/ resolve/ openurl?genre=article& sid=nlm:pubmed& issn=0105-4538& date=2007& volume=62& issue=8& spage=958). Allergy 62 (8): 95861. doi:10.1111/j.1398-9995.2007.01416.x. PMID17620076. . [27] Juillard, Guy. "Intralymphatic Injection of Immunogenic Material in Afferant Lymphatic Vessel: A Method of Choice" (http:/ / www. ilitherapy. com/ ), accessed June 29, 2011. [28] Kndig, TM (Jul 2011). "Immunotherapy concepts under investigation". Allergy 66 (Suppl 95): 602. doi:10.1111/j.1398-9995.2011.02643.x. PMID21668859. [29] Senti G, Johansen P, Kndig TM. (Dec 2009). "Intralymphatic immunotherapy". Current Opinion in Allergy and Clinical Immunology 9 (6): 53743. doi:10.1097/ACI.0b013e3283310ff7. PMID19680119. [30] Martnez-Gmez JM, Johansen P, Erdmann I, Senti G, Crameri R, Kndig TM. (Apr 2009). "Intralymphatic injections as a new administration route for allergen-specific immunotherapy". The International Archives of Allergy and Immunology. 150 (1): 5965. doi:10.1159/000210381. PMID19339803. [31] Smith H, White P, Annila I, Poole J, Andre C, Frew A (October 2004). "Randomized controlled trial of high-dose sublingual immunotherapy to treat seasonal allergic rhinitis" (http:/ / linkinghub. elsevier. com/ retrieve/ pii/ S0091674904022316). J. Allergy Clin. Immunol. 114 (4): 8317. doi:10.1016/j.jaci.2004.06.058. PMID15480323. . [32] Allison C, Fraser J (November 2007). "Grazax: an oral vaccine for the treatment of grass pollen allergy (hay fever)". Issues Emerg Health Technol (107): 14. PMID18041171. [33] Svendsen UG (January 2008). "[Grazaxtreatment for grass pollen hay fever]" (in Danish). Ugeskr. Laeg. 170 (3): 1357. PMID18208728. [34] Phillips JF, Lockey RF, Fox RW, Ledford DK, Glaum MC. (July 2011). "Systemic reactions to subcutaneous allergen immunotherapy and the response to epinephrine". Allergy and Asthma Proceedings 32 (4): 28894. doi:10.2500/aap.2011.32.3446. PMID21781404. [35] Rank MA, Oslie CL, Krogman JL, Park MA, Li JT (Jul-Aug 2008). "Allergen immunotherapy safety: characterizing systemic reactions and identifying risk factors". Allergy and Asthma Proceedings 29 (4): 4005. doi:10.2500/aap.2008.29.3141. PMID18702889. [36] Greineder DK (Dec 1996). "Risk management in allergen immunotherapy". Journal of Allergy and Clinical Immunology 98 (6 Part 3): S3304. PMID8977545. [37] Fernndez-Tvora L, Justicia JL, Moreno C, Tabar AI, Vidal C. (Jul 2011). "Safety evaluation of rapid build-up schedules with IR-standardized allergen extracts for subcutaneous immunotherapy of allergic respiratory diseases". Expert Opinion on Drug Safety [Epub ahead of print] 10 (6): 94755. doi:10.1517/14740338.2011.603724. PMID21770817. [38] Bernstein DI, Epstein T, Murphy-Berendts K, Liss GM (Jun 2010). "Surveillance of systemic reactions to subcutaneous immunotherapy injections: year 1 outcomes of the ACAAI and AAAAI collaborative study". Annals of Allergy, Asthma, and Immunology 104 (6): 5305. doi:10.1016/j.anai.2010.04.008. PMID20568387. [39] Dahl R, Kapp A, Colombo G et al (August 2006). "Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis" (http:/ / linkinghub. elsevier. com/ retrieve/ pii/ S0091-6749(06)01135-3). J. Allergy Clin. Immunol. 118 (2):
136
Allergen immunotherapy
43440. doi:10.1016/j.jaci.2006.05.003. PMID16890769. .
137
External links
"American Academy of Allergy, Asthma, and Immunology" (http://www.aaaai.org/patients.stm) information and articles of interest. "American College of Allergy, Asthma, and Immunology" (http://www.acaai.org) information and articles of interest. "American Board of Allergy and Immunology" (http://www.abai.org) American Board of Allergy and Immunology "Allergies" (http://health.rutgers.edu/brochures/allergies.htm), from Rutgers.edu "Allergy shots, allergy immunotherapy" (http://www.asthmahelpline.com/allergy-shots.htm) FAQs on Allergy Immunotherapy. D'Souza MF, Pepys J, Wells ID et al (June 1973). "Hyposensitization with Dermatophagoides pteronyssinus in house dust allergy: a controlled study of clinical and immunological effects". Clin. Allergy 3 (2): 17793. doi:10.1111/j.1365-2222.1973.tb01320.x. PMID4131252.
Sublingual immunotherapy
Sublingual Immunotherapy is method of allergy treatment that uses an allergen solution given under the tongue, which over the course of treatment, reduces sensitivity to allergens. Sublingual immunotherapy, or SLIT, has a very good safety profile and is given at home in adults and children.[1] As more patients are treated with SLIT, additional side effects are being studied. A serious anaphylactic reaction occurred in a patient being treated with multiple allergens prepared from commercially available US extracts.[2] The basis of sublingual immunotherapy is treatment of the underlying allergic sensitivity. Allergic symptoms improve as the allergic sensitivity improves. As a safe and effective method of treating the underlying disease, sublingual immunotherapy is capable of modifying the natural progression of allergic disease which can begin with allergic food sensitivities and eczema in young children and progress through allergic rhinitis and asthma in older children and adults. A recent study, published in Allergy 2007: 62: 943948, showed that a 3-year course of Sub-cutaneous immunotherapy had long-term clinical effects, by significantly reducing the development of asthma in children with allergic rhinoconjunctivitis up to 7 years after treatment. In a recent review of ALL studies on SLIT by the American Academy of Allergy, Asthma and Immunology published in Journal of Allergy and Clinical Immunology, 2007: 6: 1466-1468, 35% of studies resulted in significant reductions in medications and symptom scores but 38% of studies found no significant benefit from SLIT. When SLIT did work, it was typically less effective than with conventional subcutaneous injection immunotherapy and sometimes SLIT took two years to show significant clinical benefit.
Sublingual immunotherapy
138
Mechanism
Sublingual immunotherapy is taken as drops or tablets, placed under the tongue 3 or more times/week, containing a specific allergen which interacts with the immune system to decrease allergic sensitivity. Commonly the allergen is taken once a day. The antigen persists on the mucosal surface and is taken up by dendritic cells which interact with T lymphocytes (T-cells). Sublingual immunotherapy takes advantage of each individuals ability to develop immunologic tolerance to non-pathogenic antigens such as those in foods and in resident bacteria. Consider the vast number of antigens we are exposed to every day which do not elicit an allergic response. Dendritic cells in the oral mucosa act as antigen presenting cells (APC) to T-cells in the cervical lymph nodes. This system modulates the allergic response by creating immune tolerance to antigens. The sublingual mucosa also has pro-inflammatory cells, such as mast cells, which is the reason that SLIT sometimes results in local reactions. The dose progression used is critical to the relative safety margin of sublingual therapy. Early in treatment, sublingual dendritic cells secrete interleukin 10 (IL-10) which induces regulatory T cells to inhibit the inflammatory response.[3] Long term changes that occur with immunotherapy include a decrease in mast cell sensitivity and a decrease in IgE production by B-cells. With sublingual immunotherapy there is a decrease in the IgE/IgG4 and a decrease in the TH1/TH2 ratio. Allergic symptoms improve as the underlying basis of the allergic disease improves.
History
Specific immunotherapy has been practiced for almost 100 years. Classical immunotherapy by subcutaneous injection was demonstrated by Noon[4] and Freeman in 1911. The oral route of immunotherapy was suggested earlier in 1900 [5]. Clinical attempts to determine the best dose and route for allergy therapy increased dramatically in the 1920s and 1930s.[6] Injection of allergen became the standard therapy based in part on many scientific trials showing the effectiveness of that method for pollen, mold, dust mite, stinging insect, cat, and dog allergies. Injection therapy for foods resulted in a number of deaths and was abandoned by mid-century. Clinical use of sublingual immunotherapy for foods was described in 1969 by David Morris[7]. Recent preliminary reports of success in inducing tolerance to peanuts and a few other foods are promising, but still investigational. SLIT was reintroduced in 1970 for inhalant allergens.[8] Although some patients treated for food, pollen, pet dander and mold allergy by sublingual immunotherapy appeared to improve, the ideal dose, degree of expected improvement, and the mechanism by which improvement occurred was not established, and few studies were published in peer reviewed journals until the 1990s. Controlled clinical trials first in Italy and later in England and throughout Europe have clearly shown the effectiveness of SLIT in the treatment of allergic rhinitis and asthma when due to one pollen. A few studies have been published in the US. The mechanisms involved have been studied, and the ideal dose range for some items (for example Timothy grass) have been established. In general SLIT is about 1/2 to 2/3 as effective as subcutaneous injection therapy, when optimal doses of a single pollen are used. Studies involving patients who require treatment with multiple pollens have shown less efficacy, and there is more concern about safety when multiple items are included in the treatment plan as well. The practice of sublingual immunotherapy has been more available in Europe than in the United States. Concerns regarding the risks of oral and injection immunotherapy have always included death from anaphylaxis[9]. Because of the higher risks of injection therapy in the 1980s formal research into alternatives to injection therapy was supported in Europe. These studies demonstrated the relative safety and apparent effectiveness of sublingual immunotherapy, which resulted in widespread international acceptance of the method. In 1998 the World Health Organization concluded that sublingual immunotherapy was a viable alternative to the injection route and that its use in clinical practice is justified.[10] Public acceptance facilitated the publication of new research. Between 1990 and 2005 more
Sublingual immunotherapy than 40 controlled trials with non-injection routes were published in peer-reviewed journals.[11] Today in Europe, sublingual immunotherapy accounts for 40 percent of allergy treatment. In the United States, although sublingual immunotherapy is being tried by some practitioners of allergy it is considered an investigational therapy. There is no FDA approved product or protocol, and the procedure must be paid for directly by the patient because neither the safety nor the efficacy of the procedure is considered established. For example, current Medicare guidelines state "For antigens provided to patients on or after November 17, 1996, Medicare does not cover such antigens if they are to be administered sublingually, i.e., by placing drops under the patients tongue. This kind of allergy therapy has not been proven to be safe and effective. Antigens are covered only if they are administered by injection."[12] For more information on the current status of SLIT in the US visit AAAAI.ORG [13] or ACAAI.ORG [14].
139
Side Effects
Because sublingual drops are used several times per week, it is necessary to take them at home. This is in contrast to injection therapy, which is usually taken in a medically supervised setting due to the risks of anaphylaxis (about 1/2000) and death (about 1/2,500,000). In the early years of SLIT local sensitivities were reported in many patients (oral itching, intestinal disturbances) but these could usually be managed by dose adjustments. Although as of July 2009 no deaths have been reported from SLIT (and many millions of doses have been taken), numerous cases of anaphylaxis have now been reported. In one study, for example, sixty patients who ranged in age from 6 to 50 years were treated over a 90-day period with a progressive dose of dust mite antigens via SLIT. In this small study alone there were seven systemic reactions (meaning, atopy, a reaction that occurs through the whole body, not just where the allergen is applied). All reactions were associated with wheezing or worsening nasal symptoms, and one patient had angioedema and urticaria.[15] Sublingual immunotherapy is safe during pregnancy, as has been reported for the first time in a recent study in Allergy (European Journal of Allergy and Clinical Immunology),[16] This study also showed safety when sublingual immunotherapy is initiated for the first time in a pregnant patient.
Sublingual immunotherapy
140
References
[1] Gidaro G, Marcucci F, Sensi L, Incorvaia C, Frati F, Ciprandi G (2005). "The safety of sublingual-swallow immunotherapy: an analysis of published studies". Clin Exp Allergy 35 (5): 56571. doi:10.1111/j.1365-2222.2005.02240.x. PMID15898976. [2] Dunsky EH; Goldstein, MF; Dvorin, DJ; Belecanech, GA (2006). "Anaphylaxis to sublingual immunotherapy". Allergy 61 (10): 1235. doi:10.1111/j.1398-9995.2006.01137.x. PMID16942576. [3] Moingeon P, Batard T, Fadel R, Frati F, Sieber J, Van Overtvelt L (2006). "Immune mechanisms of allergen-specific sublingual immunotherapy". Allergy 61 (2): 15165. doi:10.1111/j.1398-9995.2006.01002.x. PMID16409190. [4] NOON L (1953). "Prophylactic inoculation against hay fever". Int Arch Allergy Appl Immunol 4 (4): 2858. doi:10.1159/000228032. PMID13096152. [5] Curtis HH. (1900) The immunizing cure of hayfever. Med News (NY);77:16-8. [6] Black JH. (1927) The oral administration of pollen. J Lab Clin Med;12:1156 [7] Morris D (1969). "Use of sublingual antigen in diagnosis and treatment of food allergy". Ann Allergy 27 (6): 28994. PMID5785921. [8] Morris D (1970). "Treatment of respiratory disease with ultra-small doses of antigens". Ann Allergy 28 (10): 494500. PMID5521180. [9] Reid M, Lockey R, Turkeltaub P, Platts-Mills T (1993). "Survey of fatalities from skin testing and immunotherapy 1985-1989". J Allergy Clin Immunol 92 (1 Pt 1): 615. doi:10.1016/0091-6749(93)90030-J. PMID8335856.. [10] Bousquet J, Lockey R, Malling H (1998). "Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper". J Allergy Clin Immunol 102 (4 Pt 1): 55862. doi:10.1016/S0091-6749(98)70271-4. PMID9802362. [11] Canonica G, Passalacqua G (2003). "Noninjection routes for immunotherapy". J Allergy Clin Immunol 111 (3): 43748; quiz 449. doi:10.1067/mai.2003.129. PMID12642818. [12] Medicare National Coverage Determinations Manual; Chapter 1, Part 2 (Sections 90 160.25), Page 14. Coverage Determinations (Rev. 45, 12-06-05)110.9 Antigens Prepared for Sublingual Administration (Rev. 1, 10-03-03)CIM 45-28 [13] http:/ / AAAAI. ORG [14] http:/ / ACAAI. ORG [15] Rodriguez-Perez, et al. Frequency of acute systemic reactions in patients with allergic rhinitis and asthma treated with sublingual immunotherapy. Annals of Allergy, Asthma and Immunology 2008; 101:304-310. [16] Shaikh WA, Shaikh SW. A prospective study on the safety of sublingual immunotherapy in pregnancy. Allergy 2012; 67 : 741-743.
External links
The World Allergy Organization (http://www.worldallergy.org) About.com Article on Sublingual Immunotherapy (http://allergies.about.com/od/allergyshots/a/slit.htm) PubMed article (http://www.ncbi.nlm.nih.gov/pubmed/15575924?dopt=Abstract)
141
142
143
144
License
145
License
Creative Commons Attribution-Share Alike 3.0 Unported //creativecommons.org/licenses/by-sa/3.0/